Colgate-Palmolive (CL) 10-K 20 Feb 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information Document (USD $)	12 Months Ended
In Billions, except Share data, unless otherwise specified	Dec. 31, 2013	Jan. 31, 2014	Jun. 30, 2013
Entity Information [Line Items]	'	'	'
Entity Registrant Name	'COLGATE PALMOLIVE CO	'	'
Entity Central Index Key	'0000021665	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Filer Category	'Large Accelerated Filer	'	'
Document Type	'10-K	'	'
Document Period End Date	31-Dec-13	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Amendment Flag	'false	'	'
Trading Symbol	'CL	'	'
Entity Common Stock, Shares Outstanding	'	918,943,637	'
Entity Well-known Seasoned Issuer	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Public Float	'	'	$53

Consolidated_Statements_of_Inc

Consolidated Statements of Income (USD $)	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Net sales	$17,420		$17,085		$16,734
Cost of sales	7,219		7,153		7,144
Gross profit	10,201	[1]	9,932	[2]	9,590
Selling, general and administrative expenses	6,223		5,930		5,758
Other (income) expense, net	422		113		-9
Operating profit	3,556		3,889		3,841
Interest (income) expense, net	-9		15		52
Income before income taxes	3,565		3,874		3,789
Provision for income taxes	1,155		1,243		1,235
Net income including noncontrolling interests	2,410	[3]	2,631	[4]	2,554
Net Income (Loss) Attributable to Noncontrolling Interest	169		159		123
Net income attributable to Colgate-Palmolive Company	$2,241	[3]	$2,472	[4]	$2,431
Earnings per common share, basic	$2.41	[3]	$2.60	[4]	$2.49
Earnings per common share, diluted	$2.38	[3]	$2.57	[4]	$2.47
[1]	Gross profit for the full year of 2013 includes $32 of charges related to the 2012 Restructuring Program and $15 of costs related to the sale of land in Mexico.
[2]	Gross profit for the full year of 2012 includes $2 of charges related to the 2012 Restructuring Program, $24 of costs related to the sale of land in Mexico and $5 of costs associated with various business realignment and other cost-saving initiatives.
[3]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2013 include $278 of aftertax charges related to the 2012 Restructuring Program, a $111 one-time aftertax charge for the impact of the devaluation in Venezuela, a $23 charge for a competition law matter in France related to the home care and personal care sectors and $12 of aftertax costs related to the sale of land in Mexico.
[4]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2012 include $70 of aftertax charges related to the 2012 Restructuring Program, $18 of aftertax costs related to the sale of land in Mexico and $14 of aftertax costs associated with various business realignment and other cost-saving initiatives.

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Net income including noncontrolling interests	$2,410	[1]	$2,631	[2]	$2,554
Other comprehensive income (loss), net of tax:	'		'		'
Cumulative translation adjustments	-166		-18		-305
Retirement Plan and other retiree benefit adjustments	318		-145		-108
Gains (losses) on available-for-sale securities	13		18		46
Gains (losses) on cash flow hedges	2		1		0
Total Other comprehensive income (loss), net of tax	167		-144		-367
Total Comprehensive income including noncontrolling interests	2,577		2,487		2,187
Less: Net income attributable to noncontrolling interests	169		159		123
Less: Cumulative translation adjustments attributable to noncontrolling interests	-3		2		-7
Total Comprehensive income attributable to noncontrolling interests	166		161		116
Total Comprehensive income attributable to Colgate-Palmolive Company	$2,411		$2,326		$2,071
[1]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2013 include $278 of aftertax charges related to the 2012 Restructuring Program, a $111 one-time aftertax charge for the impact of the devaluation in Venezuela, a $23 charge for a competition law matter in France related to the home care and personal care sectors and $12 of aftertax costs related to the sale of land in Mexico.
[2]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2012 include $70 of aftertax charges related to the 2012 Restructuring Program, $18 of aftertax costs related to the sale of land in Mexico and $14 of aftertax costs associated with various business realignment and other cost-saving initiatives.

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2013		Dec. 31, 2012
In Millions, unless otherwise specified
Current Assets	'		'
Cash and cash equivalents	$962		$884
Receivables (net of allowances of $67 and $61, respectively)	1,636		1,668
Inventories	1,425		1,365
Other current assets	799		639
Total current assets	4,822		4,556
Property, plant and equipment, net	4,083		3,842
Goodwill, net	2,474		2,500
Other intangible assets, net	1,496		1,499
Deferred income taxes	77		92
Other assets	924		905
Total assets	13,876	[1]	13,394	[1]
Current Liabilities	'		'
Notes and loans payable	13		54
Current portion of long-term debt	895		250
Accounts payable	1,343		1,290
Accrued income taxes	239		254
Other accruals	1,980		1,888
Total current liabilities	4,470		3,736
Long-term debt	4,749		4,926
Deferred income taxes	444		293
Other liabilities	1,677		2,049
Total liabilities	11,340		11,004
Commitments and contingent liabilities	0		0
Shareholders’ Equity	'		'
Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued)	1,466		1,466
Additional paid-in capital	1,004		818
Retained earnings	17,952		16,953
Accumulated other comprehensive income (loss)	-2,451		-2,621
Unearned compensation	-33		-41
Treasury stock, at cost	-15,633		-14,386
Total Colgate-Palmolive Company shareholders’ equity	2,305		2,189
Noncontrolling interests	231		201
Total shareholders’ equity	2,536		2,390
Total liabilities and shareholders’ equity	$13,876		$13,394
[1]	Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $8,248, $8,066 and $7,926 in 2013, 2012 and 2011, respectively.

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, except Share data, unless otherwise specified
Current Assets	'	'
Allowance for Doubtful Accounts Receivable, Current	$67	$61
Shareholders’ Equity	'	'
Common Stock, Par or Stated Value Per Share	$1	$1
Common Stock, Shares Authorized (in shares)	2,000,000,000	2,000,000,000
Common Stock, Shares Issued (in shares)	1,465,706,360	1,465,706,360

Consolidated_Statements_of_Cha

Consolidated Statements of Changes in Shareholders' Equity (USD $)	Total		Common Stock [Member]	Additional Paid-In Capital [Member]	Unearned Compensation [Member]	Treasury Stock [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Noncontrolling Interest [Member]
In Millions, unless otherwise specified
Beginning Balance at Dec. 31, 2010	'		$1,466	$399	($99)	($11,305)	$14,329	($2,115)	$142
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'		'	'	'	'	'	'	'
Net Income	2,554		'	'	'	'	2,431	'	123
Other comprehensive income (loss), net of tax	-367		'	'	'	'	'	-360	-7
Dividends declared:	'		'	'	'	'	'	'	'
Common stock	'		'	'	'	'	-1,111	'	-92
Stock-based compensation expense	'		'	122	'	'	'	'	'
Shares issued for stock options	'		'	88	'	251	'	'	'
Shares issued for restricted stock awards	'		'	53	'	-53	'	'	'
Treasury stock acquired	'		'	'	'	-1,806	'	'	'
Other	'		'	47	39	-1	'	'	'
Ending Balance at Dec. 31, 2011	'		1,466	603	-60	-12,808	15,649	-2,475	166
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'		'	'	'	'	'	'	'
Net Income	2,631	[1]	'	'	'	'	2,472	'	159
Other comprehensive income (loss), net of tax	-144		'	'	'	'	'	-146	2
Dividends declared:	'		'	'	'	'	'	'	'
Common stock	'		'	'	'	'	-1,168	'	-109
Stock-based compensation expense	'		'	120	'	'	'	'	'
Shares issued for stock options	'		'	99	'	297	'	'	'
Shares issued for restricted stock awards	'		'	70	'	-70	'	'	'
Treasury stock acquired	'		'	'	'	-1,943	'	'	'
Other	'		'	66	19	-2	'	'	-17
Ending Balance at Dec. 31, 2012	2,390		1,466	818	-41	-14,386	16,953	-2,621	201
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'		'	'	'	'	'	'	'
Net Income	2,410	[2]	'	'	'	'	2,241	'	169
Other comprehensive income (loss), net of tax	167		'	'	'	'	'	170	-3
Dividends declared:	'		'	'	'	'	'	'	'
Common stock	'		'	'	'	'	-1,242	'	-140
Stock-based compensation expense	'		'	128	'	'	'	'	'
Shares issued for stock options	'		'	82	'	201	'	'	'
Shares issued for restricted stock awards	'		'	-75	'	-75	'	'	'
Treasury stock acquired	'		'	'	'	-1,521	'	'	'
Other	'		'	51	8	-2	'	'	-4
Ending Balance at Dec. 31, 2013	$2,536		$1,466	$1,004	($33)	($15,633)	$17,952	($2,451)	$231
[1]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2012 include $70 of aftertax charges related to the 2012 Restructuring Program, $18 of aftertax costs related to the sale of land in Mexico and $14 of aftertax costs associated with various business realignment and other cost-saving initiatives.
[2]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2013 include $278 of aftertax charges related to the 2012 Restructuring Program, a $111 one-time aftertax charge for the impact of the devaluation in Venezuela, a $23 charge for a competition law matter in France related to the home care and personal care sectors and $12 of aftertax costs related to the sale of land in Mexico.

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Operating Activities	'		'		'
Net income including noncontrolling interests	$2,410	[1]	$2,631	[2]	$2,554
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:	'		'		'
Depreciation and amortization	439		425		421
Restructuring and termination benefits, net of cash	182		35		103
Venezuela devaluation charge	172		0		0
Gain before tax on sales of non-core product lines	0		0		207
Voluntary benefit plan contributions	-101		-101		-178
Stock-based compensation expense	128		120		122
Deferred income taxes	71		63		88
Cash effects of changes in:	'		'		'
Receivables	-37		19		-130
Inventories	-97		-21		-130
Accounts payable and other accruals	24		-5		199
Other non-current assets and liabilities	13		30		54
Net cash provided by operations	3,204		3,196		2,896
Investing Activities	'		'		'
Capital expenditures	-670		-565		-537
Sale of property and non-core product lines	15		72		263
Purchases of marketable securities and investments	-505		-545		-356
Proceeds from sale of marketable securities and investments	267		147		423
Payment for acquisitions, net of cash acquired	-3		-29		-966
Other	6		55		-40
Net cash used in investing activities	-890		-865		-1,213
Financing Activities	'		'		'
Principal payments on debt	-7,554		-5,011		-4,429
Proceeds from issuance of debt	7,976		5,452		5,843
Dividends paid	-1,382		-1,277		-1,203
Purchases of treasury shares	-1,521		-1,943		-1,806
Proceeds from exercise of stock options and excess tax benefits	339		478		353
Net cash used in financing activities	-2,142		-2,301		-1,242
Effect of exchange rate changes on Cash and cash equivalents	-94		-24		-53
Net increase (decrease) in Cash and cash equivalents	78		6		388
Cash and cash equivalents at beginning of year	884		878		490
Cash and cash equivalents at end of year	962		884		878
Supplemental Cash Flow Information	'		'		'
Income taxes paid	1,087		1,280		1,007
Interest paid	$118		$77		$58
[1]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2013 include $278 of aftertax charges related to the 2012 Restructuring Program, a $111 one-time aftertax charge for the impact of the devaluation in Venezuela, a $23 charge for a competition law matter in France related to the home care and personal care sectors and $12 of aftertax costs related to the sale of land in Mexico.
[2]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2012 include $70 of aftertax charges related to the 2012 Restructuring Program, $18 of aftertax costs related to the sale of land in Mexico and $14 of aftertax costs associated with various business realignment and other cost-saving initiatives.

Nature_of_Operations

Nature of Operations	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Nature of Operations	'
	Nature of Operations
	The Company manufactures and markets a wide variety of products in the U.S. and around the world in two distinct product segments: Oral, Personal and Home Care; and Pet Nutrition. Oral, Personal and Home Care products include toothpaste, toothbrushes and mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, laundry and dishwashing detergents, fabric conditioners, household cleaners, bleaches and other similar items. These products are sold primarily to retail trade customers and wholesale distributors worldwide. Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill’s Pet Nutrition. The principal customers for Pet Nutrition products are authorized pet supply retailers and veterinarians. Principal global and regional trademarks include Colgate, Palmolive, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, elmex, Tom’s of Maine, Sanex, Ajax, Axion, Fabuloso, Soupline and Suavitel, as well as Hill’s Science Diet, Hill’s Prescription Diet and Hill’s Ideal Balance.
	The Company’s principal classes of products accounted for the following percentages of worldwide Net sales for the past three years:
		2013		2012		2011
	Oral Care	46	%	44	%	43	%
	Personal Care	21	%	22	%	22	%
	Home Care	20	%	21	%	22	%
	Pet Nutrition	13	%	13	%	13	%
	Total	100	%	100	%	100	%

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Summary of Significant Accounting Policies	'
	Summary of Significant Accounting Policies
	Principles of Consolidation
	The Consolidated Financial Statements include the accounts of Colgate-Palmolive Company and its majority-owned or controlled subsidiaries. Intercompany transactions and balances have been eliminated. The Company’s investments in consumer products companies with interests ranging between 20% and 50%, where the Company has significant influence over the investee, are accounted for using the equity method. Net income (loss) from such investments is recorded in Other (income) expense, net in the Consolidated Statements of Income. As of December 31, 2013 and 2012, equity method investments included in Other assets in the Consolidated Balance Sheets were $27 and $25, respectively. Unrelated third parties hold the remaining ownership interests in these investments. Investments with less than a 20% interest are accounted for using the cost method.
	Use of Estimates
	The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to use judgment and make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are completed. As such, the most significant uncertainty in the Company’s assumptions and estimates involved in preparing the financial statements includes pension and other retiree benefit cost assumptions, stock-based compensation, asset impairments, uncertain tax positions, tax valuation allowances and legal and other contingency reserves. Additionally, the Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments and retirement plan assets. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. Actual results could ultimately differ from those estimates.
	Revenue Recognition
	Sales are recorded at the time products are shipped to trade customers and when risk of ownership transfers. Net sales reflect units shipped at selling list prices reduced by sales returns and the cost of current and continuing promotional programs. Current promotional programs, such as product listing allowances and co-operative advertising arrangements, are recorded in the period incurred. Continuing promotional programs are predominantly consumer coupons and volume-based sales incentive arrangements with trade customers. The redemption cost of consumer coupons is based on historical redemption experience and is recorded when coupons are distributed. Volume-based incentives offered to trade customers are based on the estimated cost of the program and are recorded as products are sold.
	Shipping and Handling Costs
	Shipping and handling costs are classified as Selling, general and administrative expenses and were $1,304, $1,262 and $1,250 for the years ended December 31, 2013, 2012 and 2011, respectively.
	Marketing Costs
	The Company markets its products through advertising and other promotional activities. Advertising costs are included in Selling, general and administrative expenses and are expensed as incurred. Certain consumer and trade promotional programs, such as consumer coupons, are recorded as a reduction of sales.
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents.
	Inventories
	Inventories are stated at the lower of cost or market. The cost of approximately 80% of inventories is determined using the first-in, first-out (“FIFO”) method. The cost of all other inventories, predominantly in the U.S. and Mexico, is determined using the last-in, first-out (“LIFO”) method.
	Property, Plant and Equipment
	Land, buildings and machinery and equipment are stated at cost. Depreciation is provided, primarily using the straight-line method, over estimated useful lives ranging from 3 to 15 years for machinery and equipment and up to 40 years for buildings. Depreciation attributable to manufacturing operations is included in Cost of sales. The remaining component of depreciation is included in Selling, general and administrative expenses.
	Goodwill and Other Intangibles
	Goodwill and indefinite life intangible assets, such as the Company’s global brands, are subject to impairment tests at least annually. These tests were performed and did not result in an impairment charge. Other intangible assets with finite lives, such as local brands and trademarks, customer relationships and non-compete agreements, are amortized over their useful lives, generally ranging from 5 to 40 years. Amortization expense related to intangible assets is included in Other (income) expense, net, which is included in Operating profit.
	Income Taxes
	The provision for income taxes is determined using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized based upon the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates that will be in effect at the time such differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Provision is made currently for taxes payable on remittances of overseas earnings; no provision is made for taxes on overseas retained earnings that are deemed to be permanently reinvested.
	The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return.  The Company recognizes interest expense and penalties related to unrecognized tax benefits within income tax expense.
	Financial Instruments
	Derivative instruments are recorded as assets and liabilities at estimated fair value based on available market information. The Company’s derivative instruments that qualify for hedge accounting are designated as either fair value hedges, cash flow hedges or net investment hedges. For fair value hedges, changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, are recognized in earnings each period. For cash flow hedges, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) and are recognized in earnings when the offsetting effect of the hedged item is also recognized in earnings. For hedges of the net investment in foreign subsidiaries, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) to offset the change in the value of the net investment being hedged.  Cash flows related to hedges are classified in the same category as the cash flows from the hedged item in the Consolidated Statements of Cash Flows.
	The Company may also enter into certain foreign currency and interest rate instruments that economically hedge certain of its risks but do not qualify for hedge accounting. Changes in fair value of these derivative instruments, based on quoted market prices, are recognized in earnings each period. The Company’s derivative instruments and other financial instruments are more fully described in Note 7, Fair Value Measurements and Financial Instruments along with the related fair value measurement considerations.
	Stock-Based Compensation
	The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock, based on the fair value of those awards at the date of grant over the requisite service period.  The Company uses the Black-Scholes-Merton (“Black-Scholes”) option pricing model to determine the fair value of stock option awards.  Stock-based compensation plans, related expenses and assumptions used in the Black-Scholes option pricing model are more fully described in Note 8, Capital Stock and Stock-Based Compensation Plans.
	Currency Translation
	The assets and liabilities of foreign subsidiaries, other than those operating in highly inflationary environments, are translated into U.S. dollars at year-end exchange rates with resulting translation gains and losses accumulated in a separate component of shareholders’ equity. Income and expense items are translated into U.S. dollars at average rates of exchange prevailing during the year.
	For subsidiaries operating in highly inflationary environments (currently, Venezuela), non-monetary assets, such as inventories, prepaid expenses, goodwill and property, plant and equipment are remeasured at their historical exchange rates, while monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these operations are included in Net income attributable to Colgate-Palmolive Company.
	Recent Accounting Pronouncements
	In July 2013, the FASB issued ASU No. 2013-11 “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” The new guidance is effective on a prospective basis for fiscal years beginning after December 15, 2013 and interim periods within those years. This new guidance is not expected to have a material impact on the Company’s financial position or results of operations.
	Reclassifications
	Certain prior year amounts have been reclassified to conform to the current year presentation.

Acquisitions_and_Divestitures

Acquisitions and Divestitures	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Acquisitions And Divestitures	'
	Acquisitions and Divestitures
	Sanex Acquisition
	On June 20, 2011, the Company, Colgate-Palmolive Europe Sàrl, Unilever N.V. and Unilever PLC (together with Unilever N.V., “Unilever”) finalized the Company’s acquisition from Unilever of the Sanex personal care business in accordance with a Business and Share Sale and Purchase Agreement for an aggregate purchase price of €676 ($966). The acquisition was financed with available cash, proceeds from the sale of the Company’s Euro-denominated investment portfolio and the issuance of commercial paper.
	Total purchase price consideration of $966 was allocated to the net assets acquired based on their respective fair values at June 20, 2011, as follows:
	Recognized amounts of assets acquired and liabilities assumed:
	Inventories	$	26
	Property, plant and equipment, net	3
	Other intangible assets, net	596
	Goodwill, net	411
	Accrued income taxes	(48		)
	Long-term deferred income taxes	(18		)
	Long-term other liabilities	(4		)
	Fair value of net assets acquired	$	966
	Other intangible assets acquired include trademarks of $403 with an indefinite useful life and customer relationships of $193 with useful lives ranging from 15 to 18 years.
	Goodwill of $411 was allocated between the Europe/South Pacific segment (90%) and the Africa/Eurasia segment (10%). The Company expects that substantially all of the goodwill will be deductible for tax purposes.
	Pro forma results of operations have not been presented, as the impact on the Company’s consolidated financial statements is not material. In 2011, Other (income) expense, net included $12 in transaction costs related to the acquisition.
	Sale of Detergent Business in Colombia
	In connection with the Sanex acquisition, Colgate sold its non-core laundry detergent business in Colombia to Unilever for $215. The detergent sale closed on July 29, 2011 and, as a result of the sale, the Company recognized a pretax gain of $207 ($135 aftertax gain) included in Other (income) expense, net in the third quarter of 2011. These operations were not material to the Company’s annual Net sales, Net income or Earnings per share.
	Sale of Land in Mexico
	On September 13, 2011, the Company’s Mexican subsidiary entered into an agreement to sell to the United States of America the Mexico City site on which its commercial operations, technology center and soap production facility are located. The sale price is payable in three installments, with the final installment due upon the transfer of the property, which is expected to occur in 2014. During the third quarter of 2011, the Company received the first installment of $24 upon signing the agreement. During the third quarter of 2012, the Company received the second installment of $36. The Company is reinvesting these payments to relocate its soap production to a new state-of-the-art facility to be constructed at its Mission Hills, Mexico site, to relocate its commercial and technology operations within Mexico City and to prepare the existing site for transfer. As a result, the Company expects to make capital improvements and incur costs to exit the site through 2014. These exit costs will primarily be related to staff leaving indemnities, accelerated depreciation and demolition to make the site building-ready. In 2013, 2012 and 2011 the Company recorded $18, $24 and $13 of pretax costs ($12, $18 and $9 of aftertax costs), respectively, related to the sale.

Restructuring_and_Related_Impl

Restructuring and Related Implementation Charges	12 Months Ended
	Dec. 31, 2013
Restructuring and Related Activities [Abstract]	'
Restructuring and Related Implementation Charges	'
	Restructuring and Related Implementation Charges
	In the fourth quarter of 2012, the Company commenced a four-year Global Growth and Efficiency Program (the “2012 Restructuring Program”) for sustained growth. The program’s initiatives are expected to help Colgate ensure continued solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses.
	Implementation of the 2012 Restructuring Program is projected to result in cumulative pretax charges, once all phases are approved and implemented, totaling between $1,100 and $1,250 ($775 and $875 aftertax), which are currently estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (50%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (15%); and Other charges, which include contract termination costs, consisting primarily of implementation-related charges resulting directly from exit activities (20%) and the implementation of new strategies (15%). Anticipated pretax charges for 2014 are expected to amount to approximately $275 to $325 ($200 to $230 aftertax). Over the course of the 2012 Restructuring Program, it is estimated that approximately 75% of the charges will result in cash expenditures.
	It is expected that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe/South Pacific (20%), Latin America (5%), Asia (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (10%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. It is expected that by the end of 2016, the 2012 Restructuring Program will reduce the Company’s global employee workforce by approximately 6% from the 2012 level of approximately 38,000.
	For the years ended December 31, 2013 and 2012, restructuring and implementation-related charges are reflected in the Consolidated Statements of Income as follows:
		2013				2012
	Cost of sales	$	32			$	2
	Selling, general and administrative expenses	137				6
	Other (income) expense, net	202				81
	Total 2012 Restructuring Program charges, pretax	$	371			$	89
	Total 2012 Restructuring Program charges, aftertax	$	278			$	70
	Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance. Total charges for the 2012 Restructuring Program for the year ended December 31, 2013 relate to initiatives undertaken in North America (11%), Europe/South Pacific (28%), Latin America (4%), Africa/Eurasia (7%), Hill’s Pet Nutrition (8%) and Corporate (42%). Total charges for the 2012 Restructuring Program for the year ended December 31, 2012 relate to initiatives undertaken in North America (2%), Europe/South Pacific (55%), Africa/Eurasia (2%), Hill’s Pet Nutrition (3%) and Corporate (38%). Total program-to-date accumulated charges for the 2012 Restructuring Program relate to initiatives undertaken in North America (10%), Europe/South Pacific (33%), Latin America (3%), Africa/Eurasia (6%), Hill’s Pet Nutrition (7%) and Corporate (41%).
	Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred pretax cumulative charges of $460 ($348 aftertax) in connection with the implementation of various projects as follows:
		Cumulative Charges
		as of December 31, 2013
	Employee-Related Costs	$	222
	Incremental Depreciation	26
	Asset Impairments	1
	Other	211
	Total	$	460
	The majority of costs incurred since inception relate to the following projects: restructuring how the Company provides retirement benefits to its U.S.-based employees by shifting them from the Company’s defined benefit retirement plans to the Company’s defined contribution plan; the closing of the Morristown, New Jersey personal care facility; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; other exit costs related to office consolidation; and the restructuring of certain commercial operations in advance of implementing an overall hubbing strategy.
	The following table summarizes the activity for the restructuring and implementation-related charges discussed above and the related accruals:
			Employee-Related				Incremental			Asset			Other			Total
			Costs				Depreciation			Impairments
	Balance at January 1, 2012		$	—			$	—		$	—		$	—		$	—
	Charges		78				—			—			11			89
	Cash payments		(1		)		—			—			(4		)	(5		)
	Charges against assets		—				—			—			—			—
	Foreign exchange		7				—			—			(2		)	5
	Balance at December 31, 2012		$	84			$	—		$	—		$	5		$	89
	Charges		144				26			1			200			371
	Cash payments		(97		)		—			—			(72		)	(169		)
	Charges against assets		(17		)		(26		)	(1		)	—			(44		)
	Foreign exchange		2				—			—			—			2
	Other		—				—			—			(91		)	(91		)
	Balance at December 31, 2013		$	116			$	—		$	—		$	42		$	158
	Employee-related costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-related costs also include pension and other retiree benefit enhancements amounting to $17 for the year ended December 31, 2013 which are reflected as Charges against assets within Employee-related costs in the preceding tables, as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities (see Note 10, Retirement Plans and Other Retiree Benefits).
	Incremental depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset impairments are recorded to write down assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset impairments are net of cash proceeds pertaining to the sale of certain assets.
	Other charges consist primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the 2012 Restructuring Program. These charges for the years ended December 31, 2013 and 2012 included third-party incremental costs related to the development and implementation of new business and strategic initiatives of $50 and $8, respectively, and contract termination costs and charges resulting directly from exit activities of $34 and $3, respectively, directly related to the 2012 Restructuring Program. These charges were expensed as incurred. Also included in Other charges for the year ended December 31, 2013 are other exit costs of $25 related to office space consolidation and a curtailment charge of $91 related to changes to the Company’s U.S. defined benefit retirement plans (see Note 10, Retirement Plans and Other Retiree Benefits).

Goodwill_and_Other_Intangible_

Goodwill and Other Intangible Assets	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Goodwill and Other Intangible Assets	'
	Goodwill and Other Intangible Assets
	The net carrying value of Goodwill as of December 31, 2013 and 2012, by segment is as follows:
		2013		2012
	Oral, Personal and Home Care
	North America	$	362	$	372
	Latin America	353		408
	Europe/South Pacific	1,525		1,478
	Asia	126		127
	Africa/Eurasia	93		100
	Total Oral, Personal and Home Care	2,459		2,485
	Pet Nutrition	15		15
	Total Goodwill, net	$	2,474	$	2,500
	The change in the amount of Goodwill, net in each year is primarily due to the impact of foreign currency translation.
	Other intangible assets as of December 31, 2013 and 2012 are comprised of the following:
		2013							2012
		Gross Carrying Amount		Accumulated Amortization			Net		Gross Carrying Amount		Accumulated Amortization			Net
	Trademarks	$	551	$	(275	)	$	276	$	548	$	(254	)	$	294
	Other finite life intangible assets	219		(45		)	174		212		(34		)	178
	Indefinite life intangible assets	1,046		—			1,046		1,027		—			1,027
	Total Other intangible assets	$	1,816	$	(320	)	$	1,496	$	1,787	$	(288	)	$	1,499
	The changes in the net carrying amounts of Other intangible assets during 2013, 2012 and 2011 were partially due to amortization expense of $32, $31 and $28, respectively, as well as the impact of foreign currency translation.  In 2013, 2012 and 2011, Indefinite life intangible assets included trademarks of $403 and Other finite life intangible assets included customer relationships of $193 acquired in connection with the Sanex acquisition (see Note 3, Acquisitions and Divestitures). Annual estimated amortization expense for each of the next five years is expected to be approximately $29.

LongTerm_Debt_and_Credit_Facil

Long-Term Debt and Credit Facilities	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Long-Term Debt and Credit Facilities	'
	Long-Term Debt and Credit Facilities
	Long-term debt consists of the following at December 31:
			Weighted Average Interest Rate	Maturities			2013		2012
	Notes		2.00%	2014	-	2078	$	5,644	$	4,733
	Commercial paper						—		443
							5,644		5,176
	Less: Current portion of long-term debt						895		250
	Total						$	4,749	$	4,926
	The weighted-average interest rate on short-term borrowings of $13 in 2013 and $54 in 2012 included in Notes and loans payable in the Consolidated Balance Sheets as of December 31, 2013 and 2012 was 2.2% and 1.0%, respectively.
	The Company classifies commercial paper as long-term debt when it has the intent and ability to refinance such obligations on a long-term basis. Excluding commercial paper reclassified as long-term debt, scheduled maturities of long-term debt and capitalized leases outstanding as of December 31, 2013, are as follows:
	Years Ended December 31,
	2014	$	895
	2015	491
	2016	255
	2017	664
	2018	695
	Thereafter	2,644
	The Company has entered into interest rate swap agreements and foreign exchange contracts related to certain of these debt instruments. See Note 7, Fair Value Measurements and Financial Instruments for further information about the Company’s financial instruments.
	During the fourth quarter of 2013, the Company issued $300 of five-year notes at a fixed rate of 1.50% and $82 of forty-year notes at a variable rate. During the second quarter of 2013, the Company issued $400 of five-year notes at a fixed rate of 0.90% and $400 of ten-year notes at a fixed rate of 2.10%. During the third quarter of 2012, the Company issued $500 of ten-year notes at a fixed rate of 1.95% and during the second quarter of 2012, the Company issued $500 of ten-year notes at a fixed rate of 2.30%.
	The debt issuances in 2013 and 2012 were U.S. dollar denominated and were under the Company’s shelf registration statement. Proceeds from the debt issuances in the second and fourth quarters of 2013 were used to reduce commercial paper borrowings, which were used by the Company for general corporate purposes. In addition, proceeds from the debt issuance in the second quarter of 2013 were used to repay and retire $250 of notes due in 2013. Proceeds from the debt issuances in the second and third quarters of 2012 were used to reduce commercial paper borrowings, which were used by the Company for general corporate purposes.
	At December 31, 2013, the Company had access to unused domestic and foreign lines of credit of $2,444 (including under the two facilities discussed below) and could also issue medium-term notes pursuant to an effective shelf registration statement. In November 2011, the Company entered into a five-year revolving credit facility with a capacity of $1,850 with a syndicate of banks. This facility was extended for an additional year in 2012 and again in 2013 and will expire in November 2018. The Company also has the ability to draw $145 from a revolving credit facility that expires in November 2014. Commitment fees related to the credit facilities are not material.
	Certain agreements with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements and believes the likelihood of noncompliance is remote.

Fair_Value_Measurements_and_Fi

Fair Value Measurements and Financial Instruments	12 Months Ended
	Dec. 31, 2013
Financial Instruments and Fair Value Measurements [Abstract]	'
Financial Instruments and Fair Value Measurements	'
	Fair Value Measurements and Financial Instruments
	The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose.  It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged.  Hedge ineffectiveness, if any, is not material for any period presented.  Provided below are details of the Company’s exposures by type of risk and derivative instruments by type of hedge designation.
	Valuation Considerations
	Assets and liabilities carried at fair value are classified as follows:
	Level 1: Based upon quoted market prices in active markets for identical assets or liabilities.
	Level 2: Based upon observable market-based inputs or unobservable inputs that are corroborated by market data.
	Level 3: Based upon unobservable inputs reflecting the reporting entity’s own assumptions.
	Foreign Exchange Risk
	As the Company markets its products in over 200 countries and territories, it is exposed to currency fluctuations related to manufacturing and selling its products in currencies other than the U.S. dollar. The Company manages its foreign currency exposures through a combination of cost-containment measures, sourcing strategies, selling price increases and the hedging of certain costs in an effort to minimize the impact on earnings of foreign currency rate movements.
	The Company primarily utilizes foreign currency contracts, including forward, option and swap contracts, local currency deposits and local currency borrowings to hedge portions of its exposures relating to foreign currency purchases, assets and liabilities created in the normal course of business and the net investment in certain foreign subsidiaries. The duration of foreign currency contracts generally does not exceed 12 months and the contracts are valued using observable market rates (Level 2 valuation).
	Interest Rate Risk
	The Company manages its targeted mix of fixed and floating rate debt with debt issuances and by entering into interest rate swaps in order to mitigate fluctuations in earnings and cash flows that may result from interest rate volatility. The notional amount, interest payment and maturity date of the swaps generally match the principal, interest payment and maturity date of the related debt, and the swaps are valued using observable benchmark rates (Level 2 valuation).
	Commodity Price Risk
	The Company is exposed to price volatility related to raw materials used in production, such as resins, pulp, essential oils, tallow, tropical oils, poultry, corn and soybeans. The Company manages its raw material exposures through a combination of cost containment measures, ongoing productivity initiatives and the limited use of commodity hedging contracts.  Futures contracts are used on a limited basis, primarily in the Hill’s Pet Nutrition segment, to manage volatility related to raw material inventory purchases of certain traded commodities, and these contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of the commodity contracts generally does not exceed 12 months.
	Credit Risk
	The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material as it is the Company’s policy to contract with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.
	The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at December 31, 2013 and December 31, 2012:
		Assets										Liabilities
		Account		Fair Value								Account	Fair Value
	Designated derivative instruments			12/31/13				12/31/12					12/31/13			12/31/12
	Interest rate swap contracts	Other current assets		$	1			$	3			Other accruals	$	—		$	—
	Interest rate swap contracts	Other assets		20				41				Other liabilities	1			—
	Foreign currency contracts	Other current assets		14				7				Other accruals	8			10
	Foreign currency contracts	Other assets		—				13				Other liabilities	10			—
	Commodity contracts	Other current assets		—				1				Other accruals	—			—
	Total designated			$	35			$	65				$	19		$	10
	Derivatives not designated
	Foreign currency contracts	Other current assets		$	—			$	—			Other accruals	$	3		$	1
	Total not designated			$	—			$	—				$	3		$	1
	Total derivative instruments			$	35			$	65				$	22		$	11
	Other financial instruments
	Marketable securities	Other current assets		$	173			$	116
	Venezuelan bonds, long-term	Other assets		685				618
	Total other financial instruments			$	858			$	734
	The carrying amount of cash, cash equivalents, accounts receivable and short-term debt approximated fair value as of December 31, 2013 and 2012. The estimated fair value of the Company’s long-term debt, including the current portion, as of December 31, 2013 and 2012, was $5,690 and $5,484, respectively, and the related carrying value was $5,644 and $5,176, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).
	Fair value hedges
	The Company has designated all interest rate swap contracts and certain foreign currency forward and option contracts as fair value hedges, for which the gain or loss on the derivative and the offsetting loss or gain on the hedged item are recognized in current earnings. The impact of foreign currency contracts is primarily recognized in Selling, general and administrative expenses and the impact of interest rate swap contracts is recognized in Interest (income) expense, net. Activity related to fair value hedges recorded during each period presented was as follows:
		2013											2012
		Foreign				Interest							Foreign			Interest
		Currency				Rate				Total			Currency			Rate			Total
		Contracts				Swaps							Contracts			Swaps
	Notional Value at December 31,	$	1,320			$	1,188			$	2,508		$	1,117		$	1,338		$	2,455
	Gain (loss) on derivative	24				(22		)		2			9			6			15
	Gain (loss) on hedged items	(24		)		22				(2		)	(9		)	(6		)	(15		)
	Cash flow hedges
	All of the Company’s commodity contracts and certain foreign currency forward contracts have been designated as cash flow hedges, for which the effective portion of the gain or loss is reported as a component of Other comprehensive income (“OCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Activity related to cash flow hedges recorded during each period presented was as follows:
		2013											2012
		Foreign				Commodity							Foreign			Commodity
		Currency				Contracts				Total			Currency			Contracts			Total
		Contracts											Contracts
	Notional Value at December 31,	$	386			$	14			$	400		$	398		$	23		$	421
	Gain (loss) recognized in OCI	20				—				20			4			9			13
	Gain (loss) reclassified into Cost of sales	16				1				17			4			7			11
	The net gain (loss) recognized in OCI for both foreign currency contracts and commodity contracts is expected to be recognized in Cost of sales within the next twelve months.
	Net investment hedges
	The Company has designated certain foreign currency forward and option contracts and certain foreign currency-denominated debt as net investment hedges, for which the gain or loss on the instrument is reported as a component of Currency translation adjustments within OCI, along with the offsetting gain or loss on the hedged items. Activity related to net investment hedges recorded during each period presented was as follows:
		2013											2012
		Foreign				Foreign							Foreign			Foreign
		Currency				Currency				Total			Currency			Currency			Total
		Contracts				Debt							Contracts			Debt
	Notional Value at December 31,	$	529			$	256			$	785		$	522		$	383		$	905
	Gain (loss) on instruments	(24		)		(4		)		(28		)	(11		)	(8		)	(19		)
	Gain (loss) on hedged items	23				4				27			8			8			16
Derivatives Not Designated as Hedging Instruments
Derivatives not designated as hedging instruments for each period consist of a cross-currency swap that serves as an economic hedge of a foreign currency deposit, for which the gain or loss on the instrument and the offsetting gain or loss on the hedged item are recognized in Other (income) expense, net for each period. Activity related to these contracts during each period presented was as follows:
	2013				2012
	Cross-currency				Cross-currency
	Swap				Swap
Notional Value at December 31,	$	96			$	96
Gain (loss) on instrument	(2		)		(4		)
Gain (loss) on hedged item	2				4
Other Financial Instruments
Other financial instruments are classified as Other current assets or Other assets.
Other financial instruments classified as Other current assets include marketable securities, which consist of bank deposits of $173 with original maturities greater than 90 days (Level 1 valuation). Other assets include the long-term portion of bonds issued by the Venezuelan government (Level 2 valuation) in the amount of $685. The current portion of these bonds was $0 as of December 31, 2013.
Through its subsidiary in Venezuela, the Company is invested in U.S. dollar-linked devaluation-protected bonds and bolivar fuerte denominated fixed interest rate bonds, both of which are issued by the Venezuelan government. These bonds are actively traded and, therefore, are considered Level 2 investments as their values are determined based upon observable market-based inputs or unobservable inputs that are corroborated by market data. As of December 31, 2013, the fair market value of U.S. dollar-linked devaluation-protected bonds and bolivar fuerte denominated fixed interest rate bonds was $233 and $452, respectively. These bonds are considered available-for-sale securities and, as noted above, $685 was included in Other assets.
The following table presents a reconciliation of the Venezuelan bonds at fair value for the twelve months ended December 31:
	2013				2012
Beginning balance as of January 1	$	642			$	236
Unrealized gain (loss) on investment	(113		)		28
Purchases and sales during the period	156				378
Ending balance as of December 31	$	685			$	642
The Unrealized loss on investment consisted primarily of a one-time loss of $133 in the first quarter of 2013 related to the remeasurement of the fixed interest rate bonds at February 9, 2013, the date of the devaluation. For further information regarding Venezuela and the devaluation, refer to Note 14, Venezuela.

Capital_Stock_and_StockBased_C

Capital Stock and Stock-Based Compensation Plans	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Capital Stock and Stock-Based Compensation Plans	'
	Capital Stock and Stock-Based Compensation Plans
	Common Stock Split
	On March 7, 2013, the Company’s Board of Directors approved a two-for-one stock split of the Company’s common stock to be effected through a 100% stock dividend (the “2013 Stock Split”). The record date for the 2013 Stock Split was the close of business on April 23, 2013, and the share distribution occurred on May 15, 2013. As a result of the stock split, shareholders received one additional share of Colgate common stock, par value $1.00, for each share they held as of the record date.
	All per share amounts and numbers of shares outstanding in these Consolidated Financial Statements and Notes to the Consolidated Financial Statements are presented on a post-split basis. In addition, the impact on the Balance Sheet as a result of the 2013 Stock Split was an increase of $733 to Common Stock and an offsetting reduction in Additional paid-in capital, which has been retroactively restated.
	Preference Stock
	The Company has the authority to issue 50,262,150 shares of preference stock.
	Stock Repurchases
	The Company repurchased its common stock at a cost of $1,521 during 2013 under a share repurchase program that was approved by the Board of Directors and publicly announced in September 2011 (the “2011 Program”). The 2011 Program authorized the Company to repurchase up to 50 million shares of its common stock. The Board authorized that the number of shares remaining under the 2011 Program as of May 15, 2013 be increased by 100% as a result of the 2013 Stock Split. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs.  The shares may be repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.
	The Company may use either authorized and unissued shares or treasury shares to meet share requirements resulting from the exercise of stock options and the vesting of restricted stock unit awards.
	A summary of common stock and treasury stock activity for the three years ended December 31, is as follows:
		Common Stock Outstanding		Treasury Stock
	Balance, January 1, 2011	989,700,934		476,005,426
	Common stock acquired	(42,641,872	)	42,641,872
	Shares issued for stock options	11,517,758		(11,517,758	)
	Shares issued for restricted stock units and other	1,459,330		(1,459,330	)
	Balance, December 31, 2011	960,036,150		505,670,210
	Common stock acquired	(38,730,602	)	38,730,602
	Shares issued for stock options	12,217,230		(12,217,230	)
	Shares issued for restricted stock units and other	2,205,898		(2,205,898	)
	Balance, December 31, 2012	935,728,676		529,977,684
	Common stock acquired	(25,573,317	)	25,573,317
	Shares issued for stock options	7,883,834		(7,883,834	)
	Shares issued for restricted stock units and other	1,907,382		(1,907,382	)
	Balance, December 31, 2013	919,946,575		545,759,785
	Stock-Based Compensation
	The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units, based on the fair value of those awards at the date of grant. The value of restricted stock units, based on market prices, is amortized on a straight-line basis over the requisite service period. The estimated fair value of stock options on the date of grant is amortized on a straight-line basis over the requisite service period for each separately vesting portion of the award.  Awards to employees eligible for retirement prior to the award becoming fully vested are recognized as compensation cost from the grant date through the date that the employee first becomes eligible to retire and is no longer required to provide service to earn the award.
	The Company has one incentive compensation plan, which was approved by the Company’s stockholders on May 10, 2013, pursuant to which it issues restricted stock units and stock options to employees and shares of common stock and stock options to non-employee directors. The Personnel and Organization Committee of the Board of Directors, comprised entirely of independent directors, administers the plan. Previously, the Company issued these awards pursuant to four different stockholder-approved plans. The total stock-based compensation expense charged against pretax income for these plans was $128, $120 and $122 for the years ended December 31, 2013, 2012 and 2011, respectively. The total income tax benefit recognized on stock-based compensation was approximately $39, $37 and $40 for the years ended December 31, 2013, 2012 and 2011, respectively.
	Stock-based compensation expense is recorded within Selling, general and administrative expenses in the Corporate segment as these amounts are not included in internal measures of segment operating performance.
	The Company uses the Black-Scholes option pricing model to determine the fair value of stock option awards.  The weighted-average estimated fair value of stock options granted in the years ended December 31, 2013, 2012 and 2011 was $7.41, $6.73 and $5.97, respectively. Fair value is estimated using the Black-Scholes option pricing model with the assumptions summarized in the following table:
		2013		2012		2011
	Expected Term of Options	4.5 years		4.5 years		4.5 years
	Expected Volatility Rate	18.4	%	20.8	%	21.3	%
	Risk-Free Rate	1.5	%	0.6	%	0.8	%
	Expected Dividend Yield	2.3	%	2.4	%	2.6	%
	The weighted-average expected term of options granted each year was determined with reference to historical exercise and post-vesting cancellation experience, the vesting period of the awards and contractual term of the awards, among other factors.  Expected volatility incorporates implied share-price volatility derived from exchange traded options on the Company’s common stock.  The risk-free rate for the expected term of the option is based on the yield of a zero-coupon U.S. Treasury bond with a maturity period equal to the option’s expected term.
	Restricted Stock Units
	The Company grants restricted stock unit awards to officers and other employees. Awards vest at the end of the restriction period, which is generally three years.  As of December 31, 2013, approximately 13,409,000 shares of common stock were available for future restricted stock unit awards.
	A summary of restricted stock unit activity during 2013 is presented below:
		Shares		Weighted Average Grant Date Fair Value Per Award
		(in thousands)
	Restricted stock units as of January 1, 2013	5,268		$	43
	Activity:
	Granted	1,214		59
	Vested	(1,854	)	41
	Forfeited	(89	)	45
	Restricted stock units as of December 31, 2013	4,539		$	48
	As of December 31, 2013, there was $66 of total unrecognized compensation expense related to nonvested restricted stock unit awards, which will be recognized over a weighted-average period of 2.2 years. The total fair value of shares vested during the years ended December 31, 2013, 2012 and 2011 was $69, $63 and $50, respectively.
	Stock Options
	The Company issues non-qualified stock options to non-employee directors, officers and other employees. Stock options generally have a contractual term of six years and vest over three years. As of December 31, 2013, 54,815,000 shares of common stock were available for future stock option grants.
	A summary of stock option activity during 2013 is presented below:
		Shares		Weighted Average Exercise Price			Weighted Average Remaining Contractual Life	Value of Unexercised
		(in thousands)					(in years)	In-the-Money Options
	Options outstanding, January 1, 2013	42,342		$	43
	Granted	9,219		59
	Exercised	(8,285	)	38
	Forfeited or expired	(444	)	49
	Options outstanding, December 31, 2013	42,832		47			4	$	773
	Options exercisable, December 31, 2013	24,151		$	42		3	$	572
	As of December 31, 2013, there was $49 of total unrecognized compensation expense related to options, which will be recognized over a weighted-average period of 1.5 years. The total intrinsic value of options exercised during the years ended December 31, 2013, 2012 and 2011 was $180, $210 and $162, respectively.
	The benefits of tax deductions in excess of grant date fair value resulting from the exercise of stock options and vesting of restricted stock unit awards for the years ended December 31, 2013, 2012 and 2011 was $51, $60 and $32, respectively, and was reported as a financing cash flow. Cash proceeds received from options exercised for the years ended December 31, 2013, 2012 and 2011 were $289, $409 and $332, respectively.

Employee_Stock_Ownership_Plan

Employee Stock Ownership Plan	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Employee Stock Ownership Plan	'
	Employee Stock Ownership Plan
	In 1989, the Company expanded its Employee Stock Ownership Plan (“ESOP”) through the introduction of a leveraged ESOP that funds certain benefits for employees who have met eligibility requirements. The ESOP issued $410 of long-term notes due through July 2009 bearing an average interest rate of 8.7%. The notes, which were guaranteed by the Company, were repaid in July 2009. The ESOP used the proceeds from the notes issuance to purchase 6,315,149 shares of Series B Convertible Preference stock (the “Series B Preference stock”) from the Company. As a result of rules issued by the IRS related to employer stock held in defined contribution plans, the Company issued a notice of redemption with respect to the remaining shares of Series B Preference stock outstanding on December 29, 2010. At the direction of the Company’s ESOP trustee, these shares of Series B Preference stock were converted into 38,483,072 shares of common stock, adjusted for the 2013 Stock Split (see Note 8, Capital Stock and Stock-Based Compensation Plans). As of December 31, 2013 and 2012, there were 29,119,135 and 31,221,296 shares of common stock, respectively, outstanding and issued to the Company’s ESOP. The common stock for the conversion was issued from treasury shares.
	During 2000, the ESOP entered into a loan agreement with the Company under which the benefits of the ESOP may be extended through 2035. As of December 31, 2013, the ESOP had outstanding borrowings from the Company of $33, which represents unearned compensation shown as a reduction in Shareholders’ equity.
	Dividends on stock held by the ESOP are paid to the ESOP trust and, together with cash contributions from the Company, are (a) used by the ESOP to repay principal and interest, (b) credited to participant accounts or (c) used for contributions to the Company’s defined contribution plans. Stock is allocated to participants based upon the ratio of the current year’s debt service to the sum of total principal and interest payments over the life of the debt. As of December 31, 2013, 19,171,587 shares of common stock were released and allocated to participant accounts and 9,947,548 shares of common stock were available for future allocation to participant accounts.
	Dividends on the stock used to repay principal and interest or credited to participant accounts are deductible for income tax purposes and, accordingly, are reflected net of their tax benefit in the Consolidated Statements of Changes in Shareholders’ Equity.
	Annual expense related to the leveraged ESOP from the ESOP was $0 in 2013, 2012 and 2011.
	The Company paid dividends on the shares held by the ESOP of $41 in 2013, $40 in 2012 and $42 in 2011. The Company did not make any contributions to the ESOP in 2013, 2012 or 2011.

Retirement_Plans_and_Other_Ret

Retirement Plans and Other Retiree Benefits	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Retirement Plans and Other Retiree Benefits	'
	Retirement Plans and Other Retiree Benefits
	Retirement Plans
	The Company and certain of its U.S. and overseas subsidiaries maintain defined benefit retirement plans. Benefits under these plans are based primarily on years of service and employees’ career earnings.
	During 2013, the Company announced changes to the way it will provide future retirement benefits to substantially all of its U.S.-based employees participating in its defined benefit retirement plan. Effective January 1, 2014, the Company will provide future retirement benefits for these U.S.-based employees through the Company’s defined contribution plan. As a result, no future service will be considered for future accruals in the U.S. defined benefit retirement plans. Participants in the Company’s U.S. defined benefit retirement plan whose retirement benefit was determined under the cash balance formula will continue to earn interest on their vested balances as of December 31, 2013. Participants whose retirement benefit was determined under the final average earnings formula will continue to have their final average earnings adjusted for pay increases until retirement. These changes resulted in a curtailment charge of $91 as all of the previously unamortized prior service costs recorded in Accumulated other comprehensive income (loss) was recognized in 2013.
	In the Company’s principal U.S. plans and certain funded overseas plans, funds are contributed to trusts in accordance with regulatory limits to provide for current service and for any unfunded projected benefit obligation over a reasonable period. The target asset allocation for the Company’s defined benefit plans are as follows:
			United States			International
	Asset Category
	Equity securities		27	%		39	%
	Fixed income securities		53			48
	Real estate and other investments		20			13
	Total		100	%		100	%
	At December 31, 2013 the allocation of the Company’s plan assets and the level of valuation input for each major asset category was as follows:
			Level of Valuation		Pension Plans
			Input		United States				International				Other Retiree
													Benefits
	Investments:
	Cash & cash equivalents		Level 1		$	97			$	23			$	3
	U.S. common stocks		Level 1		127				—				3
	International common stocks		Level 1		51				—				1
	Fixed income securities (a)		Level 2		433				—				8
	Common/collective trust funds (b):		Level 2
	Equity index funds				359				229				9
	Emerging market equity index funds				33				9				1
	Other common stock funds				123				75				3
	Fixed income funds: U.S. or foreign government and agency securities				149				73				3
	Fixed income funds: investment grade corporate bonds				203				71				5
	Fixed income funds: high yield corporate bonds and other				119				1				4
	Guaranteed investment contracts (c)		Level 2		2				56				—
	Real estate funds (d)		Level 3		40				21				1
	Total Investments at fair value				$	1,736			$	558			$	41
	At December 31, 2012 the allocation of the Company’s plan assets and the level of valuation input for each major asset category was as follows:
			Level of Valuation		Pension Plans
			Input		United States				International				Other Retiree
													Benefits
	Investments:
	Cash & cash equivalents		Level 1		$	45			$	9			$	1
	U.S. common stocks		Level 1		258				—				6
	International common stocks		Level 1		93				—				2
	Fixed income securities (a)		Level 2		142				—				—
	Common/collective trust funds (b):		Level 2
	Equity index funds				444				199				11
	Emerging market equity index funds				65				12				2
	Other common stock funds				40				65				1
	Fixed income funds: U.S. or foreign government and agency securities				227				59				6
	Fixed income funds: investment grade corporate bonds				26				72				1
	Fixed income funds: high yield corporate bonds and other				185				1				5
	Guaranteed investment contracts (c)		Level 2		2				49				—
	Real estate funds (d)		Level 3		70				20				2
	Total Investments at fair value				$	1,597			$	486			$	37
	_______
	(a)	The fixed income securities are traded over the counter and certain of these securities lack daily pricing or liquidity and as such are classified as Level 2. As of December 31, 2013 and 2012, approximately 50% of the fixed income portfolio was invested in U.S. treasury or agency securities, with the remainder invested in other government bonds and corporate bonds.
	(b)	Interests in common/collective trust funds are valued using the net asset value (“NAV”) per unit in each fund. The NAV is based on the value of the underlying investments owned by each trust, minus its liabilities, divided by the number of shares outstanding.
	(c)	The guaranteed investment contracts (“GICs”) represent contracts with insurance companies measured at the cash surrender value of each contract. The Level 2 valuation reflects that the cash surrender value is based principally on a referenced pool of investment funds with active redemption.
	(d)	Real estate is valued using the NAV per unit of funds that are invested in real estate property. The investment value of the real estate property is determined quarterly using independent market appraisals as determined by the investment manager. Since the appraisals include unobservable inputs, these investments are classified as Level 3. These unobservable inputs may include items such as annual gross rents, projected vacancy rates, collection losses and recovery rates, yield rates, growth assumptions and risk adjusted discount rates.
	The following table presents a reconciliation of Level 3 plan assets measured at fair value for the year ended December 31:
			2013								2012
			United States Real Estate Fund				International Real Estate Fund				United States Real Estate Fund				International Real Estate Fund
	Beginning balance as of January 1		$	72			$	20			$	64			$	18
	Earned income, net of management expenses		2				—				6				—
	Unrealized gain on investment		9				—				2				1
	Purchases, sales, issuances and settlements, net		(42		)		1				—				1
	Ending balance as of December 31		$	41			$	21			$	72			$	20
	Equity securities in the U.S. plans include investments in the Company’s common stock representing 6% of U.S. plan assets at December 31, 2013 and 11% of U.S. plan assets at December 31, 2012. In 2013, the U.S. plans sold 1,540,215 shares of the Company’s common stock to the Company. No shares of the Company’s common stock were purchased or sold by the plans in 2012. The plans received dividends on the Company’s common stock of $3 in 2013 and $4 in 2012.
Other Retiree Benefits
The Company and certain of its subsidiaries provide health care and life insurance benefits for retired employees to the extent not provided by government-sponsored plans.
The Company uses a December 31 measurement date for its defined benefit and other retiree benefit plans. Summarized information for the Company’s defined benefit and other retiree benefit plans are as follows:
		Pension Benefits																Other Retiree Benefits
		2013				2012				2013				2012				2013			2012
		United States								International
Change in Benefit Obligations
Benefit obligations at beginning of year		$	2,227			$	2,025			$	888			$	760			$	875		$	776
Service cost		24				24				19				12				11			9
Interest cost		90				97				34				35				38			40
Participants’ contributions		1				1				3				3				—			—
Acquisitions/plan amendments		40				—				2				21				—			(27		)
Actuarial loss (gain)		(148		)		200				(1		)		103				(101		)	119
Foreign exchange impact		—				—				12				21				(5		)	1
Termination benefits (1)		11				—				—				—				6			—
Curtailments and settlements		(12		)		—				(21		)		(23		)		—			—
Benefit payments		(131		)		(128		)		(41		)		(45		)		(32		)	(40		)
Other		—				8				(1		)		1				—			(3		)
Benefit obligations at end of year		$	2,102			$	2,227			$	894			$	888			$	792		$	875
Change in Plan Assets
Fair value of plan assets at beginning of year		$	1,597			$	1,426			$	486			$	437			$	37		$	32
Actual return on plan assets		148				173				59				47				4			5
Company contributions		121				125				61				57				32			40
Participants’ contributions		1				1				3				3				—			—
Foreign exchange impact		—				—				2				13				—			—
Settlements		—				—				(11		)		(21		)		—			—
Benefit payments		(131		)		(128		)		(41		)		(45		)		(32		)	(40		)
Other		—				—				(1		)		(5		)		—			—
Fair value of plan assets at end of year		$	1,736			$	1,597			$	558			$	486			$	41		$	37
Funded Status
Benefit obligations at end of year		$	2,102			$	2,227			$	894			$	888			$	792		$	875
Fair value of plan assets at end of year		1,736				1,597				558				486				41			37
Net amount recognized		$	(366	)		$	(630	)		$	(336	)		$	(402	)		$	(751	)	$	(838	)
Amounts Recognized in Balance Sheet
Noncurrent assets		$	16			$	—			$	12			$	2			$	—		$	—
Current liabilities		(19		)		(17		)		(36		)		(29		)		(39		)	(40		)
Noncurrent liabilities		(363		)		(613		)		(312		)		(375		)		(712		)	(798		)
Net amount recognized		$	(366	)		$	(630	)		$	(336	)		$	(402	)		$	(751	)	$	(838	)
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
Actuarial loss		$	674			$	932			$	181			$	235			$	296		$	421
Transition/prior service cost		3				63				23				26				1			2
		$	677			$	995			$	204			$	261			$	297		$	423
Accumulated benefit obligation		$	1,995			$	2,093			$	802			$	798			$	—		$	—
		Pension Benefits												Other Retiree Benefits
		2013			2012			2013			2012			2013			2012
		United States						International
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount rate		4.96	%		4.14	%		3.99	%		3.57	%		5.24	%		4.32	%
Long-term rate of return on plan assets		6.8	%		7.3	%		5.5	%		5.39	%		6.8	%		7.3	%
Long-term rate of compensation increase		3.5	%		3.5	%		3.02	%		2.8	%		—	%		—	%
ESOP growth rate		—	%		—	%		—	%		—	%		10	%		10	%
Medical cost trend rate of increase		—	%		—	%		—	%		—	%		7	%		7.5	%
_________
-1	Represents pension and other retiree benefit enhancements incurred in 2013 pursuant to the 2012 Restructuring Program.
The overall investment objective of the plans is to balance risk and return so that obligations to employees are met. The Company evaluates its long-term rate of return on plan assets on an annual basis. In determining the long-term rate of return, the Company considers the nature of the plans’ investments and the historical rates of return. The assumed rate of return as of December 31, 2013 for the U.S. plans was 6.80%. Average annual rates of return for the U.S. plans for the most recent 1-year, 5-year, 10-year, 15-year and 25-year periods were 9%, 11%, 7%, 6%, and 8%, respectively.  Similar assessments were performed in determining rates of return on international pension plan assets to arrive at the Company’s 2013 weighted-average rate of return of 5.50%.
The medical cost trend rate of increase assumed in measuring the expected cost of benefits is projected to decrease from 7.0% in 2014 to 5.0% by 2020, remaining at 5.0% for the years thereafter. Changes in the assumed rate can have a significant effect on amounts reported. A 1% change in the assumed medical cost trend rate would have the following approximate effect:
		One percentage point
		Increase				Decrease
Accumulated postretirement benefit obligation		$	109			$	(88	)
Total of service and interest cost components		9				(7		)
Plans with projected benefit obligations in excess of plan assets and plans with accumulated benefit obligations in excess of plan assets as of December 31 consist of the following:
		Years Ended December 31,
		2013				2012
Benefit Obligation Exceeds Fair Value of Plan Assets
Projected benefit obligation		$	1,130			$	3,112
Fair value of plan assets		402				2,080
Accumulated benefit obligation		700				2,855
Fair value of plan assets		66				2,044
Summarized information regarding the net periodic benefit costs for the Company’s defined benefit and other retiree benefit plans is as follows:
		Pension Benefits																						Other Retiree Benefits
		2013				2012				2011				2013				2012			2011			2013			2012			2011
		United States												International
Components of Net Periodic Benefit Cost
Service cost		$	24			$	24			$	24			$	19			$	12		$	19		$	13		$	11		$	12
Interest cost		90				97				100				34				35			36			38			40			39
Annual ESOP allocation		—				—				—				—				—			—			(2		)	(2		)	(2		)
Expected return on plan assets		(118		)		(112		)		(110		)		(26		)		(26		)	(27		)	(3		)	(3		)	(3		)
Amortization of transition & prior service costs (credits)		9				9				9				2				2			3			1			3			2
Amortization of actuarial loss		68				62				46				10				9			9			21			18			16
Net periodic benefit cost		$	73			$	80			$	69			$	39			$	32		$	40		$	68		$	67		$	64
Other postretirement charges		102				—				—				3				9			3			6			1			1
Total pension cost		$	175			$	80			$	69			$	42			$	41		$	43		$	74		$	68		$	65
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount rate		4.14		%		4.9		%		5.3		%		3.57		%		4.59		%	5.04		%	4.32		%	5.26		%	5.3		%
Long-term rate of return on plan assets		7.3		%		7.75		%		8		%		5.39		%		5.91		%	6.23		%	7.3		%	7.75		%	8		%
Long-term rate of compensation increase		3.5		%		4		%		4		%		2.8		%		2.87		%	3.05		%	—		%	—		%	—		%
ESOP growth rate		—		%		—		%		—		%		—		%		—		%	—		%	10		%	10		%	10		%
Medical cost trend rate of increase		—		%		—		%		—		%		—		%		—		%	—		%	7.5		%	8		%	8.33		%
Other postretirement charges in 2013 primarily relate to a curtailment charge of $91 resulting from changes to the Company’s defined benefit retirement plans in the U.S. and certain other one-time pension and other retiree benefit enhancements incurred pursuant to the 2012 Restructuring Program.
Other postretirement charges in 2012 primarily relate to the sale of land in Mexico.
The Company made voluntary contributions of $101, $101 and $178 in 2013, 2012 and 2011, respectively, to its U.S. retirement plans.
The estimated actuarial loss and the estimated transition/prior service cost for defined benefit and other retiree benefit plans that will be amortized from Accumulated other comprehensive income (loss) into net periodic benefit cost over the next fiscal year is as follows:
		Pension Benefits				Other Retiree Benefits
Net actuarial loss		$	39			$	15
Net transition & prior service cost		2				—
Expected Contributions & Benefit Payments
Management does not expect to make a voluntary contribution to U.S. pension plans for the year ending December 31, 2014. Actual funding may differ from current estimates depending on the variability of the market value of the assets as compared to the obligation and other market or regulatory conditions.
Total benefit payments to be paid to participants for the year ending December 31, 2014 from the Company’s assets are estimated to be approximately $98. Total benefit payments expected to be paid to participants from plan assets, or payments directly from the Company’s assets to participants in unfunded plans, are as follows:
		Pension Benefits
Years Ended December 31,		United States				International				Other Retiree Benefits				Total
2014		$	172			$	70			$	40			$	282
2015		136				55				41				232
2016		135				47				43				225
2017		136				54				44				234
2018		135				50				45				230
2019-2023		691				273				232				1,196

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Income Taxes	'
	Income Taxes
	The components of income before income taxes are as follows for the three years ended December 31:
		2013				2012				2011
	United States	$	1,018			$	1,155			$	1,098
	International	2,547				2,719				2,691
	Total Income before income taxes	$	3,565			$	3,874			$	3,789
	The provision for income taxes consists of the following for the three years ended December 31:
		2013				2012				2011
	United States	$	314			$	395			$	360
	International	841				848				875
	Total Provision for income taxes	$	1,155			$	1,243			$	1,235
	Temporary differences between accounting for financial statement purposes and accounting for tax purposes result in the current provision for taxes being higher (lower) than the total provision for income taxes as follows:
		2013				2012				2011
	Goodwill and intangible assets	$	(14	)		$	(7	)		$	(1	)
	Property, plant and equipment	—				(13		)		(19		)
	Pension and other retiree benefits	85				(14		)		(47		)
	Stock-based compensation	10				5				11
	Tax loss and tax credit carryforwards	(30		)		(39		)		(14		)
	Other, net	(33		)		32				32
	Total deferred tax provision	$	18			$	(36	)		$	(38	)
	The difference between the statutory U.S. federal income tax rate and the Company’s global effective tax rate as reflected in the Consolidated Statements of Income is as follows:
	Percentage of Income before income taxes	2013			2012			2011
	Tax at United States statutory rate	35	%		35	%		35	%
	State income taxes, net of federal benefit	0.4			0.7			0.4
	Earnings taxed at other than United States statutory rate	(1.4	)		(2.6	)		(1.7	)
	Other, net	(1.6	)		(1.0	)		(1.1	)
	Effective tax rate	32.4	%		32.1	%		32.6	%
	The components of deferred tax assets (liabilities) are as follows at December 31:
		2013				2012
	Deferred tax liabilities:
	Goodwill and intangible assets	$	(475	)		$	(476	)
	Property, plant and equipment	(375		)		(365		)
	Other	(237		)		(200		)
		(1,087		)		(1,041		)
	Deferred tax assets:
	Pension and other retiree benefits	448				544
	Tax loss and tax credit carryforwards	28				61
	Accrued liabilities	317				280
	Stock-based compensation	116				113
	Other	95				117
		1,004				1,115
	Net deferred income taxes	$	(83	)		$	74
		2013				2012
	Deferred taxes included within:
	Assets:
	Other current assets	$	284			$	275
	Deferred income taxes	77				92
	Liabilities:
	Deferred income taxes	(444		)		(293		)
	Net deferred income taxes	$	(83	)		$	74
	Applicable U.S. income and foreign withholding taxes have not been provided on approximately $4,700 of undistributed earnings of foreign subsidiaries at December 31, 2013. These earnings have been and currently are considered to be indefinitely reinvested outside of the U.S. and currently are not subject to such taxes. Determining the tax liability that would arise if these earnings were remitted is not practicable.
	In addition, net tax expense of $116 in 2013, and net tax benefits of $80 in 2012 and $79 in 2011 recorded directly through equity predominantly include current and future tax impacts related to employee equity compensation and benefit plans.
	The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return.
	Unrecognized tax benefits activity for the years ended December 31, 2013, 2012 and 2011 is summarized below:
		2013				2012				2011
	Unrecognized tax benefits:
	Balance, January 1	$	212			$	176			$	171
	Increases as a result of tax positions taken during the current year	23				34				76
	Decreases of tax positions taken during prior years	(52		)		(6		)		(46		)
	Increases of tax positions taken during prior years	37				10				10
	Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations	(22		)		(3		)		(30		)
	Effect of foreign currency rate movements	1				1				(5		)
	Balance, December 31	$	199			$	212			$	176
If all of the unrecognized tax benefits for 2013 above were recognized, approximately $173 would impact the effective tax rate.  Although it is possible that the amount of unrecognized benefits with respect to our uncertain tax positions will increase or decrease in the next 12 months, the Company does not expect material changes.
The Company recognized approximately $5, $5 and $0 of interest (income) expense related to the above unrecognized tax benefits within income tax expense in 2013, 2012 and 2011, respectively.  The Company had accrued interest of approximately $24 and $19 as of December 31, 2013 and 2012, respectively.
The Company and its subsidiaries file U.S. federal income tax returns as well as income tax returns in many state and foreign jurisdictions.  All U.S. federal income tax returns through December 31, 2009 have been audited by, and settled with, the IRS. Limited matters with respect to years 2002 through 2007 had been in administrative appeals and were settled during 2013 with no adverse effect on the Company’s results of operations, cash flows or financial condition. With a few exceptions, the Company is no longer subject to U.S., state and local income tax examinations for the years prior to 2009. In addition, the Company has subsidiaries in various foreign jurisdictions that have statutes of limitations for tax audits generally ranging from three to six years.

Earnings_Per_Share

Earnings Per Share	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Earnings Per Share	'
	Earnings Per Share
		For the Year Ended 2013					For the Year Ended 2012					For the Year Ended 2011
		Net income attributable to Colgate-Palmolive Company		Shares	Per		Net income attributable to Colgate-Palmolive Company		Shares	Per		Net income attributable to Colgate-Palmolive Company		Shares	Per
				(millions)	Share				(millions)	Share				(millions)	Share
	Basic EPS	2,241		930.8	$	2.41	2,472		952.1	$	2.6	2,431		976.7	$	2.49
	Stock options and restricted stock units			9.1					8.1					7.4
	Diluted EPS	$	2,241	939.9	$	2.38	$	2,472	960.2	$	2.57	$	2,431	984.1	$	2.47
	Basic earnings per common share is computed by dividing net income available for common stockholders by the weighted-average number of shares of common stock outstanding for the period.
	Diluted earnings per common share is computed using the treasury stock method on the basis of the weighted-average number of shares of common stock plus the dilutive effect of potential common shares outstanding during the period. Dilutive potential common shares include outstanding stock options and restricted stock units.
	As a result of the 2013 Stock Split (see Note 8, Capital Stock and Stock-Based Compensation Plans), all historical per share data and numbers of shares outstanding were retroactively adjusted.
	As of December 31, 2013, 2012 and 2011, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 1,785,032, 3,504,608 and 3,063,536, respectively.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Commitments and Contingencies	'
	Commitments and Contingencies
	Minimum rental commitments under noncancellable operating leases, primarily for office and warehouse facilities, are $196 in 2014, $172 in 2015, $138 in 2016, $126 in 2017, $121 in 2018 and $349 thereafter. Rental expense amounted to $232 in 2013, $228 in 2012 and $245 in 2011. Capital leases included in fixed assets, contingent rentals and sublease income are not significant. The Company has various contractual commitments to purchase raw, packaging and other materials totaling approximately $800 at December 31, 2013.
	As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.
	As a matter of course, the Company is regularly audited by the IRS and other tax authorities around the world in countries where it conducts business. In this regard, all U.S. federal income tax returns through December 31, 2009 have been audited by, and settled with, the IRS. Limited matters with respect to years 2002 through 2007 had been in administrative appeals and were settled during 2013 with no adverse effect on the Company’s results of operations, cash flows or financial condition. With a few exceptions, the Company is no longer subject to U.S., state and local income tax examinations for the years prior to 2009. In addition, the Company has subsidiaries in various foreign jurisdictions that have statutes of limitations for tax audits generally ranging from three to six years.
	The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.
	The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $250 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company from the matters in question. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.
	Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more of these matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.
	Brazilian Matters
	There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”).
	The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, at the current exchange rate, are approximately $120. The Company has been disputing the disallowances by appealing the assessments within the internal revenue authority’s appellate process with the following results to date:
	▪	In June 2005, the First Board of Taxpayers ruled in the Company’s favor and allowed all of the previously claimed deductions for 1996 through 1998. In March 2007, the First Board of Taxpayers ruled in the Company’s favor and allowed all of the previously claimed deductions for 1999 through 2001. The tax authorities appealed these decisions to the next administrative level.
	▪	In August 2009, the First Taxpayers’ Council (the next and final administrative level of appeal) overruled the decisions of the First Board of Taxpayers, upholding the majority of the assessments, disallowing a portion of the assessments and remanding a portion of the assessments for further consideration by the First Board of Taxpayers.
	The Company has filed a motion for clarification with a special appeals chamber of the Taxpayers’ Council and further appeals are available within the Brazilian federal courts. The Company intends to challenge these assessments vigorously. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel and other advisors, that the disallowances are without merit and that the Company should ultimately prevail on appeal, if necessary, in the Brazilian federal courts.
	In 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company intends to challenge this action vigorously.
	In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest and penalties of approximately $75, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company is disputing the assessment within the internal revenue authority’s administrative appeals process. In October 2007, the Second Board of Taxpayers, which has jurisdiction over these matters, ruled in favor of the internal revenue authority. In January 2008, the Company appealed this decision, and in January 2012, a special appeals chamber of the Taxpayers’ Council denied the Company’s appeal. The Company has filed a motion for clarification with a special appeals chamber of the Taxpayers’ Council and further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the advice of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should prevail on appeal, if not at the administrative level, in the Brazilian federal courts. The Company intends to challenge this assessment vigorously.
	Competition Matters
	European Competition Matters
	Certain of the Company’s subsidiaries in Europe are subject to investigations, and in some cases, fines by governmental authorities in a number of European countries related to potential competition law violations. The Company understands that substantially all of these matters also involve other consumer goods companies and/or retail customers. The status of the various pending matters is discussed below.
	Fines have been imposed on the Company in the following matters, although, as noted below, the Company has appealed each of these fines:
	▪	In December 2009, the Swiss competition law authority imposed a fine of $6 on the Company’s GABA subsidiary for alleged violations of restrictions on parallel imports into Switzerland, which the Company appealed. In January 2014, this appeal was denied. The Company is appealing before the Swiss Supreme Court.
	▪	In January 2010, the Company’s Spanish subsidiary was fined $3 by the Spanish competition law authority on the basis that it had entered an agreement with other shower gel manufacturers regarding product downsizing, which the Company contested. The fine was annulled by the Court of Appeal in July 2013. The Spanish competition law authority is appealing this judgment before the Spanish Supreme Court.
	▪	In December 2010, the Italian competition law authority found that 16 consumer goods companies, including the Company’s Italian subsidiary, exchanged competitively sensitive information in the cosmetics sector, for which the Company’s Italian subsidiary was fined $3. The Company is appealing the fine in the Italian courts.
	▪	In December 2011, the French competition law authority found that four consumer goods companies had entered into agreements on pricing and promotion of heavy duty detergents for which the Company’s French subsidiary was fined $46 in connection with a divested business. The decision was confirmed by the Court of Appeal in January 2014, and the Company is reviewing this decision to evaluate its options.
	▪	In March 2012, the French competition law authority found that three pet food producers, including the Company’s Hill’s French subsidiary, had violated the competition law, for which it imposed a fine of $7 on the Company’s Hill’s French subsidiary for alleged restrictions on exports from France, which the Company contested. In October 2013, the Company’s appeal was denied. The Company is appealing before the French Supreme Court.
	Currently, formal claims of violations or statements of objections are pending against the Company as follows:
	▪	In October 2012, the Belgian competition law authority alleged that 11 branded goods companies, including the Company’s Belgian subsidiary, assisted retailers to coordinate their retail prices on the Belgian market. The Company is in the process of responding to this statement of objections.
	▪	In June 2013, the French competition law authority issued a statement of objections alleging that the Company’s French subsidiary and a number of its competitors exchanged sensitive information related to the French home care and personal care sectors. The Company has responded to this statement of objections.
	An investigation is ongoing in Greece, but no formal claim of violations has been filed.
	In March 2013, the German competition authority completed its investigation into alleged exchange of sensitive information by 17 branded goods companies and no penalties were imposed against the Company or its German subsidiary.
	Australian Competition Matter
	In December 2013, the Australian competition law authority instituted civil proceedings in the Sydney registry of the Federal Court of Australia alleging that three consumer goods companies, including the Company’s Australian subsidiary, a retailer and a former employee of the Company’s Australian subsidiary violated the Australian competition law by coordinating the launching and pricing of ultra concentrated laundry detergents. The Company intends to challenge these proceedings vigorously. Since the amount of any potential losses from these proceedings cannot be estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these proceedings.
	The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. Competition and antitrust law investigations often continue for several years and can result in substantial fines for violations that are found. While the Company cannot predict the final financial impact of these competition law issues as these matters may change, the Company evaluates developments in these matters quarterly and accrues liabilities as and when appropriate.
	Talcum Powder Matters
	The Company is a defendant in a number of civil actions alleging that certain talc products it sold prior to 1996 were contaminated with asbestos. Since 2008, the Company has and will continue to challenge these cases vigorously, and although there can be no assurances, it believes, based on the advice of its legal counsel, that they are without merit and the Company should ultimately prevail. Currently, there are 13 single plaintiff cases pending against the Company in state courts in Delaware, Maryland, New Jersey and New York and one case pending in federal court in North Carolina. Fourteen similar cases previously filed against the Company have been dismissed and final judgment entered in favor of the Company. To date, there have been no findings of liability against the Company in any of these cases. Since the amount of any potential losses from these cases at trial cannot be estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases.
	In 2014, several of these cases are tentatively scheduled to go to trial, although the Company may succeed in dismissing some or all of them prior to trial. As stated above, the Company believes that it will ultimately prevail as it has in all similar cases.
	ERISA Matters
	In October 2007, a putative class action claiming that certain aspects of the cash balance portion of the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) do not comply with the Employee Retirement Income Security Act was filed against the Plan and the Company in the United States District Court for the Southern District of New York. Specifically, Proesel, et al. v. Colgate-Palmolive Company Employees’ Retirement Income Plan, et al. alleges improper calculation of lump sum distributions, age discrimination and failure to satisfy minimum accrual requirements, thereby resulting in the underpayment of benefits to Plan participants.
	Two other putative class actions filed earlier in 2007, Abelman, et al. v. Colgate-Palmolive Company Employees’ Retirement Income Plan, et al., in the United States District Court for the Southern District of Ohio, and Caufield v. Colgate-Palmolive Company Employees’ Retirement Income Plan, in the United States District Court for the Southern District of Indiana, both alleging improper calculation of lump sum distributions and, in the case of Abelman, claims for failure to satisfy minimum accrual requirements, were transferred to the Southern District of New York and consolidated with Proesel into one action, In re Colgate-Palmolive ERISA Litigation. The complaint in the consolidated action alleges improper calculation of lump sum distributions and failure to satisfy minimum accrual requirements, but does not include a claim for age discrimination. The relief sought includes recalculation of benefits in unspecified amounts, pre- and post-judgment interest, injunctive relief and attorneys’ fees. In October 2013, the parties executed a settlement agreement under which the Plan would pay approximately $40 after application of certain offsets to resolve the litigation. The settlement agreement is subject to court approval. On December 16, 2013, a motion for preliminary approval of a class action settlement, class certification and appointment of class counsel was approved and a final approval hearing is scheduled for April 4, 2014. The Company and the Plan intend to contest this action vigorously should the settlement not be approved and finalized.

Venezuela

Venezuela	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Venezuela	'
	Venezuela
	Effective January 1, 2010, Venezuela was designated hyper-inflationary and, therefore, the functional currency for the Company’s Venezuelan subsidiary (“CP Venezuela”) is the U.S. dollar and Venezuelan currency fluctuations are reported in income.
	The Venezuelan government devalued its currency effective February 9, 2013. As a result of the devaluation the official exchange rate changed from 4.30 to 6.30 Venezuelan bolivares fuerte per dollar. The Company incurred a one-time pretax loss of $172 ($111 aftertax loss) in the first quarter of 2013 related to the remeasurement of the net monetary assets included in the local balance sheet at the date of the devaluation. The impact of this one-time aftertax loss of $111 on diluted earnings per common share was $0.12 for the year ended December 31, 2013. The Company remeasured the financial statements of CP Venezuela at the rate at which it expects to remit future dividends, which was 6.30 for 2013 and 4.30 for 2012 and 2011. As the local currency operations in Venezuela translated into fewer U.S. dollars, this had and will continue to have an ongoing adverse effect on the Company’s reported results.
	For the year ended December 31, 2013, CP Venezuela represented approximately 4% of the Company’s consolidated Net sales. At December 31, 2013, CP Venezuela’s bolivar fuerte-denominated net monetary asset position, which would be subject to remeasurement in the event of a further devaluation, was approximately $600. This amount does not include $233 of devaluation-protected bonds issued by the Venezuelan government, as these bonds provide protection against devaluations by adjusting the amount of bolivares fuerte received at maturity for any devaluation subsequent to issuance. CP Venezuela’s local currency-denominated non-monetary assets were approximately $335 at December 31, 2013 and included approximately $225 of fixed assets that could be subject to impairment if the Company continues to be unable to implement price increases to offset the impacts of continued high inflation or further devaluations or if it does not have sufficient access to U.S. dollars to fund imports.

Segment_Information

Segment Information	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Segment Information	'
	Segment Information
	The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition.  The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia. During 2013, the Company made certain changes in its segment reporting affecting several of the geographic operating segments within its Oral, Personal and Home Care product segment. These changes have no impact on the Company’s historical consolidated financial position, results of operations or cash flows.
	Effective January 1, 2013, the Company realigned the geographic structure of its North America and Latin America reportable operating segments. In order to better leverage Latin America management’s knowledge of emerging market consumers to accelerate growth in the region, management responsibility for the Puerto Rico and CARICOM operations was transferred from North America to Latin America management. Accordingly, commencing with the Company’s financial reporting for the quarter ended March 31, 2013, the results of the Puerto Rico and CARICOM operations, which represent less than 1% of the Company’s global business, are reported in the Latin America reportable operating segment. Previously, Puerto Rico and CARICOM represented approximately 4% of Net sales of North America and now represent approximately 3% of Net sales of Latin America.
	Given the growing importance of the Company’s operations in emerging markets, effective with the quarter ended September 30 2013, the Company began to separately report financial information for its Asia and Africa/Eurasia operating segments. Previously, the financial information for these operating segments was aggregated into the Greater Asia/Africa reportable operating segment.
	The Company has recast its historical geographic segment information to conform to the new reporting structure which results in modification to the geographic components of the Oral, Personal and Home Care segment, with no impact on historical Company results overall.
	The Company evaluates segment performance based on several factors, including Operating profit.  The Company uses Operating profit as a measure of the operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes.
	The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies.  Intercompany sales have been eliminated.  Corporate operations include costs related to stock options and restricted stock unit awards, research and development costs, Corporate overhead costs, restructuring and related implementation costs, and gains and losses on sales of non-core product lines and assets.  The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.
	Approximately 80% of the Company’s Net sales are generated from markets outside the U.S., with over 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).
	In 2013, Corporate Operating profit (loss) includes charges of $371 associated with the 2012 Restructuring Program, a one-time $172 charge for the impact of the devaluation in Venezuela, a charge of $23 for a competition law matter in France related to the home care and personal care sectors and costs of $18 related to the sale of land in Mexico. In 2012, Corporate Operating profit (loss) included charges of $89 associated with the 2012 Restructuring Program, costs of $21 associated with various business realignment and other cost-saving initiatives and costs of $24 related to the sale of land in Mexico. In 2011, Corporate Operating profit (loss) included a gain on the sale of the non-core laundry detergent business in Colombia of $207, costs of $190 associated with various business realignment and other cost-saving initiatives, costs of $13 related to the sale of land in Mexico and a charge of $21 for a competition law matter in France related to a divested detergent business. The various business realignment and other cost-saving initiatives included the integration of Sanex, the right-sizing of the Colombia business and the closing of an oral care facility in Mississauga, Canada and a Hill’s facility in Los Angeles, California. For further information regarding the 2012 Restructuring Program, refer to Note 4, Restructuring and Related Implementation Charges. For further information regarding Venezuela, refer to Note 14, Venezuela. For further information regarding the competition law matter in France, refer to Note 13, Commitments and Contingencies. For further information regarding the sale of land in Mexico and the sale of the non-core laundry detergent business in Colombia, refer to Note 3, Acquisitions and Divestitures.
			2013			2012			2011
	Net sales
	Oral, Personal and Home Care
	North America(1)		$	3,072		$	2,971		$	2,878
	Latin America		5,012			5,032			4,895
	Europe/South Pacific		3,396			3,417			3,508
	Asia		2,472			2,264			2,074
	Africa/Eurasia		1,257			1,241			1,207
	Total Oral, Personal and Home Care		15,209			14,925			14,562
	Pet Nutrition(2)		2,211			2,160			2,172
	Total Net sales		$	17,420		$	17,085		$	16,734
	_________
	(1)	Net sales in the U.S. for Oral, Personal and Home Care were $2,771, $2,669 and $2,567 in 2013, 2012 and 2011, respectively.
	(2)	Net sales in the U.S. for Pet Nutrition were $1,116, $1,052 and $1,032 in 2013, 2012 and 2011, respectively.
			2013			2012			2011
	Operating profit
	Oral, Personal and Home Care
	North America		$	927		$	810		$	768
	Latin America		1,385			1,454			1,437
	Europe/South Pacific		805			747			715
	Asia		698			619			565
	Africa/Eurasia		268			267			242
	Total Oral, Personal and Home Care		4,083			3,897			3,727
	Pet Nutrition		563			589			560
	Corporate		(1,090		)	(597		)	(446		)
	Total Operating profit		$	3,556		$	3,889		$	3,841
			2013			2012			2011
	Capital expenditures
	Oral, Personal and Home Care
	North America		$	54		$	43		$	53
	Latin America		235			237			195
	Europe/South Pacific		74			71			64
	Asia		123			88			103
	Africa/Eurasia		11			16			16
	Total Oral, Personal and Home Care		497			455			431
	Pet Nutrition		45			37			32
	Corporate		128			73			74
	Total Capital expenditures		$	670		$	565		$	537
			2013			2012			2011
	Depreciation and amortization
	Oral, Personal and Home Care
	North America		$	51		$	50		$	56
	Latin America		93			91			92
	Europe/South Pacific		85			85			82
	Asia		72			70			67
	Africa/Eurasia		11			11			12
	Total Oral, Personal and Home Care		312			307			309
	Pet Nutrition		51			50			51
	Corporate		76			68			61
	Total Depreciation and amortization		$	439		$	425		$	421
			2013			2012			2011
	Identifiable assets
	Oral, Personal and Home Care
	North America		$	2,301		$	2,157		$	2,247
Latin America		4,122			4,288			3,677
Europe/South Pacific		3,949			3,649			3,555
Asia		1,794			1,608			1,548
Africa/Eurasia		557			561			521
Total Oral, Personal and Home Care		12,723			12,263			11,548
Pet Nutrition		1,087			1,045			1,078
Corporate(3)		66			86			98
Total Identifiable assets(4)		$	13,876		$	13,394		$	12,724
____________
(3)	In 2013, Corporate identifiable assets primarily consist of derivative instruments (32%) and investments in equity securities (41%).  In 2012, Corporate identifiable assets primarily consist of derivative instruments (67%) and investments in equity securities (28%).  In 2011, Corporate identifiable assets primarily consist of derivative instruments (73%) and investments in equity securities (22%).
(4)	Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $8,248, $8,066 and $7,926 in 2013, 2012 and 2011, respectively.

Supplemental_Income_Statement_

Supplemental Income Statement Information	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Supplemental Income Statement Information	'
	Supplemental Income Statement Information
	Other (income) expense, net	2013			2012			2011
	Amortization of intangible assets	$	32		$	31		$	28
	2012 Restructuring Program	202			81			—
	Venezuela devaluation charge	172			—			—
	Charges for French competition law matters	23			—			21
	Costs related to the sale of land in Mexico	3			—			13
	Business realignment and other cost-saving initiatives	—			2			136
	Gain on sales of non-core product lines	—			—			(207		)
	Sanex acquisition transaction costs	—			—			12
	Equity (income)	(5		)	(7		)	(6		)
	Other, net	(5		)	6			(6		)
	Total Other (income) expense, net	$	422		$	113		$	(9	)
	Interest (income) expense, net	2013			2012			2011
	Interest incurred	$	119		$	81		$	59
	Interest capitalized	(3		)	(1		)	(1		)
	Interest income	(125		)	(65		)	(6		)
	Total Interest (income) expense, net	$	(9	)	$	15		$	52
		2013			2012			2011
	Research and development	$	267		$	259		$	262
	Advertising	$	1,891		$	1,792		$	1,734

Supplemental_Balance_Sheet_Inf

Supplemental Balance Sheet Information	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Supplemental Balance Sheet Information	'
	Supplemental Balance Sheet Information
	Inventories by major class are as follows:
	Inventories	2013			2012
	Raw materials and supplies	$	340		$	362
	Work-in-process	60			81
	Finished goods	1,025			922
	Total Inventories	$	1,425		$	1,365
	Inventories valued under LIFO amounted to $289 and $268 at December 31, 2013 and 2012, respectively. The excess of current cost over LIFO cost at the end of each year was $37. The liquidations of LIFO inventory quantities had no material effect on income in 2013, 2012 and 2011.
	Property, plant and equipment, net	2013			2012
	Land	$	254		$	251
	Buildings	1,625			1,439
	Manufacturing machinery and equipment	5,220			4,987
	Other equipment	1,231			1,144
		8,330			7,821
	Accumulated depreciation	(4,247		)	(3,979		)
	Total Property, plant and equipment, net	$	4,083		$	3,842
	Other accruals	2013			2012
	Accrued advertising and coupon redemption	$	676		$	646
	Accrued payroll and employee benefits	361			345
	Accrued taxes other than income taxes	22			48
	Restructuring accrual	142			89
	Pension and other retiree benefits	94			86
	Accrued interest	27			26
	Derivatives	11			10
	Other	647			638
	Total Other accruals	$	1,980		$	1,888
	Other liabilities	2013			2012
	Pension and other retiree benefits	$	1,387		$	1,786
	Restructuring accrual	16			—
	Other	274			263
	Total Other liabilities	$	1,677		$	2,049

Supplemental_Comprehensive_Inc

Supplemental Comprehensive Income Information	12 Months Ended
	Dec. 31, 2013
Other Comprehensive Income (Loss), Net of Tax [Abstract]	'
Supplemental Comprehensive Income Information	'
	Supplemental Other Comprehensive Income (Loss) Information
	Other Comprehensive Income (Loss) components attributable to Colgate-Palmolive Company before tax and net of tax during the years ended December 31 were as follows:
			2013						2012						2011
			Pre-tax			Net of Tax			Pre-tax			Net of Tax			Pre-tax			Net of Tax
	Cumulative translation adjustments		$	(188	)	$	(163	)	$	18		$	(20	)	$	(291	)	$	(298	)
	Pension and other benefits:
	Net actuarial gain (loss) and prior		295			189			(317		)	(207		)	(249		)	(163		)
	service costs arising during the
	period
	Amortization of net actuarial loss,		111			70			101			62			85			55
	transition and prior service costs(1)
	Curtailment loss - unamortized		91			59			—			—			—			—
	prior service costs(1)
	Retirement Plan and other retiree benefit		497			318			(216		)	(145		)	(164		)	(108		)
	adjustments
	Available-for-sale securities:
	Unrealized gains (losses) on available-		(113		)	(73		)	28			18			60			46
	for-sale securities
	Reclassification of (gains) losses		133			86			—			—			—			—
	into net earnings on available-
	for-sale securities(2)
	Gains (losses) on available-for-sale		20			13			28			18			60			46
	securities
	Cash flow hedges:
	Unrealized gains (losses) on cash flow		20			13			13			8			(10		)	(7		)
	hedges
	Reclassification of (gains) losses		(17		)	(11		)	(11		)	(7		)	9			7
	into net earnings on cash flow
	hedges(3)
	Gains (losses) on cash flow hedges		3			2			2			1			(1		)	—
	Total Other comprehensive income (loss)		$	332		$	170		$	(168	)	$	(146	)	$	(396	)	$	(360	)
	_________
	(1)	These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.
	(2)	Represents the one-time loss related to the remeasurement of the fixed interest rate bonds in Venezuela, which was recorded in Other (income) expense, net. See Note 7, Fair Value Measurements and Financial Instruments for additional details.
	(3)	These (gains) losses are reclassified into Cost of sales. See Note 7, Fair Value Measurements and Financial Instruments for additional details.
	There were no tax impacts on Other comprehensive income (loss) attributable to Noncontrolling interests.
	Accumulated Other Comprehensive Income (Loss)
	Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs, unrealized gains and losses from derivative instruments designated as cash flow hedges and unrealized gains and losses on available-for-sale securities. At December 31, 2013 and 2012, Accumulated other comprehensive income (loss) consisted primarily of aftertax unrecognized pension and other retiree benefit costs of $735 and $1,053, respectively, and cumulative foreign currency translation adjustments of $1,772 and $1,609, respectively. Foreign currency translation adjustments in 2013 primarily reflect gains from the Mexican peso, the Euro and the Swiss franc, which were offset by losses from the Brazilian real, the Australian dollar and the Argentine peso. In 2012, foreign currency translation adjustments primarily reflect gains from the Mexican peso and the Swiss franc, which were partially offset by losses from the Brazilian real, as well as deferred tax related to intercompany loans considered to be long-term in nature.

Quarterly_Financial_Data_Unaud

Quarterly Financial Data (Unaudited)	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Quarterly Financial Data (Unaudited)	'
	Quarterly Financial Data (Unaudited)
		Total			First			Second			Third			Fourth
					Quarter			Quarter			Quarter			Quarter
	2013
	Net sales	$	17,420		$	4,315		$	4,346		$	4,398		$	4,361
	Gross profit	10,201		(1)	2,515		(3)	2,534		(5)	2,585		(7)	2,567		(9)
	Net income including noncontrolling interests	2,410		(2)	506		(4)	604		(6)	699		(8)	601		(10)
	Net income attributable to Colgate-Palmolive Company	2,241		(2)	460		(4)	561		(6)	656		(8)	564		(10)
	Earnings per common share:
	Basic	2.41		(2)	0.49		(4)	0.6		(6)	0.71		(8)	0.61		(10)
	Diluted	2.38		(2)	0.48		(4)	0.6		(6)	0.7		(8)	0.6		(10)
	2012
	Net sales	$	17,085		$	4,200		$	4,267		$	4,332		$	4,286
	Gross profit	9,932		(11)	2,437		(13)	2,461		(15)	2,529		(17)	2,505		(19)
	Net income including noncontrolling interests	2,631		(12)	633		(14)	665		(16)	697		(18)	636		(20)
	Net income attributable to Colgate-Palmolive Company	2,472		(12)	593		(14)	627		(16)	654		(18)	598		(20)
	Earnings per common share:
	Basic	2.6		(12)	0.62		(14)	0.66		(16)	0.69		(18)	0.63		(20)
	Diluted	2.57		(12)	0.61		(14)	0.65		(16)	0.68		(18)	0.63		(20)
	____________
	Note:	Basic and diluted earnings per share are computed independently for each quarter and the year-to-date period presented. Accordingly, the sum of the quarterly earnings per common share may not necessarily equal the earnings per share for the year-to-date period.
	(1)	Gross profit for the full year of 2013 includes $32 of charges related to the 2012 Restructuring Program and $15 of costs related to the sale of land in Mexico.
	(2)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2013 include $278 of aftertax charges related to the 2012 Restructuring Program, a $111 one-time aftertax charge for the impact of the devaluation in Venezuela, a $23 charge for a competition law matter in France related to the home care and personal care sectors and $12 of aftertax costs related to the sale of land in Mexico.
	(3)	Gross profit for the first quarter of 2013 includes $8 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
	(4)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the first quarter of 2013 include $52 of aftertax charges related to the 2012 Restructuring Program, a $111 one-time aftertax charge for the impact of the devaluation in Venezuela and $3 of aftertax costs related to the sale of land in Mexico.
	(5)	Gross profit for the second quarter of 2013 includes $10 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
	(6)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the second quarter of 2013 include $79 of aftertax charges related to the 2012 Restructuring Program, an $18 charge for a competition law matter in France related to the home care and personal care sectors and $4 of aftertax costs related to the sale of land in Mexico.
	(7)	Gross profit for the third quarter of 2013 includes $8 of charges related to the 2012 Restructuring Program and $3 of costs related to the sale of land in Mexico.
	(8)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the third quarter of 2013 include $22 of aftertax charges related to the 2012 Restructuring Program and $2 of aftertax costs related to the sale of land in Mexico.
	(9)	Gross profit for the fourth quarter of 2013 includes $6 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
	(10)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the fourth quarter of 2013 include $125 of aftertax charges related to the 2012 Restructuring Program, a $5 charge for a competition law matter in France related to the home care and personal care sectors and $3 of aftertax costs related to the sale of land in Mexico.
	(11)	Gross profit for the full year of 2012 includes $2 of charges related to the 2012 Restructuring Program, $24 of costs related to the sale of land in Mexico and $5 of costs associated with various business realignment and other cost-saving initiatives.
	(12)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2012 include $70 of aftertax charges related to the 2012 Restructuring Program, $18 of aftertax costs related to the sale of land in Mexico and $14 of aftertax costs associated with various business realignment and other cost-saving initiatives.
	(13)	Gross profit for the first quarter of 2012 includes $7 of costs related to the sale of land in Mexico and $2 of costs associated with various business realignment and other cost-saving initiatives.
	(14)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the first quarter of 2012 include $5 of aftertax costs related to the sale of land in Mexico and $3 of aftertax costs associated with various business realignment and other cost-saving initiatives.
	(15)	Gross profit for the second quarter of 2012 includes $6 of costs related to the sale of land in Mexico and $2 of costs associated with various business realignment and other cost-saving initiatives.
	(16)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the second quarter of 2012 include $5 of aftertax costs related to the sale of land in Mexico and $9 of aftertax costs associated with various business realignment and other cost-saving initiatives.
	(17)	Gross profit for the third quarter of 2012 includes $7 of costs related to the sale of land in Mexico and $1 of costs associated with various business realignment and other cost-saving initiatives.
	(18)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the third quarter of 2012 include $5 of aftertax costs related to the sale of land in Mexico and $2 of aftertax costs associated with various business realignment and other cost-saving initiatives.
	(19)	Gross profit for the fourth quarter of 2012 includes $2 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
	(20)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the fourth quarter of 2012 include $70 of aftertax charges related to the 2012 Restructuring Program and $3 of aftertax costs related to the sale of land in Mexico.

Schedule_II_Valuation_and_Qual

Schedule II - Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2013
Schedule II - Valuation and Qualifying Accounts [Abstract]	'
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS	'
	Column A	Column B		Column C				Column D			Column E
				Additions
		Balance at Beginning of Period		Charged to Costs and Expenses		Other		Deductions			Balance at End of Period
	Year Ended December 31, 2013
	Allowance for doubtful accounts and estimated returns	$	61	$	15	$	—	$	9		$	67
	Valuation allowance for deferred tax assets	$	1	$	6	$	—	$	(1	)	$	6
	Year Ended December 31, 2012
	Allowance for doubtful accounts and estimated returns	$	49	$	18	$	—	$	6		$	61
	Valuation allowance for deferred tax assets	$	1	$	—	$	—	$	—		$	1
	Year Ended December 31, 2011
	Allowance for doubtful accounts and estimated returns	$	53	$	6	$	—	$	10		$	49
	Valuation allowance for deferred tax assets	$	1	$	—	$	—	$	—		$	1

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Principles of Consolidation	'
	Principles of Consolidation
	The Consolidated Financial Statements include the accounts of Colgate-Palmolive Company and its majority-owned or controlled subsidiaries. Intercompany transactions and balances have been eliminated. The Company’s investments in consumer products companies with interests ranging between 20% and 50%, where the Company has significant influence over the investee, are accounted for using the equity method. Net income (loss) from such investments is recorded in Other (income) expense, net in the Consolidated Statements of Income. As of December 31, 2013 and 2012, equity method investments included in Other assets in the Consolidated Balance Sheets were $27 and $25, respectively. Unrelated third parties hold the remaining ownership interests in these investments. Investments with less than a 20% interest are accounted for using the cost method.
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to use judgment and make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are completed. As such, the most significant uncertainty in the Company’s assumptions and estimates involved in preparing the financial statements includes pension and other retiree benefit cost assumptions, stock-based compensation, asset impairments, uncertain tax positions, tax valuation allowances and legal and other contingency reserves. Additionally, the Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments and retirement plan assets. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. Actual results could ultimately differ from those estimates.
Revenue Recognition	'
	Revenue Recognition
	Sales are recorded at the time products are shipped to trade customers and when risk of ownership transfers. Net sales reflect units shipped at selling list prices reduced by sales returns and the cost of current and continuing promotional programs. Current promotional programs, such as product listing allowances and co-operative advertising arrangements, are recorded in the period incurred. Continuing promotional programs are predominantly consumer coupons and volume-based sales incentive arrangements with trade customers. The redemption cost of consumer coupons is based on historical redemption experience and is recorded when coupons are distributed. Volume-based incentives offered to trade customers are based on the estimated cost of the program and are recorded as products are sold.
Shipping and Handling Costs	'
	Shipping and Handling Costs
	Shipping and handling costs are classified as Selling, general and administrative expenses and were $1,304, $1,262 and $1,250 for the years ended December 31, 2013, 2012 and 2011, respectively.
Marketing Costs	'
	Marketing Costs
	The Company markets its products through advertising and other promotional activities. Advertising costs are included in Selling, general and administrative expenses and are expensed as incurred. Certain consumer and trade promotional programs, such as consumer coupons, are recorded as a reduction of sales.
Cash and Cash equivalents	'
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents.
Inventories	'
	Inventories
	Inventories are stated at the lower of cost or market. The cost of approximately 80% of inventories is determined using the first-in, first-out (“FIFO”) method. The cost of all other inventories, predominantly in the U.S. and Mexico, is determined using the last-in, first-out (“LIFO”) method.
Property, Plant and Equipment	'
	Property, Plant and Equipment
	Land, buildings and machinery and equipment are stated at cost. Depreciation is provided, primarily using the straight-line method, over estimated useful lives ranging from 3 to 15 years for machinery and equipment and up to 40 years for buildings. Depreciation attributable to manufacturing operations is included in Cost of sales. The remaining component of depreciation is included in Selling, general and administrative expenses.
Goodwill and Other Intangibles	'
	Goodwill and Other Intangibles
	Goodwill and indefinite life intangible assets, such as the Company’s global brands, are subject to impairment tests at least annually. These tests were performed and did not result in an impairment charge. Other intangible assets with finite lives, such as local brands and trademarks, customer relationships and non-compete agreements, are amortized over their useful lives, generally ranging from 5 to 40 years. Amortization expense related to intangible assets is included in Other (income) expense, net, which is included in Operating profit.
Income Taxes	'
	Income Taxes
	The provision for income taxes is determined using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized based upon the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates that will be in effect at the time such differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Provision is made currently for taxes payable on remittances of overseas earnings; no provision is made for taxes on overseas retained earnings that are deemed to be permanently reinvested.
	The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return.  The Company recognizes interest expense and penalties related to unrecognized tax benefits within income tax expense.
Financial Instruments	'
	Financial Instruments
	Derivative instruments are recorded as assets and liabilities at estimated fair value based on available market information. The Company’s derivative instruments that qualify for hedge accounting are designated as either fair value hedges, cash flow hedges or net investment hedges. For fair value hedges, changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, are recognized in earnings each period. For cash flow hedges, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) and are recognized in earnings when the offsetting effect of the hedged item is also recognized in earnings. For hedges of the net investment in foreign subsidiaries, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) to offset the change in the value of the net investment being hedged.  Cash flows related to hedges are classified in the same category as the cash flows from the hedged item in the Consolidated Statements of Cash Flows.
	The Company may also enter into certain foreign currency and interest rate instruments that economically hedge certain of its risks but do not qualify for hedge accounting. Changes in fair value of these derivative instruments, based on quoted market prices, are recognized in earnings each period. The Company’s derivative instruments and other financial instruments are more fully described in Note 7, Fair Value Measurements and Financial Instruments along with the related fair value measurement considerations.
Stock-Based Compensation	'
	Stock-Based Compensation
	The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock, based on the fair value of those awards at the date of grant over the requisite service period.  The Company uses the Black-Scholes-Merton (“Black-Scholes”) option pricing model to determine the fair value of stock option awards.  Stock-based compensation plans, related expenses and assumptions used in the Black-Scholes option pricing model are more fully described in Note 8, Capital Stock and Stock-Based Compensation Plans.
Currency Translation	'
	Currency Translation
	The assets and liabilities of foreign subsidiaries, other than those operating in highly inflationary environments, are translated into U.S. dollars at year-end exchange rates with resulting translation gains and losses accumulated in a separate component of shareholders’ equity. Income and expense items are translated into U.S. dollars at average rates of exchange prevailing during the year.
	For subsidiaries operating in highly inflationary environments (currently, Venezuela), non-monetary assets, such as inventories, prepaid expenses, goodwill and property, plant and equipment are remeasured at their historical exchange rates, while monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these operations are included in Net income attributable to Colgate-Palmolive Company.
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	In July 2013, the FASB issued ASU No. 2013-11 “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” The new guidance is effective on a prospective basis for fiscal years beginning after December 15, 2013 and interim periods within those years. This new guidance is not expected to have a material impact on the Company’s financial position or results of operations.
Reclassifications	'
	Reclassifications
	Certain prior year amounts have been reclassified to conform to the current year presentation.

Nature_of_Operations_Tables

Nature of Operations (Tables)	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Percentage of worldwide sales	'
	The Company’s principal classes of products accounted for the following percentages of worldwide Net sales for the past three years:
		2013		2012		2011
	Oral Care	46	%	44	%	43	%
	Personal Care	21	%	22	%	22	%
	Home Care	20	%	21	%	22	%
	Pet Nutrition	13	%	13	%	13	%
	Total	100	%	100	%	100	%

Acquisitions_and_Divestitures_

Acquisitions and Divestitures (Tables)	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Schedule of Business Acquisitions, by Acquisition	'
	Total purchase price consideration of $966 was allocated to the net assets acquired based on their respective fair values at June 20, 2011, as follows:
	Recognized amounts of assets acquired and liabilities assumed:
	Inventories	$	26
	Property, plant and equipment, net	3
	Other intangible assets, net	596
	Goodwill, net	411
	Accrued income taxes	(48		)
	Long-term deferred income taxes	(18		)
	Long-term other liabilities	(4		)
	Fair value of net assets acquired	$	966

Restructuring_and_Related_Impl1

Restructuring and Related Implementation Charges (Tables)	12 Months Ended
	Dec. 31, 2013
Restructuring and Related Activities [Abstract]	'
Schedule of Restructuring and Related Costs	'
	For the years ended December 31, 2013 and 2012, restructuring and implementation-related charges are reflected in the Consolidated Statements of Income as follows:
		2013				2012
	Cost of sales	$	32			$	2
	Selling, general and administrative expenses	137				6
	Other (income) expense, net	202				81
	Total 2012 Restructuring Program charges, pretax	$	371			$	89
	Total 2012 Restructuring Program charges, aftertax	$	278			$	70
Schedule of Restructuring and Related Costs Incurred to Date	'
	Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred pretax cumulative charges of $460 ($348 aftertax) in connection with the implementation of various projects as follows:
		Cumulative Charges
		as of December 31, 2013
	Employee-Related Costs	$	222
	Incremental Depreciation	26
	Asset Impairments	1
	Other	211
	Total	$	460
Schedule of Restructuring Reserve by Type of Cost	'
	The following table summarizes the activity for the restructuring and implementation-related charges discussed above and the related accruals:
			Employee-Related				Incremental			Asset			Other			Total
			Costs				Depreciation			Impairments
	Balance at January 1, 2012		$	—			$	—		$	—		$	—		$	—
	Charges		78				—			—			11			89
	Cash payments		(1		)		—			—			(4		)	(5		)
	Charges against assets		—				—			—			—			—
	Foreign exchange		7				—			—			(2		)	5
	Balance at December 31, 2012		$	84			$	—		$	—		$	5		$	89
	Charges		144				26			1			200			371
	Cash payments		(97		)		—			—			(72		)	(169		)
	Charges against assets		(17		)		(26		)	(1		)	—			(44		)
	Foreign exchange		2				—			—			—			2
	Other		—				—			—			(91		)	(91		)
	Balance at December 31, 2013		$	116			$	—		$	—		$	42		$	158

Goodwill_and_Other_Intangible_1

Goodwill and Other Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Schedule of Goodwill	'
	The net carrying value of Goodwill as of December 31, 2013 and 2012, by segment is as follows:
		2013		2012
	Oral, Personal and Home Care
	North America	$	362	$	372
	Latin America	353		408
	Europe/South Pacific	1,525		1,478
	Asia	126		127
	Africa/Eurasia	93		100
	Total Oral, Personal and Home Care	2,459		2,485
	Pet Nutrition	15		15
	Total Goodwill, net	$	2,474	$	2,500
Schedule Of Finite And Indefinite Lived Intangible Assets By Major Class	'
	Other intangible assets as of December 31, 2013 and 2012 are comprised of the following:
		2013							2012
		Gross Carrying Amount		Accumulated Amortization			Net		Gross Carrying Amount		Accumulated Amortization			Net
	Trademarks	$	551	$	(275	)	$	276	$	548	$	(254	)	$	294
	Other finite life intangible assets	219		(45		)	174		212		(34		)	178
	Indefinite life intangible assets	1,046		—			1,046		1,027		—			1,027
	Total Other intangible assets	$	1,816	$	(320	)	$	1,496	$	1,787	$	(288	)	$	1,499

LongTerm_Debt_and_Credit_Facil1

Long-Term Debt and Credit Facilities (Tables)	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Schedule of Long-term Debt Instruments	'
	Long-term debt consists of the following at December 31:
			Weighted Average Interest Rate	Maturities			2013		2012
	Notes		2.00%	2014	-	2078	$	5,644	$	4,733
	Commercial paper						—		443
							5,644		5,176
	Less: Current portion of long-term debt						895		250
	Total						$	4,749	$	4,926
Schedule of Maturities of Long-term Debt	'
	Excluding commercial paper reclassified as long-term debt, scheduled maturities of long-term debt and capitalized leases outstanding as of December 31, 2013, are as follows:
	Years Ended December 31,
	2014	$	895
	2015	491
	2016	255
	2017	664
	2018	695
	Thereafter	2,644

Fair_Value_Measurements_and_Fi1

Fair Value Measurements and Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	'
	The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at December 31, 2013 and December 31, 2012:
		Assets										Liabilities
		Account		Fair Value								Account	Fair Value
	Designated derivative instruments			12/31/13				12/31/12					12/31/13			12/31/12
	Interest rate swap contracts	Other current assets		$	1			$	3			Other accruals	$	—		$	—
	Interest rate swap contracts	Other assets		20				41				Other liabilities	1			—
	Foreign currency contracts	Other current assets		14				7				Other accruals	8			10
	Foreign currency contracts	Other assets		—				13				Other liabilities	10			—
	Commodity contracts	Other current assets		—				1				Other accruals	—			—
	Total designated			$	35			$	65				$	19		$	10
	Derivatives not designated
	Foreign currency contracts	Other current assets		$	—			$	—			Other accruals	$	3		$	1
	Total not designated			$	—			$	—				$	3		$	1
	Total derivative instruments			$	35			$	65				$	22		$	11
	Other financial instruments
	Marketable securities	Other current assets		$	173			$	116
	Venezuelan bonds, long-term	Other assets		685				618
	Total other financial instruments			$	858			$	734
Activity related to fair value hedges	'
	Activity related to fair value hedges recorded during each period presented was as follows:
		2013											2012
		Foreign				Interest							Foreign			Interest
		Currency				Rate				Total			Currency			Rate			Total
		Contracts				Swaps							Contracts			Swaps
	Notional Value at December 31,	$	1,320			$	1,188			$	2,508		$	1,117		$	1,338		$	2,455
	Gain (loss) on derivative	24				(22		)		2			9			6			15
	Gain (loss) on hedged items	(24		)		22				(2		)	(9		)	(6		)	(15		)
Activity related to cash flow hedges	'
	Activity related to cash flow hedges recorded during each period presented was as follows:
		2013											2012
		Foreign				Commodity							Foreign			Commodity
		Currency				Contracts				Total			Currency			Contracts			Total
		Contracts											Contracts
	Notional Value at December 31,	$	386			$	14			$	400		$	398		$	23		$	421
	Gain (loss) recognized in OCI	20				—				20			4			9			13
	Gain (loss) reclassified into Cost of sales	16				1				17			4			7			11
Activity related to net investment hedges	'
	Activity related to net investment hedges recorded during each period presented was as follows:
		2013											2012
		Foreign				Foreign							Foreign			Foreign
		Currency				Currency				Total			Currency			Currency			Total
		Contracts				Debt							Contracts			Debt
	Notional Value at December 31,	$	529			$	256			$	785		$	522		$	383		$	905
	Gain (loss) on instruments	(24		)		(4		)		(28		)	(11		)	(8		)	(19		)
	Gain (loss) on hedged items	23				4				27			8			8			16
Activity related to derivatives not designated as hedging instruments	'
	Activity related to these contracts during each period presented was as follows:
		2013				2012
		Cross-currency				Cross-currency
		Swap				Swap
	Notional Value at December 31,	$	96			$	96
	Gain (loss) on instrument	(2		)		(4		)
	Gain (loss) on hedged item	2				4
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation	'
		2013				2012
	Beginning balance as of January 1	$	642			$	236
	Unrealized gain (loss) on investment	(113		)		28
	Purchases and sales during the period	156				378
	Ending balance as of December 31	$	685			$	642

Capital_Stock_and_StockBased_C1

Capital Stock and Stock-Based Compensation Plans (Tables)	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Schedule Of Common And Treasury Stock Activity	'
	A summary of common stock and treasury stock activity for the three years ended December 31, is as follows:
		Common Stock Outstanding		Treasury Stock
	Balance, January 1, 2011	989,700,934		476,005,426
	Common stock acquired	(42,641,872	)	42,641,872
	Shares issued for stock options	11,517,758		(11,517,758	)
	Shares issued for restricted stock units and other	1,459,330		(1,459,330	)
	Balance, December 31, 2011	960,036,150		505,670,210
	Common stock acquired	(38,730,602	)	38,730,602
	Shares issued for stock options	12,217,230		(12,217,230	)
	Shares issued for restricted stock units and other	2,205,898		(2,205,898	)
	Balance, December 31, 2012	935,728,676		529,977,684
	Common stock acquired	(25,573,317	)	25,573,317
	Shares issued for stock options	7,883,834		(7,883,834	)
	Shares issued for restricted stock units and other	1,907,382		(1,907,382	)
	Balance, December 31, 2013	919,946,575		545,759,785
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions	'
	Fair value is estimated using the Black-Scholes option pricing model with the assumptions summarized in the following table:
		2013		2012		2011
	Expected Term of Options	4.5 years		4.5 years		4.5 years
	Expected Volatility Rate	18.4	%	20.8	%	21.3	%
	Risk-Free Rate	1.5	%	0.6	%	0.8	%
	Expected Dividend Yield	2.3	%	2.4	%	2.6	%
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity	'
	A summary of restricted stock unit activity during 2013 is presented below:
		Shares		Weighted Average Grant Date Fair Value Per Award
		(in thousands)
	Restricted stock units as of January 1, 2013	5,268		$	43
	Activity:
	Granted	1,214		59
	Vested	(1,854	)	41
	Forfeited	(89	)	45
	Restricted stock units as of December 31, 2013	4,539		$	48
Schedule of Share-based Compensation, Stock Options, Activity	'
	A summary of stock option activity during 2013 is presented below:
		Shares		Weighted Average Exercise Price			Weighted Average Remaining Contractual Life	Value of Unexercised
		(in thousands)					(in years)	In-the-Money Options
	Options outstanding, January 1, 2013	42,342		$	43
	Granted	9,219		59
	Exercised	(8,285	)	38
	Forfeited or expired	(444	)	49
	Options outstanding, December 31, 2013	42,832		47			4	$	773
	Options exercisable, December 31, 2013	24,151		$	42		3	$	572

Retirement_Plans_and_Other_Ret1

Retirement Plans and Other Retiree Benefits (Tables)	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Schedule of Allocation of Plan Assets	'
	The target asset allocation for the Company’s defined benefit plans are as follows:
			United States			International
	Asset Category
	Equity securities		27	%		39	%
	Fixed income securities		53			48
	Real estate and other investments		20			13
	Total		100	%		100	%
	At December 31, 2013 the allocation of the Company’s plan assets and the level of valuation input for each major asset category was as follows:
			Level of Valuation		Pension Plans
			Input		United States				International				Other Retiree
													Benefits
	Investments:
	Cash & cash equivalents		Level 1		$	97			$	23			$	3
	U.S. common stocks		Level 1		127				—				3
	International common stocks		Level 1		51				—				1
	Fixed income securities (a)		Level 2		433				—				8
	Common/collective trust funds (b):		Level 2
	Equity index funds				359				229				9
	Emerging market equity index funds				33				9				1
	Other common stock funds				123				75				3
	Fixed income funds: U.S. or foreign government and agency securities				149				73				3
	Fixed income funds: investment grade corporate bonds				203				71				5
	Fixed income funds: high yield corporate bonds and other				119				1				4
	Guaranteed investment contracts (c)		Level 2		2				56				—
	Real estate funds (d)		Level 3		40				21				1
	Total Investments at fair value				$	1,736			$	558			$	41
	At December 31, 2012 the allocation of the Company’s plan assets and the level of valuation input for each major asset category was as follows:
			Level of Valuation		Pension Plans
			Input		United States				International				Other Retiree
													Benefits
	Investments:
	Cash & cash equivalents		Level 1		$	45			$	9			$	1
	U.S. common stocks		Level 1		258				—				6
	International common stocks		Level 1		93				—				2
	Fixed income securities (a)		Level 2		142				—				—
	Common/collective trust funds (b):		Level 2
	Equity index funds				444				199				11
	Emerging market equity index funds				65				12				2
	Other common stock funds				40				65				1
	Fixed income funds: U.S. or foreign government and agency securities				227				59				6
	Fixed income funds: investment grade corporate bonds				26				72				1
	Fixed income funds: high yield corporate bonds and other				185				1				5
	Guaranteed investment contracts (c)		Level 2		2				49				—
	Real estate funds (d)		Level 3		70				20				2
	Total Investments at fair value				$	1,597			$	486			$	37
	_______
	(a)	The fixed income securities are traded over the counter and certain of these securities lack daily pricing or liquidity and as such are classified as Level 2. As of December 31, 2013 and 2012, approximately 50% of the fixed income portfolio was invested in U.S. treasury or agency securities, with the remainder invested in other government bonds and corporate bonds.
	(b)	Interests in common/collective trust funds are valued using the net asset value (“NAV”) per unit in each fund. The NAV is based on the value of the underlying investments owned by each trust, minus its liabilities, divided by the number of shares outstanding.
	(c)	The guaranteed investment contracts (“GICs”) represent contracts with insurance companies measured at the cash surrender value of each contract. The Level 2 valuation reflects that the cash surrender value is based principally on a referenced pool of investment funds with active redemption.
	(d)	Real estate is valued using the NAV per unit of funds that are invested in real estate property. The investment value of the real estate property is determined quarterly using independent market appraisals as determined by the investment manager. Since the appraisals include unobservable inputs, these investments are classified as Level 3. These unobservable inputs may include items such as annual gross rents, projected vacancy rates, collection losses and recovery rates, yield rates, growth assumptions and risk adjusted discount rates.
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	'
	The following table presents a reconciliation of Level 3 plan assets measured at fair value for the year ended December 31:
			2013								2012
			United States Real Estate Fund				International Real Estate Fund				United States Real Estate Fund				International Real Estate Fund
	Beginning balance as of January 1		$	72			$	20			$	64			$	18
	Earned income, net of management expenses		2				—				6				—
	Unrealized gain on investment		9				—				2				1
	Purchases, sales, issuances and settlements, net		(42		)		1				—				1
	Ending balance as of December 31		$	41			$	21			$	72			$	20
Defined benefit plans disclosures	'
	The Company uses a December 31 measurement date for its defined benefit and other retiree benefit plans. Summarized information for the Company’s defined benefit and other retiree benefit plans are as follows:
			Pension Benefits																Other Retiree Benefits
			2013				2012				2013				2012				2013			2012
			United States								International
	Change in Benefit Obligations
	Benefit obligations at beginning of year		$	2,227			$	2,025			$	888			$	760			$	875		$	776
	Service cost		24				24				19				12				11			9
	Interest cost		90				97				34				35				38			40
	Participants’ contributions		1				1				3				3				—			—
	Acquisitions/plan amendments		40				—				2				21				—			(27		)
	Actuarial loss (gain)		(148		)		200				(1		)		103				(101		)	119
	Foreign exchange impact		—				—				12				21				(5		)	1
	Termination benefits (1)		11				—				—				—				6			—
	Curtailments and settlements		(12		)		—				(21		)		(23		)		—			—
	Benefit payments		(131		)		(128		)		(41		)		(45		)		(32		)	(40		)
	Other		—				8				(1		)		1				—			(3		)
	Benefit obligations at end of year		$	2,102			$	2,227			$	894			$	888			$	792		$	875
	Change in Plan Assets
	Fair value of plan assets at beginning of year		$	1,597			$	1,426			$	486			$	437			$	37		$	32
	Actual return on plan assets		148				173				59				47				4			5
	Company contributions		121				125				61				57				32			40
	Participants’ contributions		1				1				3				3				—			—
	Foreign exchange impact		—				—				2				13				—			—
	Settlements		—				—				(11		)		(21		)		—			—
	Benefit payments		(131		)		(128		)		(41		)		(45		)		(32		)	(40		)
	Other		—				—				(1		)		(5		)		—			—
	Fair value of plan assets at end of year		$	1,736			$	1,597			$	558			$	486			$	41		$	37
	Funded Status
	Benefit obligations at end of year		$	2,102			$	2,227			$	894			$	888			$	792		$	875
	Fair value of plan assets at end of year		1,736				1,597				558				486				41			37
	Net amount recognized		$	(366	)		$	(630	)		$	(336	)		$	(402	)		$	(751	)	$	(838	)
	Amounts Recognized in Balance Sheet
	Noncurrent assets		$	16			$	—			$	12			$	2			$	—		$	—
	Current liabilities		(19		)		(17		)		(36		)		(29		)		(39		)	(40		)
	Noncurrent liabilities		(363		)		(613		)		(312		)		(375		)		(712		)	(798		)
	Net amount recognized		$	(366	)		$	(630	)		$	(336	)		$	(402	)		$	(751	)	$	(838	)
	Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
	Actuarial loss		$	674			$	932			$	181			$	235			$	296		$	421
	Transition/prior service cost		3				63				23				26				1			2
			$	677			$	995			$	204			$	261			$	297		$	423
	Accumulated benefit obligation		$	1,995			$	2,093			$	802			$	798			$	—		$	—
Schedule of Assumptions Used	'
			Pension Benefits												Other Retiree Benefits
			2013			2012			2013			2012			2013			2012
			United States						International
	Weighted-Average Assumptions Used to Determine Benefit Obligations
	Discount rate		4.96	%		4.14	%		3.99	%		3.57	%		5.24	%		4.32	%
	Long-term rate of return on plan assets		6.8	%		7.3	%		5.5	%		5.39	%		6.8	%		7.3	%
	Long-term rate of compensation increase		3.5	%		3.5	%		3.02	%		2.8	%		—	%		—	%
	ESOP growth rate		—	%		—	%		—	%		—	%		10	%		10	%
	Medical cost trend rate of increase		—	%		—	%		—	%		—	%		7	%		7.5	%
	_________
	-1	Represents pension and other retiree benefit enhancements incurred in 2013 pursuant to the 2012 Restructuring Program.
Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates	'
	A 1% change in the assumed medical cost trend rate would have the following approximate effect:
			One percentage point
			Increase				Decrease
	Accumulated postretirement benefit obligation		$	109			$	(88	)
	Total of service and interest cost components		9				(7		)
Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets	'
	Plans with projected benefit obligations in excess of plan assets and plans with accumulated benefit obligations in excess of plan assets as of December 31 consist of the following:
			Years Ended December 31,
			2013				2012
	Benefit Obligation Exceeds Fair Value of Plan Assets
	Projected benefit obligation		$	1,130			$	3,112
	Fair value of plan assets		402				2,080
	Accumulated benefit obligation		700				2,855
	Fair value of plan assets		66				2,044
Schedule of Net Benefit Costs	'
	Summarized information regarding the net periodic benefit costs for the Company’s defined benefit and other retiree benefit plans is as follows:
			Pension Benefits																						Other Retiree Benefits
			2013				2012				2011				2013				2012			2011			2013			2012			2011
			United States												International
	Components of Net Periodic Benefit Cost
	Service cost		$	24			$	24			$	24			$	19			$	12		$	19		$	13		$	11		$	12
	Interest cost		90				97				100				34				35			36			38			40			39
	Annual ESOP allocation		—				—				—				—				—			—			(2		)	(2		)	(2		)
	Expected return on plan assets		(118		)		(112		)		(110		)		(26		)		(26		)	(27		)	(3		)	(3		)	(3		)
	Amortization of transition & prior service costs (credits)		9				9				9				2				2			3			1			3			2
	Amortization of actuarial loss		68				62				46				10				9			9			21			18			16
	Net periodic benefit cost		$	73			$	80			$	69			$	39			$	32		$	40		$	68		$	67		$	64
	Other postretirement charges		102				—				—				3				9			3			6			1			1
	Total pension cost		$	175			$	80			$	69			$	42			$	41		$	43		$	74		$	68		$	65
	Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
	Discount rate		4.14		%		4.9		%		5.3		%		3.57		%		4.59		%	5.04		%	4.32		%	5.26		%	5.3		%
	Long-term rate of return on plan assets		7.3		%		7.75		%		8		%		5.39		%		5.91		%	6.23		%	7.3		%	7.75		%	8		%
	Long-term rate of compensation increase		3.5		%		4		%		4		%		2.8		%		2.87		%	3.05		%	—		%	—		%	—		%
	ESOP growth rate		—		%		—		%		—		%		—		%		—		%	—		%	10		%	10		%	10		%
	Medical cost trend rate of increase		—		%		—		%		—		%		—		%		—		%	—		%	7.5		%	8		%	8.33		%
Schedule of Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized over Next Fiscal Year	'
	The estimated actuarial loss and the estimated transition/prior service cost for defined benefit and other retiree benefit plans that will be amortized from Accumulated other comprehensive income (loss) into net periodic benefit cost over the next fiscal year is as follows:
			Pension Benefits				Other Retiree Benefits
	Net actuarial loss		$	39			$	15
	Net transition & prior service cost		2				—
Schedule of Expected Benefit Payments	'
	Total benefit payments expected to be paid to participants from plan assets, or payments directly from the Company’s assets to participants in unfunded plans, are as follows:
			Pension Benefits
	Years Ended December 31,		United States				International				Other Retiree Benefits				Total
	2014		$	172			$	70			$	40			$	282
	2015		136				55				41				232
	2016		135				47				43				225
	2017		136				54				44				234
	2018		135				50				45				230
	2019-2023		691				273				232				1,196

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Components of income before income taxes	'
	The components of income before income taxes are as follows for the three years ended December 31:
		2013				2012				2011
	United States	$	1,018			$	1,155			$	1,098
	International	2,547				2,719				2,691
	Total Income before income taxes	$	3,565			$	3,874			$	3,789
Provision for Income Taxes	'
	The provision for income taxes consists of the following for the three years ended December 31:
		2013				2012				2011
	United States	$	314			$	395			$	360
	International	841				848				875
	Total Provision for income taxes	$	1,155			$	1,243			$	1,235
Schedule of Components of Income Tax Expense (Benefit)	'
	Temporary differences between accounting for financial statement purposes and accounting for tax purposes result in the current provision for taxes being higher (lower) than the total provision for income taxes as follows:
		2013				2012				2011
	Goodwill and intangible assets	$	(14	)		$	(7	)		$	(1	)
	Property, plant and equipment	—				(13		)		(19		)
	Pension and other retiree benefits	85				(14		)		(47		)
	Stock-based compensation	10				5				11
	Tax loss and tax credit carryforwards	(30		)		(39		)		(14		)
	Other, net	(33		)		32				32
	Total deferred tax provision	$	18			$	(36	)		$	(38	)
Effective tax rate reconciliation	'
	The difference between the statutory U.S. federal income tax rate and the Company’s global effective tax rate as reflected in the Consolidated Statements of Income is as follows:
	Percentage of Income before income taxes	2013			2012			2011
	Tax at United States statutory rate	35	%		35	%		35	%
	State income taxes, net of federal benefit	0.4			0.7			0.4
	Earnings taxed at other than United States statutory rate	(1.4	)		(2.6	)		(1.7	)
	Other, net	(1.6	)		(1.0	)		(1.1	)
	Effective tax rate	32.4	%		32.1	%		32.6	%
Components of deferred tax assets (liabilities)	'
	The components of deferred tax assets (liabilities) are as follows at December 31:
		2013				2012
	Deferred tax liabilities:
	Goodwill and intangible assets	$	(475	)		$	(476	)
	Property, plant and equipment	(375		)		(365		)
	Other	(237		)		(200		)
		(1,087		)		(1,041		)
	Deferred tax assets:
	Pension and other retiree benefits	448				544
	Tax loss and tax credit carryforwards	28				61
	Accrued liabilities	317				280
	Stock-based compensation	116				113
	Other	95				117
		1,004				1,115
	Net deferred income taxes	$	(83	)		$	74
		2013				2012
	Deferred taxes included within:
	Assets:
	Other current assets	$	284			$	275
	Deferred income taxes	77				92
	Liabilities:
	Deferred income taxes	(444		)		(293		)
	Net deferred income taxes	$	(83	)		$	74
Unrecognized tax benefits activity	'
	Unrecognized tax benefits activity for the years ended December 31, 2013, 2012 and 2011 is summarized below:
		2013				2012				2011
	Unrecognized tax benefits:
	Balance, January 1	$	212			$	176			$	171
	Increases as a result of tax positions taken during the current year	23				34				76
	Decreases of tax positions taken during prior years	(52		)		(6		)		(46		)
	Increases of tax positions taken during prior years	37				10				10
	Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations	(22		)		(3		)		(30		)
	Effect of foreign currency rate movements	1				1				(5		)
	Balance, December 31	$	199			$	212			$	176

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted	'
		For the Year Ended 2013					For the Year Ended 2012					For the Year Ended 2011
		Net income attributable to Colgate-Palmolive Company		Shares	Per		Net income attributable to Colgate-Palmolive Company		Shares	Per		Net income attributable to Colgate-Palmolive Company		Shares	Per
				(millions)	Share				(millions)	Share				(millions)	Share
	Basic EPS	2,241		930.8	$	2.41	2,472		952.1	$	2.6	2,431		976.7	$	2.49
	Stock options and restricted stock units			9.1					8.1					7.4
	Diluted EPS	$	2,241	939.9	$	2.38	$	2,472	960.2	$	2.57	$	2,431	984.1	$	2.47

Segment_Information_Tables

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Schedule of Segment Reporting Information, by Segment	'
			2013			2012			2011
	Net sales
	Oral, Personal and Home Care
	North America(1)		$	3,072		$	2,971		$	2,878
	Latin America		5,012			5,032			4,895
	Europe/South Pacific		3,396			3,417			3,508
	Asia		2,472			2,264			2,074
	Africa/Eurasia		1,257			1,241			1,207
	Total Oral, Personal and Home Care		15,209			14,925			14,562
	Pet Nutrition(2)		2,211			2,160			2,172
	Total Net sales		$	17,420		$	17,085		$	16,734
	_________
	(1)	Net sales in the U.S. for Oral, Personal and Home Care were $2,771, $2,669 and $2,567 in 2013, 2012 and 2011, respectively.
	(2)	Net sales in the U.S. for Pet Nutrition were $1,116, $1,052 and $1,032 in 2013, 2012 and 2011, respectively.
			2013			2012			2011
	Operating profit
	Oral, Personal and Home Care
	North America		$	927		$	810		$	768
	Latin America		1,385			1,454			1,437
	Europe/South Pacific		805			747			715
	Asia		698			619			565
	Africa/Eurasia		268			267			242
	Total Oral, Personal and Home Care		4,083			3,897			3,727
	Pet Nutrition		563			589			560
	Corporate		(1,090		)	(597		)	(446		)
	Total Operating profit		$	3,556		$	3,889		$	3,841
			2013			2012			2011
	Capital expenditures
	Oral, Personal and Home Care
	North America		$	54		$	43		$	53
	Latin America		235			237			195
	Europe/South Pacific		74			71			64
	Asia		123			88			103
	Africa/Eurasia		11			16			16
	Total Oral, Personal and Home Care		497			455			431
	Pet Nutrition		45			37			32
	Corporate		128			73			74
	Total Capital expenditures		$	670		$	565		$	537
			2013			2012			2011
	Depreciation and amortization
	Oral, Personal and Home Care
	North America		$	51		$	50		$	56
	Latin America		93			91			92
	Europe/South Pacific		85			85			82
	Asia		72			70			67
	Africa/Eurasia		11			11			12
	Total Oral, Personal and Home Care		312			307			309
	Pet Nutrition		51			50			51
	Corporate		76			68			61
	Total Depreciation and amortization		$	439		$	425		$	421
			2013			2012			2011
	Identifiable assets
	Oral, Personal and Home Care
	North America		$	2,301		$	2,157		$	2,247
	Latin America		4,122			4,288			3,677
	Europe/South Pacific		3,949			3,649			3,555
	Asia		1,794			1,608			1,548
	Africa/Eurasia		557			561			521
	Total Oral, Personal and Home Care		12,723			12,263			11,548
	Pet Nutrition		1,087			1,045			1,078
	Corporate(3)		66			86			98
	Total Identifiable assets(4)		$	13,876		$	13,394		$	12,724
	____________
(3)	In 2013, Corporate identifiable assets primarily consist of derivative instruments (32%) and investments in equity securities (41%).  In 2012, Corporate identifiable assets primarily consist of derivative instruments (67%) and investments in equity securities (28%).  In 2011, Corporate identifiable assets primarily consist of derivative instruments (73%) and investments in equity securities (22%).
(4)	Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $8,248, $8,066 and $7,926 in 2013, 2012 and 2011, respectively.

Supplemental_Income_Statement_1

Supplemental Income Statement Information (Tables)	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Other (income) expense, net	'
	Other (income) expense, net	2013			2012			2011
	Amortization of intangible assets	$	32		$	31		$	28
	2012 Restructuring Program	202			81			—
	Venezuela devaluation charge	172			—			—
	Charges for French competition law matters	23			—			21
	Costs related to the sale of land in Mexico	3			—			13
	Business realignment and other cost-saving initiatives	—			2			136
	Gain on sales of non-core product lines	—			—			(207		)
	Sanex acquisition transaction costs	—			—			12
	Equity (income)	(5		)	(7		)	(6		)
	Other, net	(5		)	6			(6		)
	Total Other (income) expense, net	$	422		$	113		$	(9	)
Interest expense, net	'
	Interest (income) expense, net	2013			2012			2011
	Interest incurred	$	119		$	81		$	59
	Interest capitalized	(3		)	(1		)	(1		)
	Interest income	(125		)	(65		)	(6		)
	Total Interest (income) expense, net	$	(9	)	$	15		$	52
Research and development and Advertising	'
		2013			2012			2011
	Research and development	$	267		$	259		$	262
	Advertising	$	1,891		$	1,792		$	1,734

Supplemental_Balance_Sheet_Inf1

Supplemental Balance Sheet Information (Tables)	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Schedule of Inventory, Current	'
	Inventories by major class are as follows:
	Inventories	2013			2012
	Raw materials and supplies	$	340		$	362
	Work-in-process	60			81
	Finished goods	1,025			922
	Total Inventories	$	1,425		$	1,365
Property, Plant and Equipment	'
	Property, plant and equipment, net	2013			2012
	Land	$	254		$	251
	Buildings	1,625			1,439
	Manufacturing machinery and equipment	5,220			4,987
	Other equipment	1,231			1,144
		8,330			7,821
	Accumulated depreciation	(4,247		)	(3,979		)
	Total Property, plant and equipment, net	$	4,083		$	3,842
Other accruals	'
	Other accruals	2013			2012
	Accrued advertising and coupon redemption	$	676		$	646
	Accrued payroll and employee benefits	361			345
	Accrued taxes other than income taxes	22			48
	Restructuring accrual	142			89
	Pension and other retiree benefits	94			86
	Accrued interest	27			26
	Derivatives	11			10
	Other	647			638
	Total Other accruals	$	1,980		$	1,888
Other liabilities	'
	Other liabilities	2013			2012
	Pension and other retiree benefits	$	1,387		$	1,786
	Restructuring accrual	16			—
	Other	274			263
	Total Other liabilities	$	1,677		$	2,049

Supplemental_Comprehensive_Inc1

Supplemental Comprehensive Income Information (Tables)	12 Months Ended
	Dec. 31, 2013
Other Comprehensive Income (Loss), Net of Tax [Abstract]	'
Schedule of Comprehensive Income (Loss)	'
	Other Comprehensive Income (Loss) components attributable to Colgate-Palmolive Company before tax and net of tax during the years ended December 31 were as follows:
			2013						2012						2011
			Pre-tax			Net of Tax			Pre-tax			Net of Tax			Pre-tax			Net of Tax
	Cumulative translation adjustments		$	(188	)	$	(163	)	$	18		$	(20	)	$	(291	)	$	(298	)
	Pension and other benefits:
	Net actuarial gain (loss) and prior		295			189			(317		)	(207		)	(249		)	(163		)
	service costs arising during the
	period
	Amortization of net actuarial loss,		111			70			101			62			85			55
	transition and prior service costs(1)
	Curtailment loss - unamortized		91			59			—			—			—			—
	prior service costs(1)
	Retirement Plan and other retiree benefit		497			318			(216		)	(145		)	(164		)	(108		)
	adjustments
	Available-for-sale securities:
	Unrealized gains (losses) on available-		(113		)	(73		)	28			18			60			46
	for-sale securities
	Reclassification of (gains) losses		133			86			—			—			—			—
	into net earnings on available-
	for-sale securities(2)
	Gains (losses) on available-for-sale		20			13			28			18			60			46
	securities
	Cash flow hedges:
	Unrealized gains (losses) on cash flow		20			13			13			8			(10		)	(7		)
	hedges
	Reclassification of (gains) losses		(17		)	(11		)	(11		)	(7		)	9			7
	into net earnings on cash flow
	hedges(3)
	Gains (losses) on cash flow hedges		3			2			2			1			(1		)	—
	Total Other comprehensive income (loss)		$	332		$	170		$	(168	)	$	(146	)	$	(396	)	$	(360	)
	_________
	(1)	These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.
	(2)	Represents the one-time loss related to the remeasurement of the fixed interest rate bonds in Venezuela, which was recorded in Other (income) expense, net. See Note 7, Fair Value Measurements and Financial Instruments for additional details.
	(3)	These (gains) losses are reclassified into Cost of sales. See Note 7, Fair Value Measurements and Financial Instruments for additional details.

Quarterly_Financial_Data_Unaud1

Quarterly Financial Data (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements [Abstract]	'
Schedule of Quarterly Financial Information	'
	Quarterly Financial Data (Unaudited)
		Total			First			Second			Third			Fourth
					Quarter			Quarter			Quarter			Quarter
	2013
	Net sales	$	17,420		$	4,315		$	4,346		$	4,398		$	4,361
	Gross profit	10,201		(1)	2,515		(3)	2,534		(5)	2,585		(7)	2,567		(9)
	Net income including noncontrolling interests	2,410		(2)	506		(4)	604		(6)	699		(8)	601		(10)
	Net income attributable to Colgate-Palmolive Company	2,241		(2)	460		(4)	561		(6)	656		(8)	564		(10)
	Earnings per common share:
	Basic	2.41		(2)	0.49		(4)	0.6		(6)	0.71		(8)	0.61		(10)
	Diluted	2.38		(2)	0.48		(4)	0.6		(6)	0.7		(8)	0.6		(10)
	2012
	Net sales	$	17,085		$	4,200		$	4,267		$	4,332		$	4,286
	Gross profit	9,932		(11)	2,437		(13)	2,461		(15)	2,529		(17)	2,505		(19)
	Net income including noncontrolling interests	2,631		(12)	633		(14)	665		(16)	697		(18)	636		(20)
	Net income attributable to Colgate-Palmolive Company	2,472		(12)	593		(14)	627		(16)	654		(18)	598		(20)
	Earnings per common share:
	Basic	2.6		(12)	0.62		(14)	0.66		(16)	0.69		(18)	0.63		(20)
	Diluted	2.57		(12)	0.61		(14)	0.65		(16)	0.68		(18)	0.63		(20)
	____________
	Note:	Basic and diluted earnings per share are computed independently for each quarter and the year-to-date period presented. Accordingly, the sum of the quarterly earnings per common share may not necessarily equal the earnings per share for the year-to-date period.
	(1)	Gross profit for the full year of 2013 includes $32 of charges related to the 2012 Restructuring Program and $15 of costs related to the sale of land in Mexico.
	(2)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2013 include $278 of aftertax charges related to the 2012 Restructuring Program, a $111 one-time aftertax charge for the impact of the devaluation in Venezuela, a $23 charge for a competition law matter in France related to the home care and personal care sectors and $12 of aftertax costs related to the sale of land in Mexico.
	(3)	Gross profit for the first quarter of 2013 includes $8 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
	(4)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the first quarter of 2013 include $52 of aftertax charges related to the 2012 Restructuring Program, a $111 one-time aftertax charge for the impact of the devaluation in Venezuela and $3 of aftertax costs related to the sale of land in Mexico.
	(5)	Gross profit for the second quarter of 2013 includes $10 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
	(6)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the second quarter of 2013 include $79 of aftertax charges related to the 2012 Restructuring Program, an $18 charge for a competition law matter in France related to the home care and personal care sectors and $4 of aftertax costs related to the sale of land in Mexico.
	(7)	Gross profit for the third quarter of 2013 includes $8 of charges related to the 2012 Restructuring Program and $3 of costs related to the sale of land in Mexico.
	(8)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the third quarter of 2013 include $22 of aftertax charges related to the 2012 Restructuring Program and $2 of aftertax costs related to the sale of land in Mexico.
	(9)	Gross profit for the fourth quarter of 2013 includes $6 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
	(10)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the fourth quarter of 2013 include $125 of aftertax charges related to the 2012 Restructuring Program, a $5 charge for a competition law matter in France related to the home care and personal care sectors and $3 of aftertax costs related to the sale of land in Mexico.
	(11)	Gross profit for the full year of 2012 includes $2 of charges related to the 2012 Restructuring Program, $24 of costs related to the sale of land in Mexico and $5 of costs associated with various business realignment and other cost-saving initiatives.
	(12)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2012 include $70 of aftertax charges related to the 2012 Restructuring Program, $18 of aftertax costs related to the sale of land in Mexico and $14 of aftertax costs associated with various business realignment and other cost-saving initiatives.
	(13)	Gross profit for the first quarter of 2012 includes $7 of costs related to the sale of land in Mexico and $2 of costs associated with various business realignment and other cost-saving initiatives.
	(14)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the first quarter of 2012 include $5 of aftertax costs related to the sale of land in Mexico and $3 of aftertax costs associated with various business realignment and other cost-saving initiatives.
	(15)	Gross profit for the second quarter of 2012 includes $6 of costs related to the sale of land in Mexico and $2 of costs associated with various business realignment and other cost-saving initiatives.
	(16)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the second quarter of 2012 include $5 of aftertax costs related to the sale of land in Mexico and $9 of aftertax costs associated with various business realignment and other cost-saving initiatives.
	(17)	Gross profit for the third quarter of 2012 includes $7 of costs related to the sale of land in Mexico and $1 of costs associated with various business realignment and other cost-saving initiatives.
	(18)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the third quarter of 2012 include $5 of aftertax costs related to the sale of land in Mexico and $2 of aftertax costs associated with various business realignment and other cost-saving initiatives.
	(19)	Gross profit for the fourth quarter of 2012 includes $2 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
	(20)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the fourth quarter of 2012 include $70 of aftertax charges related to the 2012 Restructuring Program and $3 of aftertax costs related to the sale of land in Mexico.

Nature_of_Operations_Details

Nature of Operations (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
	business_segment
Notes to Financial Statements [Abstract]	'	'	'
Number of business segments (in number of segments)	2	'	'
Entity-Wide Information, Revenue from External Customer [Line Items]	'	'	'
Percentage of worldwide sales (in hundredths)	100.00%	100.00%	100.00%
Oral Care [Member]	'	'	'
Entity-Wide Information, Revenue from External Customer [Line Items]	'	'	'
Percentage of worldwide sales (in hundredths)	46.00%	44.00%	43.00%
Personal Care [Member]	'	'	'
Entity-Wide Information, Revenue from External Customer [Line Items]	'	'	'
Percentage of worldwide sales (in hundredths)	21.00%	22.00%	22.00%
Home Care [Member]	'	'	'
Entity-Wide Information, Revenue from External Customer [Line Items]	'	'	'
Percentage of worldwide sales (in hundredths)	20.00%	21.00%	22.00%
Pet Nutrition [Member]	'	'	'
Entity-Wide Information, Revenue from External Customer [Line Items]	'	'	'
Percentage of worldwide sales (in hundredths)	13.00%	13.00%	13.00%

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Principles of Consolidation [Abstract]	'	'	'
Investments accounted for using the equity method, minimum interest (in hundredths)	20.00%	'	'
Investments accounted for using the equity method, maximum interest (in hundredths)	50.00%	'	'
Equity method investments included in Other assets	$27	$25	'
Investments accounted for using the cost method, maximum interest (in hundredths)	20.00%	'	'
Shipping and Handling Costs [Abstract]	'	'	'
Shipping and handling costs classified as Selling, general and administrative expenses	$1,304	$1,262	$1,250
Inventories [Abstract]	'	'	'
Approximate percentage of inventories determined using the first-in, first-out (FIFO) method (in hundredths)	80.00%	'	'
Minimum [Member] | Machinery and equipment [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Estimated useful life (in years)	'3 years	'	'
Maximum [Member] | Machinery and equipment [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Estimated useful life (in years)	'15 years	'	'
Maximum [Member] | Buildings [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Estimated useful life (in years)	'40 years	'	'

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details 1) (Trademarks, local brands, and non-compete agreements [Member])	12 Months Ended
	Dec. 31, 2013
Minimum [Member]	'
Finite-Lived Intangible Assets [Line Items]	'
Estimated useful life of finite-lived intangible assets (in years)	'5 years
Maximum [Member]	'
Finite-Lived Intangible Assets [Line Items]	'
Estimated useful life of finite-lived intangible assets (in years)	'40 years

Acquisitions_and_Divestitures_1

Acquisitions and Divestitures (Details)

3 Months Ended

12 Months Ended

3 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

In Millions, unless otherwise specified

Sep. 30, 2012

Sep. 30, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2011

Jun. 20, 2011

Jun. 20, 2011

Jun. 30, 2011

Jun. 30, 2011

Jun. 30, 2011

Jun. 30, 2011

Jun. 20, 2011

Jun. 20, 2011

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Sanex Personal Care Business [Member]

Sanex Personal Care Business [Member]

Sanex Personal Care Business [Member]

Sanex Personal Care Business [Member]

Sanex Personal Care Business [Member]

Minimum [Member]

Maximum [Member]

Europe/South Pacific [Member]

Africa/Eurasia [Member]

MEXICO

MEXICO

MEXICO

MEXICO

MEXICO

MEXICO

MEXICO

MEXICO

MEXICO

MEXICO

MEXICO

Cost of Sales [Member]

Cost of Sales [Member]

Cost of Sales [Member]

Cost of Sales [Member]

Cost of Sales [Member]

Cost of Sales [Member]

Cost of Sales [Member]

Cost of Sales [Member]

Cost of Sales [Member]

Cost of Sales [Member]

USD ($)

USD ($)

EUR (€)

Customer Relationships

Trademarks

Sanex Personal Care Business [Member]

Sanex Personal Care Business [Member]

Sanex Personal Care Business [Member]

Sanex Personal Care Business [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

MEXICO

MEXICO

MEXICO

MEXICO

MEXICO

MEXICO

MEXICO

MEXICO

MEXICO

MEXICO

USD ($)

USD ($)

Customer Relationships

Customer Relationships

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Acquisition and Divestitures [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Aggregate purchase price

'

'

'

'

'

'

$966

€ 676

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Recognized amounts of assets acquired and liabilities assumed [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Inventories

'

'

'

'

'

'

26

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Property, plant and equipment, net

'

'

'

'

'

'

3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other intangible assets, net

'

'

'

'

'

'

596

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Goodwill, net

'

'

2,474

2,500

'

'

411

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Accrued income taxes

'

'

'

'

'

'

-48

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term deferred income taxes

'

'

'

'

'

'

-18

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term other liabilities

'

'

'

'

'

'

-4

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair value of net assets acquired

'

'

'

'

'

'

966

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Acquired indefinite-lived intangible assets

'

'

'

'

'

'

'

'

'

403

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Acquired finite-lived intangible assets

'

'

'

'

'

'

'

'

193

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Estimated useful life of finite-lived intangible assets (in years)

'

'

'

'

'

'

'

'

'

'

'15 years

'18 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Allocation of goodwill (in hundredths)

'

'

'

'

'

'

'

'

'

'

'

'

90.00%

10.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sanex acquisition transaction costs

'

'

0

0

12

12

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sale of Land in Mexico [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

First Installment received from the sale of land in Mexico

'

24

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Second Installment received from the sale of land in Mexico

36

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Pretax costs related to sale of land

'

'

3

0

13

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

18

24

13

4

3

4

4

4

7

6

7

15

24

Aftertax costs related to sale of land

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3

2

4

3

3

5

5

5

12

18

9

'

'

'

'

'

'

'

'

'

'

Sale of brands [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Sales of Assets

'

215

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gain on sales of non-core product lines

'

207

0

0

207

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gain after tax of sales on non-core product line

'

$135

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Restructuring_and_Related_Impl2

Restructuring and Related Implementation Charges (Details) (USD $)

12 Months Ended

15 Months Ended

12 Months Ended

15 Months Ended

12 Months Ended

15 Months Ended

12 Months Ended

15 Months Ended

12 Months Ended

12 Months Ended

15 Months Ended

In Millions, unless otherwise specified

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

One-time Termination Benefits [Member]

One-time Termination Benefits [Member]

One-time Termination Benefits [Member]

Incremental Depreciation And Asset Impairment [Member]

Incremental Depreciation [Member]

Incremental Depreciation [Member]

Incremental Depreciation [Member]

Asset Impairment [Member]

Asset Impairment [Member]

Asset Impairment [Member]

Charges Resulting Directly From Exit Activities [Member]

Contract Termination [Member]

Contract Termination [Member]

Implementation Of New Strategies [Member]

Third party Incremental Cost [Member]

Third party Incremental Cost [Member]

Land and Building [Member]

Other Restructuring [Member]

Other Restructuring [Member]

Other Restructuring [Member]

Expected Completion Date 2016 [Member]

Expected Completion Date 2016 [Member]

Expected Completion Date 2016 [Member]

Expected Completion Date December 2014 [Member]

Expected Completion Date December 2014 [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

employees

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Restructuring Cost and Reserve [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Duration Of Restructuring Program

'

'

'

'4 years

'

'4 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Restructuring Program Expected Cost Before Tax

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1,100

$1,250

$275

$325

Restructuring Program Expected Cost After Tax

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

775

875

200

230

Expected Percent of Total Pretax Charges by Category

'

'

'

'

'

'

50.00%

'

50.00%

15.00%

'

'

'

'

'

'

20.00%

'

'

15.00%

'

'

'

'

'

'

'

'

'

'

'

Expected Percent of Total Charges Resulting In Cash Expenditure

'

'

'

75.00%

'

75.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage Reduction Of Global Employee Workforce

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6.00%

'

'

'

'

Number of Employees as of the Start of the 2012 Restructuring Program

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

38,000

'

'

'

'

Pretax charges related to the 2012 Restructuring Program

202

81

0

371

89

'

144

78

'

'

26

0

'

1

0

'

'

34

3

'

50

8

25

200

11

'

'

'

'

'

'

Pretax charges related to the 2012 Restructuring Program to date

'

'

'

'

'

460

'

'

222

'

'

'

26

'

'

1

'

'

'

'

'

'

'

'

'

211

'

'

'

'

'

Aftertax charges related to the 2012 Restructuring Program to date

'

'

'

'

'

348

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Restructuring Reserve, Charges Against Assets

'

'

'

44

0

'

17

0

'

'

26

0

'

1

0

'

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

Other

'

'

'

$91

'

'

$0

'

'

'

$0

'

'

$0

'

'

'

'

'

'

'

'

'

$91

'

'

'

'

'

'

'

Restructuring_and_Related_Impl3

Restructuring and Related Implementation Charges (Details 1) (USD $)

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

15 Months Ended

12 Months Ended

15 Months Ended

12 Months Ended

15 Months Ended

12 Months Ended

15 Months Ended

12 Months Ended

15 Months Ended

12 Months Ended

15 Months Ended

In Millions, unless otherwise specified

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Two Thousand Twelve Restructuring Program [Member]

Cost of Sales [Member]

Cost of Sales [Member]

Cost of Sales [Member]

Cost of Sales [Member]

Cost of Sales [Member]

Cost of Sales [Member]

Cost of Sales [Member]

Selling, General and Administrative Expenses [Member]

Selling, General and Administrative Expenses [Member]

Other (Income) Expense, Net [Member]

Other (Income) Expense, Net [Member]

Pet Nutrition [Member]

Pet Nutrition [Member]

Pet Nutrition [Member]

Corporate, Non-Segment [Member]

Corporate, Non-Segment [Member]

Corporate, Non-Segment [Member]

North America [Member]

North America [Member]

North America [Member]

Europe/South Pacific [Member]

Europe/South Pacific [Member]

Europe/South Pacific [Member]

Latin America [Member]

Latin America [Member]

Asia [Member]

Africa/Eurasia [Member]

Africa/Eurasia [Member]

Africa/Eurasia [Member]

Restructuring Cost and Reserve [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Expected Percent of Total Restructuring Charges Related to Segment

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10.00%

'

10.00%

40.00%

'

40.00%

15.00%

'

15.00%

20.00%

'

20.00%

5.00%

5.00%

5.00%

5.00%

'

5.00%

Percent of Restructuring Charges Related to Segment for Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8.00%

3.00%

'

42.00%

38.00%

'

11.00%

2.00%

'

28.00%

55.00%

'

4.00%

'

'

7.00%

2.00%

'

Percent of Restructuring Charges Related to Segment Program to Date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7.00%

'

'

41.00%

'

'

10.00%

'

'

33.00%

'

3.00%

'

'

'

6.00%

Pretax charges related to the 2012 Restructuring Program

$202

$81

$0

'

'

'

'

'

$371

$89

$6

$8

$10

$8

$2

$32

$2

$137

$6

$202

$81

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Aftertax charges related to the 2012 Restructuring Program

'

'

'

$125

$22

$79

$52

$70

$278

$70

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Restructuring_and_Related_Impl4

Restructuring and Related Implementation Charges (Details 2) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Restructuring Reserve [Roll Forward]	'	'	'
Charges	$202	$81	$0
Two Thousand Twelve Restructuring Program [Member]	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'
Balance	89	0	'
Charges	371	89	'
Cash payments	-169	-5	'
Charges against assets	-44	0	'
Foreign exchange	2	5	'
Other	-91	'	'
Balance	158	89	'
One-time Termination Benefits [Member] | Two Thousand Twelve Restructuring Program [Member]	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'
Balance	84	0	'
Charges	144	78	'
Cash payments	-97	-1	'
Charges against assets	-17	0	'
Foreign exchange	2	7	'
Other	0	'	'
Balance	116	84	'
Incremental Depreciation [Member] | Two Thousand Twelve Restructuring Program [Member]	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'
Balance	0	0	'
Charges	26	0	'
Cash payments	0	0	'
Charges against assets	-26	0	'
Foreign exchange	0	0	'
Other	0	'	'
Balance	0	0	'
Asset Impairment [Member] | Two Thousand Twelve Restructuring Program [Member]	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'
Balance	0	0	'
Charges	1	0	'
Cash payments	0	0	'
Charges against assets	-1	0	'
Foreign exchange	0	0	'
Other	0	'	'
Balance	0	0	'
Other Restructuring [Member] | Two Thousand Twelve Restructuring Program [Member]	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'
Balance	5	0	'
Charges	200	11	'
Cash payments	-72	-4	'
Charges against assets	0	0	'
Foreign exchange	0	-2	'
Other	-91	'	'
Balance	$42	$5	'

Goodwill_and_Other_Intangible_2

Goodwill and Other Intangible Assets (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Goodwill [Line Items]	'	'
Goodwill	$2,474	$2,500
Oral, Personal and Home Care [Member]	'	'
Goodwill [Line Items]	'	'
Goodwill	2,459	2,485
Pet Nutrition [Member]	'	'
Goodwill [Line Items]	'	'
Goodwill	15	15
North America [Member] | Oral, Personal and Home Care [Member]	'	'
Goodwill [Line Items]	'	'
Goodwill	362	372
Latin America [Member] | Oral, Personal and Home Care [Member]	'	'
Goodwill [Line Items]	'	'
Goodwill	353	408
Europe/South Pacific [Member] | Oral, Personal and Home Care [Member]	'	'
Goodwill [Line Items]	'	'
Goodwill	1,525	1,478
Asia [Member] | Oral, Personal and Home Care [Member]	'	'
Goodwill [Line Items]	'	'
Goodwill	126	127
Africa/Eurasia [Member] | Oral, Personal and Home Care [Member]	'	'
Goodwill [Line Items]	'	'
Goodwill	$93	$100

Goodwill_and_Other_Intangible_3

Goodwill and Other Intangible Assets (Details 1) (USD $)	12 Months Ended									3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Jun. 30, 2011	Jun. 30, 2011
				Trademarks	Trademarks	Other finite life intangible assets	Other finite life intangible assets	Indefinite life intangible assets	Indefinite life intangible assets	Trademarks	Customer Relationships
										Sanex Personal Care Business [Member]	Sanex Personal Care Business [Member]
Finite and indefinite-lived intangible assets [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Finite-Lived Intangible Assets, Gross	'	'	'	$551	$548	$219	$212	'	'	'	'
Indefinite-Lived Intangible Assets (Excluding Goodwill)	'	'	'	'	'	'	'	1,046	1,027	'	'
Finite & Indefinite Life Intangibles, Gross	1,816	1,787	'	'	'	'	'	'	'	'	'
Finite-Lived Intangible Assets, Accumulated Amortization	-320	-288	'	-275	-254	-45	-34	0	0	'	'
Finite-Lived Intangible Assets, Net	'	'	'	276	294	174	178	'	'	'	'
Intangible Assets, Net (Excluding Goodwill)	1,496	1,499	'	'	'	'	'	'	'	'	'
Amortization of Intangible Assets	32	31	28	'	'	'	'	'	'	'	'
Acquired Indefinite-lived Intangible Asset, Amount	'	'	'	'	'	'	'	'	'	403	'
Acquired Finite-lived Intangible Asset, Amount	'	'	'	'	'	'	'	'	'	'	193
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Future amortization expense - 2014	29	'	'	'	'	'	'	'	'	'	'
Future amortization expense - 2015	29	'	'	'	'	'	'	'	'	'	'
Future amortization expense - 2016	29	'	'	'	'	'	'	'	'	'	'
Future amortization expense - 2017	29	'	'	'	'	'	'	'	'	'	'
Future amortization expense - 2018	$29	'	'	'	'	'	'	'	'	'	'

LongTerm_Debt_and_Credit_Facil2

Long-Term Debt and Credit Facilities (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Debt Instrument [Line Items]	'	'
Total Debt	$5,644	$5,176
Less: Current portion of long-term debt	-895	-250
Total Debt, Excluding Current Maturities	4,749	4,926
Short-term Bank Loans and Notes Payable	13	54
Weighted-average interest rate on short term borrowings (in hundredths)	2.20%	1.00%
Scheduled maturities of long-term debt [Abstract]	'	'
2014	895	'
2015	491	'
2016	255	'
2017	664	'
2018	695	'
Thereafter	2,644	'
Notes	'	'
Debt Instrument [Line Items]	'	'
Weighted average interest rate (in hundredths)	2.00%	'
Maturity date range, start	31-Dec-14	'
Maturity date range, end	31-Dec-78	'
Total Debt	5,644	4,733
Commercial paper	'	'
Debt Instrument [Line Items]	'	'
Weighted average interest rate (in hundredths)	'	'
Maturity date	'	'
Total Debt	$0	$443

LongTerm_Debt_and_Credit_Facil3

Long-Term Debt and Credit Facilities (Details 1) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2012
In Millions, unless otherwise specified			Five Year Notes at 1 Point 5 Percent [Member]	Forty Year Notes at Variable Rate [Member]	Five Year Notes at Point 9 Percent [Member]	Ten Year Notes at 2 Point 1 Percent [Member]	Ten Year Notes at 1 Point 95 Percent [Member]	Ten Year Notes at 2 Point 3 Percent [Member]
Schedule of U.S. dollar-denominated notes [Line Items]	'	'	'	'	'	'	'	'
Face amount	'	'	$300	$82	$400	$400	$500	$500
Debt Instrument, Term	'	'	'5 years	'40 years	'5 years	'10 years	'10 years	'10 years
Fixed Interest rate (in hundredths)	'	'	1.50%	'	0.90%	2.10%	1.95%	2.30%
Current portion of long-term debt	$895	$250	'	'	'	'	'	'

LongTerm_Debt_and_Credit_Facil4

Long-Term Debt and Credit Facilities (Details 2) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013
Line of credit facility [Line Items]	'
Unused borrowing capacity	$2,444
Domestic Revolving Credit Facility 1850 Million Capacity [Member]	'
Line of credit facility [Line Items]	'
Maximum borrowing capacity	1,850
Line of Credit Facility, Expiration Date	30-Nov-18
Domestic Revolving Credit Facility 145 Million Capacity [Member]	'
Line of credit facility [Line Items]	'
Maximum borrowing capacity	$145
Line of Credit Facility, Expiration Date	30-Nov-14

Fair_Value_Measurements_and_Fi2

Fair Value Measurements and Financial Instruments (Details 1) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
	country_and_territory
Derivative and Financial Instruments, Fair Value [Line Items]	'	'
Number Of Countries And Territories Serving Consumers (more than 200)	200	'
Derivative Instruments [Abstract]	'	'
Total asset derivative instruments	$35	$65
Derivative Asset Designated as Hedging Instrument	35	65
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	0	0
Total liability derivative instruments	22	11
Derivative Liability Designated as Hedging Instrument	19	10
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	3	1
Other Assets [Member]	'	'
Financial Instruments [Abstract]	'	'
Venezuelan bonds, long-term	685	618
Other Current Assets [Member]	'	'
Financial Instruments [Abstract]	'	'
Marketable securities	173	116
Interest Rate Swap Contracts [Member] | Other Assets [Member]	'	'
Derivative Instruments [Abstract]	'	'
Derivative Asset Designated as Hedging Instrument	20	41
Interest Rate Swap Contracts [Member] | Other Current Assets [Member]	'	'
Derivative Instruments [Abstract]	'	'
Derivative Asset Designated as Hedging Instrument	1	3
Interest Rate Swap Contracts [Member] | Other Liabilities [Member]	'	'
Derivative Instruments [Abstract]	'	'
Derivative Liability Designated as Hedging Instrument	1	0
Interest Rate Swap Contracts [Member] | Other Accruals [Member]	'	'
Derivative Instruments [Abstract]	'	'
Derivative Liability Designated as Hedging Instrument	0	0
Foreign Currency Contracts [Member] | Other Assets [Member]	'	'
Derivative Instruments [Abstract]	'	'
Derivative Asset Designated as Hedging Instrument	0	13
Foreign Currency Contracts [Member] | Other Current Assets [Member]	'	'
Derivative Instruments [Abstract]	'	'
Derivative Asset Designated as Hedging Instrument	14	7
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	0	0
Foreign Currency Contracts [Member] | Other Liabilities [Member]	'	'
Derivative Instruments [Abstract]	'	'
Derivative Liability Designated as Hedging Instrument	10	0
Foreign Currency Contracts [Member] | Other Accruals [Member]	'	'
Derivative Instruments [Abstract]	'	'
Derivative Liability Designated as Hedging Instrument	8	10
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	3	1
Commodity Contracts [Member] | Other Current Assets [Member]	'	'
Derivative Instruments [Abstract]	'	'
Derivative Asset Designated as Hedging Instrument	0	1
Commodity Contracts [Member] | Other Accruals [Member]	'	'
Derivative Instruments [Abstract]	'	'
Derivative Liability Designated as Hedging Instrument	0	0
Fair Value, Inputs, Level 1 [Member] | Other Current Assets [Member]	'	'
Derivative and Financial Instruments, Fair Value [Line Items]	'	'
Marketable Securities	173	'
Estimate of Fair Value Measurement [Member]	'	'
Financial Instruments [Abstract]	'	'
Total other financial instruments	858	734
Estimate of Fair Value Measurement [Member] | Other Assets [Member]	'	'
Financial Instruments [Abstract]	'	'
Venezuelan bonds, long-term	685	'
Foreign Government Debt Securities [Member] | Other Current Assets [Member]	'	'
Derivative and Financial Instruments, Fair Value [Line Items]	'	'
Marketable Securities	$0	'

Fair_Value_Measurements_and_Fi3

Fair Value Measurements and Financial Instruments (Details 2) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Debt Instrument [Line Items]	'	'
Total Debt	$5,644	$5,176
Carrying Value [Member]	'	'
Debt Instrument [Line Items]	'	'
Total Debt	5,644	5,176
Fair Value, Inputs, Level 2 [Member]	'	'
Debt Instrument [Line Items]	'	'
Debt Instrument, Fair Value Disclosure	$5,690	$5,484

Fair_Value_Measurements_and_Fi4

Fair Value Measurements and Financial Instruments (Details 3) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Fair Value Hedging [Member]	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Notional Value	$2,508	$2,455
Activity related to fair value hedges [Abstract]	'	'
Gain (loss) on derivative	2	15
Gain (loss) on hedged items	-2	-15
Fair Value Hedging [Member] | Interest Rate Swap Contracts [Member]	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Notional Value	1,188	1,338
Activity related to fair value hedges [Abstract]	'	'
Gain (loss) on derivative	-22	6
Gain (loss) on hedged items	22	-6
Fair Value Hedging [Member] | Foreign Currency Contracts [Member]	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Notional Value	1,320	1,117
Activity related to fair value hedges [Abstract]	'	'
Gain (loss) on derivative	24	9
Gain (loss) on hedged items	-24	-9
Cash Flow Hedging [Member]	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Notional Value	400	421
Activity related to cash flow hedges [Abstract]	'	'
Gain (loss) recognized in OCI	20	13
Gain (loss) reclassified into Cost of sales	17	11
Cash Flow Hedging [Member] | Foreign Currency Contracts [Member]	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Notional Value	386	398
Activity related to cash flow hedges [Abstract]	'	'
Gain (loss) recognized in OCI	20	4
Gain (loss) reclassified into Cost of sales	16	4
Cash Flow Hedging [Member] | Commodity Contracts [Member]	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Notional Value	14	23
Activity related to cash flow hedges [Abstract]	'	'
Gain (loss) recognized in OCI	0	9
Gain (loss) reclassified into Cost of sales	1	7
Net Investment Hedging [Member]	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Notional Value	785	905
Activity related to net investment hedges [Abstract]	'	'
Gain (loss) on instruments	-28	-19
Gain (loss) on hedged items	27	16
Net Investment Hedging [Member] | Foreign Currency Contracts [Member]	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Notional Value	529	522
Activity related to net investment hedges [Abstract]	'	'
Gain (loss) on instruments	-24	-11
Gain (loss) on hedged items	23	8
Net Investment Hedging [Member] | Foreign Currency Denominated Debt [Member]	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Notional Value	256	383
Activity related to net investment hedges [Abstract]	'	'
Gain (loss) on instruments	-4	-8
Gain (loss) on hedged items	4	8
Not Designated as Hedging Instrument [Member] | Cross-Currency Swap (Member)	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Notional Value	96	96
Activity related to derivatives not designated as hedging instruments [Abstract]	'	'
Gain (loss) on instrument	-2	-4
Gain (loss) on hedged item	$2	$4

Fair_Value_Measurements_and_Fi5

Fair Value Measurements and Financial Instruments (Details 4) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Schedule of Available-for-sale Securities [Line Items]	'	'
Fair Value of U.S. dollar-linked, devaluation-protected bonds	$233	'
Fair Value of fixed interest rate bonds	452	'
Bonds Issued By Venezuelan Government [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
One-time loss related to the remeasurement of fixed interest rate bonds in Venezuela	133	'
Venezuelan Investments [Roll Forward]	'	'
Beginning balance	642	236
Unrealized gain (loss) on investment	-113	28
Purchases and sales during the period	156	378
Ending balance	$685	$642

Capital_Stock_and_StockBased_C2

Capital Stock and Stock-Based Compensation Plans (Details) (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Preference Stock [Abstract]	'	'	'
Shares authorized (in shares)	50,262,150	'	'
Stock Repurchases [Abstract]	'	'	'
Repurchased stock	$1,521	$1,943	$1,806
Summary of common stock activity [Roll Forward]	'	'	'
Common Stock Balance, January 1 (in shares)	935,728,676	960,036,150	989,700,934
Common stock acquired (in shares)	-25,573,317	-38,730,602	-42,641,872
Shares issued for stock options (in shares)	7,883,834	12,217,230	11,517,758
Shares issued for restricted stock and other (in shares)	1,907,382	2,205,898	1,459,330
Common Stock Balance, December 31 (in shares)	919,946,575	935,728,676	960,036,150
Summary Of Treasury Stock Activity [Roll Forward]	'	'	'
Treasury Stock Balance, January 1 (in shares)	529,977,684	505,670,210	476,005,426
Common stock acquired (in shares)	25,573,317	38,730,602	42,641,872
Shares issued for stock options (in shares)	-7,883,834	-12,217,230	-11,517,758
Shares issued for restricted stock and other (in shares)	-1,907,382	-2,205,898	-1,459,330
Treasury Stock Balance, December 31 (in shares)	545,759,785	529,977,684	505,670,210
Stock-based compensation [Abstract]	'	'	'
Allocated Share-based Compensation Expense	128	120	122
Total income tax benefit	39	37	40
Fair Value Assumptions [Abstract]	'	'	'
Weighted-average estimated fair value of stock options granted (in dollars per share)	$7.41	$6.73	$5.97
Expected term (in years)	'4 years 6 months	'4 years 6 months	'4 years 6 months
Expected Volatility Rate (in hundredths)	18.40%	20.80%	21.30%
Risk-Free Rate (in hundredths)	1.50%	0.60%	0.80%
Expected Dividend Yield (in hundredths)	2.30%	2.40%	2.60%
Summary of restricted stock award activity [Roll Forward]	'	'	'
Restricted stock awards - beginning balance (in shares)	5,268,000	'	'
Granted (in shares)	1,214,000	'	'
Vested (in shares)	-1,854,000	'	'
Forfeited (in shares)	-89,000	'	'
Restricted stock awards - ending balance (in shares)	4,539,000	5,268,000	'
Weighted average grant date fair value per award [Roll Forward]	'	'	'
Weighted average grant date fair value of restricted stock awards - beginning of period (in dollars per share)	$43	'	'
Weighted average grant date fair value of restricted stock awards - shares granted (in dollars per share)	$59	'	'
Weighted average grant date fair value of restricted stock awards - shares vested (in dollars per share)	$41	'	'
Weighted average grant date fair value of restricted stock awards - shares forfeited (in dollars per share)	$45	'	'
Weighted average grant date fair value of restricted stock awards - end of period (in dollars per share)	$48	$43	'
Summary of stock option plan activity [Roll Forward]	'	'	'
Options - beginning balance (in shares)	42,342,000	'	'
Granted (in shares)	9,219,000	'	'
Shares issued for stock options (in shares)	-8,285,000	'	'
Forfeited or expired (in shares)	-444,000	'	'
Options - ending balance (in shares)	42,832,000	42,342,000	'
Options exercisable (in shares)	24,151,000	'	'
Additional disclosures pertaining to stock options [Abstract]	'	'	'
Weighted average exercise price of options - beginning of period (in dollars per share)	$43	'	'
Weighted average exercise price of options - shares granted (in dollars per share)	$59	'	'
Weighted average exercise price of options - shares exercised (in dollars per share)	$38	'	'
Weighted average exercise price of options - shares forfeited or expired (in dollars per share)	$49	'	'
Weighted average exercise price of options - end of period (in dollars per share)	$47	$43	'
Weighted average exercise price of options exercisable - end of period (in dollars per share)	$42	'	'
Weighted average remaining contractual life, options outstanding (in years)	'4 years	'	'
Weighted average remaining contractual life, options exercisable (in years)	'3 years	'	'
Value of unexercised in-the-money options, options outstanding	773	'	'
Value of unexercised in-the-money options, options exercisable	572	'	'
Stock-based compensation, additional disclosures [Abstract]	'	'	'
Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options	51	60	32
Proceeds from Stock Options Exercised	289	409	332
Program 2011 [Member]	'	'	'
Stock Repurchases [Abstract]	'	'	'
Treasury stock repurchase authorization (in shares)	50,000,000	'	'
Incentive Stock Plans [Member]	'	'	'
Additional disclosures pertaining to restricted stock awards [Abstract]	'	'	'
Number of shares available for grant (in shares)	13,409,000	'	'
Unrecognized compensation expense	66	'	'
Unrecognized compensation expense, weighted-average period of recognition in years	'2 years 2 months 12 days	'	'
Total fair value of shares vested	69	63	50
Stock Option Plans [Member]	'	'	'
Additional disclosures pertaining to restricted stock awards [Abstract]	'	'	'
Number of shares available for grant (in shares)	54,815,000	'	'
Unrecognized compensation expense	49	'	'
Unrecognized compensation expense, weighted-average period of recognition in years	'1 year 6 months	'	'
Stock-based compensation, additional disclosures [Abstract]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value	$180	$210	$162
Vesting period (in years)	'3 years	'	'
Contractual term (in years)	'6 years	'	'

Capital_Stock_and_StockBased_C3

Capital Stock and Stock-Based Compensation Plans Common Stock Split (Details) (USD $)	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2013	Apr. 23, 2013	Dec. 31, 2012
Common Stock Split, Pro Forma Information [Line Items]	'	'	'
Stockholders' Equity Note, Stock Split, Conversion Ratio	2	'	'
Stockholders' Equity Note Percent of Dividend in Shares	100.00%	'	'
Common Stock, Par or Stated Value Per Share	$1	$1	$1
Common Stock [Member]	'	'	'
Common Stock Split, Pro Forma Information [Line Items]	'	'	'
Stock Issued During Period, Value, Stock Dividend	$733	'	'
Adjustments to Additional Paid in Capital, Stock Split	$733	'	'

Employee_Stock_Ownership_Plan_

Employee Stock Ownership Plan (Details) (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 29, 2010	Dec. 31, 1989
Notes to Financial Statements [Abstract]	'	'	'	'	'
Long-term notes issued by ESOP	'	'	'	'	$410
Average interest rate on ESOP notes (in hundredths)	'	'	'	'	8.70%
Preference stock purchased from the proceeds of the notes (in shares)	'	'	'	'	6,315,149
Common stock converted (in shares)	'	'	'	38,483,072	'
Employee Stock Ownership Plan (ESOP), Shares in ESOP	29,119,135	31,221,296	'	'	'
Outstanding Borrowings from the Company	33	'	'	'	'
Common shares released and allocated to participant accounts (in shares)	19,171,587	'	'	'	'
Common shares available for future allocation to participant accounts (in shares)	9,947,548	'	'	'	'
Annual ESOP expense	0	0	0	'	'
Dividends paid by the Company on shares held by the ESOP	41	40	42	'	'
Company contributions to the ESOP	$0	$0	$0	'	'

Retirement_Plans_and_Other_Ret2

Retirement Plans and Other Retiree Benefits (Details) (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Defined Benefit Plan Disclosure [Line Items]	'		'		'
Percentage Of Fixed Income Portfolio Invested In Us Treasury Or Agency Securities	50.00%		50.00%		'
Two Thousand Twelve Restructuring Program [Member]	'		'		'
Defined Benefit Plan Disclosure [Line Items]	'		'		'
Defined Benefit Plan, Curtailments	($91)		'		'
Other Restructuring [Member] | Two Thousand Twelve Restructuring Program [Member]	'		'		'
Defined Benefit Plan Disclosure [Line Items]	'		'		'
Defined Benefit Plan, Curtailments	-91		'		'
United States Pension Benefits [Member]	'		'		'
Defined Benefit Plan, Assets, Target Allocations [Abstract]	'		'		'
Equity securities (in hundredths)	100.00%		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	1,736		1,597		1,426
Dividends received by plans on the Company's common stock	3		4		'
Defined Benefit Plan Percentage Of Equity Securities Invested In Employer Securities	6.00%		11.00%		'
Defined Benefit Plan, Plan Assets, Common Shares Sold	1,540,215		'		'
United States Pension Benefits [Member] | Equity Securities [Member]	'		'		'
Defined Benefit Plan, Assets, Target Allocations [Abstract]	'		'		'
Equity securities (in hundredths)	27.00%		'		'
United States Pension Benefits [Member] | Cash & cash equivalents [Member] | Level 1 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	97		45		'
United States Pension Benefits [Member] | U.S. common stocks [Member] | Level 1 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	127		258		'
United States Pension Benefits [Member] | International common stocks [Member] | Level 1 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	51		93		'
United States Pension Benefits [Member] | Fixed income securities [Member]	'		'		'
Defined Benefit Plan, Assets, Target Allocations [Abstract]	'		'		'
Equity securities (in hundredths)	53.00%		'		'
United States Pension Benefits [Member] | Fixed income securities [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	433	[1]	142	[1]	'
United States Pension Benefits [Member] | Equity index funds [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	359	[2]	444	[2]	'
United States Pension Benefits [Member] | Emerging market equity index funds [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	33	[2]	65	[2]	'
United States Pension Benefits [Member] | Other common stock funds [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	123	[2]	40	[2]	'
United States Pension Benefits [Member] | Fixed income funds: U.S. or foreign government and agency securities [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	149	[2]	227	[2]	'
United States Pension Benefits [Member] | Fixed income funds: investment grade corporate bonds [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	203	[2]	26	[2]	'
United States Pension Benefits [Member] | Fixed income funds: high yield corporate bonds and other [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	119	[2]	185	[2]	'
United States Pension Benefits [Member] | Guaranteed investment contracts [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	2	[3]	2	[3]	'
United States Pension Benefits [Member] | Real estate [Member] | Level 3 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	40	[4]	70	[4]	'
United States Pension Benefits [Member] | Real Estate and Other Investments [Member]	'		'		'
Defined Benefit Plan, Assets, Target Allocations [Abstract]	'		'		'
Equity securities (in hundredths)	20.00%		'		'
International Pension Benefits [Member]	'		'		'
Defined Benefit Plan, Assets, Target Allocations [Abstract]	'		'		'
Equity securities (in hundredths)	100.00%		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	558		486		437
International Pension Benefits [Member] | Equity Securities [Member]	'		'		'
Defined Benefit Plan, Assets, Target Allocations [Abstract]	'		'		'
Equity securities (in hundredths)	39.00%		'		'
International Pension Benefits [Member] | Cash & cash equivalents [Member] | Level 1 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	23		9		'
International Pension Benefits [Member] | U.S. common stocks [Member] | Level 1 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	0		0		'
International Pension Benefits [Member] | International common stocks [Member] | Level 1 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	0		0		'
International Pension Benefits [Member] | Fixed income securities [Member]	'		'		'
Defined Benefit Plan, Assets, Target Allocations [Abstract]	'		'		'
Equity securities (in hundredths)	48.00%		'		'
International Pension Benefits [Member] | Fixed income securities [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	0	[1]	0	[1]	'
International Pension Benefits [Member] | Equity index funds [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	229	[2]	199	[2]	'
International Pension Benefits [Member] | Emerging market equity index funds [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	9	[2]	12	[2]	'
International Pension Benefits [Member] | Other common stock funds [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	75	[2]	65	[2]	'
International Pension Benefits [Member] | Fixed income funds: U.S. or foreign government and agency securities [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	73	[2]	59	[2]	'
International Pension Benefits [Member] | Fixed income funds: investment grade corporate bonds [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	71	[2]	72	[2]	'
International Pension Benefits [Member] | Fixed income funds: high yield corporate bonds and other [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	1	[2]	1	[2]	'
International Pension Benefits [Member] | Guaranteed investment contracts [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	56	[3]	49	[3]	'
International Pension Benefits [Member] | Real estate [Member] | Level 3 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	21	[4]	20	[4]	18
International Pension Benefits [Member] | Real Estate and Other Investments [Member]	'		'		'
Defined Benefit Plan, Assets, Target Allocations [Abstract]	'		'		'
Equity securities (in hundredths)	13.00%		'		'
Other Retiree Benefits [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	41		37		32
Other Retiree Benefits [Member] | Cash & cash equivalents [Member] | Level 1 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	3		1		'
Other Retiree Benefits [Member] | U.S. common stocks [Member] | Level 1 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	3		6		'
Other Retiree Benefits [Member] | International common stocks [Member] | Level 1 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	1		2		'
Other Retiree Benefits [Member] | Fixed income securities [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	8	[1]	0	[1]	'
Other Retiree Benefits [Member] | Equity index funds [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	9	[2]	11	[2]	'
Other Retiree Benefits [Member] | Emerging market equity index funds [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	1	[2]	2	[2]	'
Other Retiree Benefits [Member] | Other common stock funds [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	3	[2]	1	[2]	'
Other Retiree Benefits [Member] | Fixed income funds: U.S. or foreign government and agency securities [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	3	[2]	6	[2]	'
Other Retiree Benefits [Member] | Fixed income funds: investment grade corporate bonds [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	5	[2]	1	[2]	'
Other Retiree Benefits [Member] | Fixed income funds: high yield corporate bonds and other [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	4	[2]	5	[2]	'
Other Retiree Benefits [Member] | Guaranteed investment contracts [Member] | Level 2 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	0	[3]	0	[3]	'
Other Retiree Benefits [Member] | Real estate [Member] | Level 3 [Member]	'		'		'
Allocation of plan assets and level of valuation input for each major asset category [Abstract]	'		'		'
Total investments at fair value	$1	[4]	$2	[4]	'
[1]	The fixed income securities are traded over the counter and certain of these securities lack daily pricing or liquidity and as such are classified as Level 2. As of December 31, 2013 and 2012, approximately 50% of the fixed income portfolio was invested in U.S. treasury or agency securities, with the remainder invested in other government bonds and corporate bonds.
[2]	Interests in common/collective trust funds are valued using the net asset value (“NAV”) per unit in each fund. The NAV is based on the value of the underlying investments owned by each trust, minus its liabilities, divided by the number of shares outstanding.
[3]	The guaranteed investment contracts (“GICs”) represent contracts with insurance companies measured at the cash surrender value of each contract. The Level 2 valuation reflects that the cash surrender value is based principally on a referenced pool of investment funds with active redemption.
[4]	Real estate is valued using the NAV per unit of funds that are invested in real estate property. The investment value of the real estate property is determined quarterly using independent market appraisals as determined by the investment manager. Since the appraisals include unobservable inputs, these investments are classified as Level 3. These unobservable inputs may include items such as annual gross rents, projected vacancy rates, collection losses and recovery rates, yield rates, growth assumptions and risk adjusted discount rates.

Retirement_Plans_and_Other_Ret3

Retirement Plans and Other Retiree Benefits Additional Disclosures (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Amounts Recognized in Balance Sheet	'		'		'
Current liabilities	($94)		($86)		'
Estimated amounts that will be amortized from accumulated other comprehensive income [Abstract]	'		'		'
Expected Benefit Payments From Company Assets	98		'		'
Total benefit payments [Abstract]	'		'		'
2014	282		'		'
2015	232		'		'
2016	225		'		'
2017	234		'		'
2018	230		'		'
2019-2023	1,196		'		'
United States Pension Plans of US Entity, Defined Benefit [Member]	'		'		'
Change in Benefit Obligations	'		'		'
Benefit obligations at beginning of year	2,227		2,025		'
Service Cost including ESOP	24		24		'
Interest cost	90		97		100
Participants' contributions	1		1		'
Acquisitions/plan amendments	40		0		'
Actuarial loss (gain)	-148		200		'
Foreign exchange impact	0		0		'
Termination benefits	11	[1]	0	[1]	'
Curtailments and settlements	-12		0		'
Benefit payments	-131		-128		'
Defined Benefit Plan, Other Changes	0		8		'
Benefit obligations at end of year	2,102		2,227		2,025
Change in Plan Assets	'		'		'
Fair value of plan assets at beginning of year	1,597		1,426		'
Actual return on plan assets	148		173		'
Company's benefit plan contributions	121		125		'
Participants' contributions	1		1		'
Foreign exchange impact	0		0		'
Settlements	0		0		'
Benefit payments	-131		-128		'
Defined Benefit Plan Change in Plan Asset Other	0		0		'
Fair value of plan assets at end of year	1,736		1,597		1,426
Funded Status	'		'		'
Benefit obligations at end of year	2,102		2,227		2,025
Fair value of plan assets at end of year	1,736		1,597		1,426
Net amount recognized	-366		-630		'
Amounts Recognized in Balance Sheet	'		'		'
Noncurrent assets	16		0		'
Current liabilities	-19		-17		'
Noncurrent liabilities	-363		-613		'
Net amount recognized	-366		-630		'
Amounts recognized in Accumulated other comprehensive income consist of	'		'		'
Actuarial loss	674		932		'
Transition/prior service cost	3		63		'
Amounts recognized in accumulated other comprehensive income	677		995		'
Accumulated benefit obligation	1,995		2,093		'
Weighted-Average Assumptions Used to Determine Benefit Obligations	'		'		'
Discount Rate	4.96%		4.14%		'
Long-term rate of return on plan assets (in hundredths)	6.80%		7.30%		'
Long-term rate of compensation increase (in hundredths)	3.50%		3.50%		'
ESOP growth rate (in hundredths)	0.00%		0.00%		'
Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Medical Cost Trend Rate	0.00%		0.00%		'
Long-term rate of return on plan assets [Abstract]	'		'		'
Average annual rates of return for the most recent 1-year period (in hundredths)	9.00%		'		'
Average annual rates of return for the most recent 5-year period (in hundredths)	11.00%		'		'
Average annual rates of return for the most recent 10-year period (in hundredths)	7.00%		'		'
Average annual rates of return for the most recent 15-year period (in hundredths)	6.00%		'		'
Average annual rates of return for the most recent 25-year period (in hundredths)	8.00%		'		'
Components of Net Periodic Benefit Cost	'		'		'
Service cost	24		24		24
Interest cost	90		97		100
Annual ESOP allocation	0		0		0
Expected return on plan assets	-118		-112		-110
Amortization of transition and prior service costs (credits)	9		9		9
Amortization of actuarial loss	68		62		46
Net periodic benefit cost	73		80		69
Other postretirement charges	102		0		0
Total pension cost	175		80		69
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost	'		'		'
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate	4.14%		4.90%		5.30%
Long-term rate of return on plan assets (in hundredths)	7.30%		7.75%		8.00%
Long-term rate of compensation increase (in hundredths)	3.50%		4.00%		4.00%
ESOP growth rate (in hundredths)	0.00%		0.00%		0.00%
Defined Benefit Plan Assumptions Used Calculating Net Periodic Medical Cost Trend Rate	0.00%		0.00%		0.00%
Voluntary contributions to postretirement plans	101		101		178
Total benefit payments [Abstract]	'		'		'
2014	172		'		'
2015	136		'		'
2016	135		'		'
2017	136		'		'
2018	135		'		'
2019-2023	691		'		'
United States Pension Plans of US Entity, Defined Benefit [Member] | Real estate [Member] | Level 3 [Member]	'		'		'
Change in Plan Assets	'		'		'
Fair value of plan assets at end of year	40	[2]	70	[2]	'
Funded Status	'		'		'
Fair value of plan assets at end of year	40	[2]	70	[2]	'
United States Pension Benefits [Member] | Real estate [Member] | Level 3 [Member]	'		'		'
Change in Plan Assets	'		'		'
Fair value of plan assets at beginning of year	72		64		'
Earned income, net of management expenses	2		6		'
Unrealized gain (loss) on investment	9		2		'
Purchases, sales, issuances and settlements, net	-42		0		'
Fair value of plan assets at end of year	41		72		'
Funded Status	'		'		'
Fair value of plan assets at end of year	41		72		'
International Pension Benefits [Member]	'		'		'
Change in Benefit Obligations	'		'		'
Benefit obligations at beginning of year	888		760		'
Service Cost including ESOP	19		12		'
Interest cost	34		35		36
Participants' contributions	3		3		'
Acquisitions/plan amendments	2		21		'
Actuarial loss (gain)	-1		103		'
Foreign exchange impact	12		21		'
Termination benefits	0	[1]	0	[1]	'
Curtailments and settlements	-21		-23		'
Benefit payments	-41		-45		'
Defined Benefit Plan, Other Changes	-1		1		'
Benefit obligations at end of year	894		888		760
Change in Plan Assets	'		'		'
Fair value of plan assets at beginning of year	486		437		'
Actual return on plan assets	59		47		'
Company's benefit plan contributions	61		57		'
Participants' contributions	3		3		'
Foreign exchange impact	2		13		'
Settlements	-11		-21		'
Benefit payments	-41		-45		'
Defined Benefit Plan Change in Plan Asset Other	-1		-5		'
Fair value of plan assets at end of year	558		486		437
Funded Status	'		'		'
Benefit obligations at end of year	894		888		760
Fair value of plan assets at end of year	558		486		437
Net amount recognized	-336		-402		'
Amounts Recognized in Balance Sheet	'		'		'
Noncurrent assets	12		2		'
Current liabilities	-36		-29		'
Noncurrent liabilities	-312		-375		'
Net amount recognized	-336		-402		'
Amounts recognized in Accumulated other comprehensive income consist of	'		'		'
Actuarial loss	181		235		'
Transition/prior service cost	23		26		'
Amounts recognized in accumulated other comprehensive income	204		261		'
Accumulated benefit obligation	802		798		'
Weighted-Average Assumptions Used to Determine Benefit Obligations	'		'		'
Discount Rate	3.99%		3.57%		'
Long-term rate of return on plan assets (in hundredths)	5.50%		5.39%		'
Long-term rate of compensation increase (in hundredths)	3.02%		2.80%		'
ESOP growth rate (in hundredths)	0.00%		0.00%		'
Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Medical Cost Trend Rate	0.00%		0.00%		'
Components of Net Periodic Benefit Cost	'		'		'
Service cost	19		12		19
Interest cost	34		35		36
Annual ESOP allocation	0		0		0
Expected return on plan assets	-26		-26		-27
Amortization of transition and prior service costs (credits)	2		2		3
Amortization of actuarial loss	10		9		9
Net periodic benefit cost	39		32		40
Other postretirement charges	3		9		3
Total pension cost	42		41		43
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost	'		'		'
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate	3.57%		4.59%		5.04%
Long-term rate of return on plan assets (in hundredths)	5.39%		5.91%		6.23%
Long-term rate of compensation increase (in hundredths)	2.80%		2.87%		3.05%
ESOP growth rate (in hundredths)	0.00%		0.00%		0.00%
Defined Benefit Plan Assumptions Used Calculating Net Periodic Medical Cost Trend Rate	0.00%		0.00%		0.00%
Total benefit payments [Abstract]	'		'		'
2014	70		'		'
2015	55		'		'
2016	47		'		'
2017	54		'		'
2018	50		'		'
2019-2023	273		'		'
International Pension Benefits [Member] | Real estate [Member] | Level 3 [Member]	'		'		'
Change in Plan Assets	'		'		'
Fair value of plan assets at beginning of year	20	[2]	18		'
Earned income, net of management expenses	0		0		'
Unrealized gain (loss) on investment	0		1		'
Purchases, sales, issuances and settlements, net	1		1		'
Fair value of plan assets at end of year	21	[2]	20	[2]	'
Funded Status	'		'		'
Fair value of plan assets at end of year	21	[2]	20	[2]	'
Pension Benefits [Member]	'		'		'
Benefit Obligation Exceeds Fair Value of Plan Assets	'		'		'
Projected benefit obligation	1,130		3,112		'
Fair value of plan assets	402		2,080		'
Accumulated benefit obligation	700		2,855		'
Fair value of plan assets	66		2,044		'
Estimated amounts that will be amortized from accumulated other comprehensive income [Abstract]	'		'		'
Net actuarial loss	39		'		'
Net transition & prior service cost	2		'		'
Other Retiree Benefits [Member]	'		'		'
Change in Benefit Obligations	'		'		'
Benefit obligations at beginning of year	875		776		'
Service Cost including ESOP	11		9		'
Interest cost	38		40		39
Participants' contributions	0		0		'
Acquisitions/plan amendments	0		-27		'
Actuarial loss (gain)	-101		119		'
Foreign exchange impact	-5		1		'
Termination benefits	6	[1]	0	[1]	'
Curtailments and settlements	0		0		'
Benefit payments	-32		-40		'
Defined Benefit Plan, Other Changes	0		-3		'
Benefit obligations at end of year	792		875		776
Change in Plan Assets	'		'		'
Fair value of plan assets at beginning of year	37		32		'
Actual return on plan assets	4		5		'
Company's benefit plan contributions	32		40		'
Participants' contributions	0		0		'
Foreign exchange impact	0		0		'
Settlements	0		0		'
Benefit payments	-32		-40		'
Defined Benefit Plan Change in Plan Asset Other	0		0		'
Fair value of plan assets at end of year	41		37		32
Funded Status	'		'		'
Benefit obligations at end of year	792		875		776
Fair value of plan assets at end of year	41		37		32
Net amount recognized	-751		-838		'
Amounts Recognized in Balance Sheet	'		'		'
Noncurrent assets	0		0		'
Current liabilities	-39		-40		'
Noncurrent liabilities	-712		-798		'
Net amount recognized	-751		-838		'
Amounts recognized in Accumulated other comprehensive income consist of	'		'		'
Actuarial loss	296		421		'
Transition/prior service cost	1		2		'
Amounts recognized in accumulated other comprehensive income	297		423		'
Accumulated benefit obligation	0		0		'
Weighted-Average Assumptions Used to Determine Benefit Obligations	'		'		'
Discount Rate	5.24%		4.32%		'
Long-term rate of return on plan assets (in hundredths)	6.80%		7.30%		'
Long-term rate of compensation increase (in hundredths)	0.00%		0.00%		'
ESOP growth rate (in hundredths)	10.00%		10.00%		'
Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Medical Cost Trend Rate	7.00%		7.50%		'
Assumed medical cost trend rates [Abstract]	'		'		'
Medical cost trend rate assumed for next fiscal year (in hundredths)	7.00%		'		'
Ultimate medical cost trend rate (in hundredths)	5.00%		'		'
Year which ultimate medical cost trend rate is reached	'2020		'		'
Defined Benefit Plan Health Care Cost Trend Rate After Ultimate Trend Rate Is Reached	5.00%		'		'
Effect of a 1% change in the assumed medical cost trend rate [Abstract]	'		'		'
Effect of one percentage point increase on accumulated postretirement benefit obligation	109		'		'
Effect of one percentage point decrease on accumulated postretirement benefit obligation	-88		'		'
Effect of one percentage point increase on annual expense	9		'		'
Effect of one percentage point decrease on annual expense	-7		'		'
Components of Net Periodic Benefit Cost	'		'		'
Service cost	13		11		12
Interest cost	38		40		39
Annual ESOP allocation	-2		-2		-2
Expected return on plan assets	-3		-3		-3
Amortization of transition and prior service costs (credits)	1		3		2
Amortization of actuarial loss	21		18		16
Net periodic benefit cost	68		67		64
Other postretirement charges	6		1		1
Total pension cost	74		68		65
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost	'		'		'
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate	4.32%		5.26%		5.30%
Long-term rate of return on plan assets (in hundredths)	7.30%		7.75%		8.00%
Long-term rate of compensation increase (in hundredths)	0.00%		0.00%		0.00%
ESOP growth rate (in hundredths)	10.00%		10.00%		10.00%
Defined Benefit Plan Assumptions Used Calculating Net Periodic Medical Cost Trend Rate	7.50%		8.00%		8.33%
Estimated amounts that will be amortized from accumulated other comprehensive income [Abstract]	'		'		'
Net actuarial loss	15		'		'
Net transition & prior service cost	0		'		'
Total benefit payments [Abstract]	'		'		'
2014	40		'		'
2015	41		'		'
2016	43		'		'
2017	44		'		'
2018	45		'		'
2019-2023	232		'		'
Other Retiree Benefits [Member] | Real estate [Member] | Level 3 [Member]	'		'		'
Change in Plan Assets	'		'		'
Fair value of plan assets at end of year	1	[2]	2	[2]	'
Funded Status	'		'		'
Fair value of plan assets at end of year	$1	[2]	$2	[2]	'
[1]	Represents pension and other retiree benefit enhancements incurred in 2013 pursuant to the 2012 Restructuring Program.
[2]	Real estate is valued using the NAV per unit of funds that are invested in real estate property. The investment value of the real estate property is determined quarterly using independent market appraisals as determined by the investment manager. Since the appraisals include unobservable inputs, these investments are classified as Level 3. These unobservable inputs may include items such as annual gross rents, projected vacancy rates, collection losses and recovery rates, yield rates, growth assumptions and risk adjusted discount rates.

Income_Taxes_Details

Income Taxes (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Components of income before income taxes [Abstract]	'	'	'
United States	$1,018	$1,155	$1,098
International	2,547	2,719	2,691
Total Income before income taxes	3,565	3,874	3,789
Provision for income taxes [Abstract]	'	'	'
United States	314	395	360
International	841	848	875
Total Provision for income taxes	1,155	1,243	1,235
Income tax provision reconciliation [Abstract]	'	'	'
Goodwill and intangible assets	-14	-7	-1
Property, plant and equipment	0	-13	-19
Pension and other retiree benefits	85	-14	-47
Stock-based compensation	10	5	11
Tax loss and tax credit carryforwards	-30	-39	-14
Other, net	-33	32	32
Total deferred tax provision	18	-36	-38
Effective Tax Rate Reconciliation [Abstract]	'	'	'
Tax at United States statutory rate (in hundredths)	35.00%	35.00%	35.00%
State income taxes, net of federal benefit (in hundredths)	0.40%	0.70%	0.40%
Earnings taxed at other than United States statutory rate (in hundredths)	-1.40%	-2.60%	-1.70%
Other, net (in hundredths)	-1.60%	-1.00%	-1.10%
Effective tax rate (in hundredths)	32.40%	32.10%	32.60%
Deferred tax liabilities:	'	'	'
Goodwill and intangible assets	-475	-476	'
Property, plant and equipment	-375	-365	'
Other	-237	-200	'
Deferred tax liabilities, total	-1,087	-1,041	'
Deferred tax assets:	'	'	'
Pension and other retiree benefits	448	544	'
Tax loss and tax credit carryforwards	28	61	'
Accrued liabilities	317	280	'
Stock-based compensation	116	113	'
Other	95	117	'
Deferred tax assets, total	1,004	1,115	'
Net deferred income taxes	-83	74	'
Deferred taxes included within:	'	'	'
Other current assets	284	275	'
Deferred Tax Assets, Noncurrent	77	92	'
Deferred Tax Liabilities, Noncurrent	-444	-293	'
Net deferred income taxes	-83	74	'
Undistributed earnings of foreign subsidiaries	4,700	'	'
Income Tax Effects Allocated Directly to Equity	116	80	79
Unrecognized tax benefits:	'	'	'
Balance, January 1	212	176	171
Increases as a result of tax positions taken during the current year	23	34	76
Decreases of tax positions taken during prior years	-52	-6	-46
Increases of tax positions taken during prior years	37	10	10
Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations	-22	-3	-30
Effect of foreign currency rate movements	1	1	-5
Balance, December 31	199	212	176
Unrecognized tax benefits that would impact effective tax rate	173	'	'
Interest (income) expense recognized related to unrecognized tax benefits	5	5	0
Accrued interest related to unrecognized tax benefits	$24	$19	'
Minimum [Member]	'	'	'
Income Taxes [Line Items]	'	'	'
Statue Of Limitations Of Certain Foreign Entities	'3 years	'	'
Maximum [Member]	'	'	'
Income Taxes [Line Items]	'	'	'
Statue Of Limitations Of Certain Foreign Entities	'6 years	'	'

Earnings_Per_Share_Details

Earnings Per Share (Details) (USD $)

3 Months Ended

12 Months Ended

In Millions, except Share data, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Income [Abstract]

'

'

'

'

'

'

'

'

'

'

'

Net Income (Loss) Attributable to Parent

$564

[1]

$656

[2]

$561

[3]

$460

[4]

$598

[5]

$654

[6]

$627

[7]

$593

[8]

$2,241

[9]

$2,472

[10]

$2,431

Basic EPS

'

'

'

'

'

'

'

'

2,241

2,472

2,431

Diluted EPS

'

'

'

'

'

'

'

'

$2,241

$2,472

$2,431

Shares [Abstract]

'

'

'

'

'

'

'

'

'

'

'

Basic EPS (in shares)

'

'

'

'

'

'

'

'

930,800,000

952,100,000

976,700,000

Stock options and restricted stock (in shares)

'

'

'

'

'

'

'

'

9,100,000

8,100,000

7,400,000

Diluted EPS (in shares)

'

'

'

'

'

'

'

'

939,900,000

960,200,000

984,100,000

Per Share [Abstract]

'

'

'

'

'

'

'

'

'

'

'

Basic EPS (in dollars per share)

$0.61

[1]

$0.71

[2]

$0.60

[3]

$0.49

[4]

$0.63

[5]

$0.69

[6]

$0.66

[7]

$0.62

[8]

$2.41

[9]

$2.60

[10]

$2.49

Diluted EPS (in dollars per share)

$0.60

[1]

$0.70

[2]

$0.60

[3]

$0.48

[4]

$0.63

[5]

$0.68

[6]

$0.65

[7]

$0.61

[8]

$2.38

[9]

$2.57

[10]

$2.47

Average number of anti-dilutive shares (in shares)

'

'

'

'

'

'

'

'

1,785,032

3,504,608

3,063,536

[1]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the fourth quarter of 2013 include $125 of aftertax charges related to the 2012 Restructuring Program, a $5 charge for a competition law matter in France related to the home care and personal care sectors and $3 of aftertax costs related to the sale of land in Mexico.

[2]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the third quarter of 2013 include $22 of aftertax charges related to the 2012 Restructuring Program and $2 of aftertax costs related to the sale of land in Mexico.

[3]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the second quarter of 2013 include $79 of aftertax charges related to the 2012 Restructuring Program, an $18 charge for a competition law matter in France related to the home care and personal care sectors and $4 of aftertax costs related to the sale of land in Mexico.

[4]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the first quarter of 2013 include $52 of aftertax charges related to the 2012 Restructuring Program, a $111 one-time aftertax charge for the impact of the devaluation in Venezuela and $3 of aftertax costs related to the sale of land in Mexico.

[5]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the fourth quarter of 2012 include $70 of aftertax charges related to the 2012 Restructuring Program and $3 of aftertax costs related to the sale of land in Mexico.

[6]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the third quarter of 2012 include $5 of aftertax costs related to the sale of land in Mexico and $2 of aftertax costs associated with various business realignment and other cost-saving initiatives.

[7]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the second quarter of 2012 include $5 of aftertax costs related to the sale of land in Mexico and $9 of aftertax costs associated with various business realignment and other cost-saving initiatives.

[8]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the first quarter of 2012 include $5 of aftertax costs related to the sale of land in Mexico and $3 of aftertax costs associated with various business realignment and other cost-saving initiatives.

[9]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2013 include $278 of aftertax charges related to the 2012 Restructuring Program, a $111 one-time aftertax charge for the impact of the devaluation in Venezuela, a $23 charge for a competition law matter in France related to the home care and personal care sectors and $12 of aftertax costs related to the sale of land in Mexico.

[10]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2012 include $70 of aftertax charges related to the 2012 Restructuring Program, $18 of aftertax costs related to the sale of land in Mexico and $14 of aftertax costs associated with various business realignment and other cost-saving initiatives.

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
	country_and_territory
Operating leases,minimum rental commitments[Abstract]	'	'	'
Minimum rental commitments under noncancellable operating leases due within one year of the balance sheet date	$196	'	'
Minimum rental commitments under noncancellable operating leases due in two years of the balance sheet date	172	'	'
Minimum rental commitments under noncancellable operating leases due in three years of the balance sheet date	138	'	'
Minimum rental commitments under noncancellable operating leases due in four years of the balance sheet date	126	'	'
Minimum rental commitments under noncancellable operating leases due in five years of the balance sheet date	121	'	'
Minimum rental commitments under noncancellable operating leases due after five years of the balance sheet date	349	'	'
Operating leases, rental expense [Abstract]	'	'	'
Rental expense	232	228	245
Contractual commitments (Abstract)	'	'	'
Contractual commitments, amount	800	'	'
Contingencies [Abstract]	'	'	'
Number Of Countries And Territories Serving Consumers (more than 200)	200	'	'
Loss Contingency, Range of Possible Loss, Minimum	0	'	'
Loss Contingency, Range of Possible Loss, Maximum	250	'	'
Brazilian internal revenue authority, matter 1	120	'	'
Brazilian internal revenue authority, matter 2	75	'	'
European competition matters - Swiss competition law authority	6	'	'
European competition matters - Spanish competition law authority	3	'	'
European competition matters - Italian competition law authority	3	'	'
European competition matters - French competition law authority	46	'	'
European competition matters - Hill's France Subsidiary	7	'	'
ERISA Matter	$40	'	'

Venezuela_Details

Venezuela (Details)	3 Months Ended	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
	USD ($)	USD ($)	USD ($)	USD ($)	VEF	VEF	VEF
Notes to Financial Statements [Abstract]	'	'	'	'	'	'	'
Official currency exchange rate in Venezuela for non-essential goods prior to devaluation beginning February 9, 2013	'	'	'	'	'	4.3	4.3
Official currency exchange rate in Venezuela for non-essential goods beginning February 9, 2013	'	'	'	'	6.3	'	'
Pretax Venezuela Devaluation Charge	$172	$172	$0	$0	'	'	'
Aftertax Venezuela Devaluation Charge	111	111	'	'	'	'	'
One time effect of Venezuela devaluation charge on Diluted EPS	'	$0.12	'	'	'	'	'
Percentage Of Consolidated Net sales Represented By Venezuela Subsidiary	'	4.00%	'	'	'	'	'
Venezuela Subsidiary Bolivar Fuerte Denominated Monetary Net Asset Position	'	600	'	'	'	'	'
Fair Value of U.S. dollar-linked, devaluation-protected bonds	'	233	'	'	'	'	'
Venezuela Subsidiary Bolivar Fuerte Denominated Non Monetary Asset Position	'	335	'	'	'	'	'
Venezuela Subsidiary Bolivar Fuerte Denominated Non Monetary Fixed Asset Position	'	$225	'	'	'	'	'

Segment_Information_Details

Segment Information (Details) (USD $)	3 Months Ended		12 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2013	Sep. 30, 2011	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Segment Reporting Information [Line Items]	'	'	'		'		'
Percentage Of Consolidated Net sales Represented By Caricom and Puerto Rico Subsidiary	'	'	1.00%		'		'
Percentage Of North America's Net sales Represented By Caricom and Puerto Rico Subsidiary	4.00%	'	'		'		'
Percentage Of Latin America's Net sales Represented By Caricom and Puerto Rico Subsidiary	'	'	3.00%		'		'
Percentage of Consolidated Net Sales represented by Sales outside US	'	'	80.00%		'		'
Percentage of Consolidated Net Sales coming from Emerging Markets	'	'	50.00%		'		'
2012 Restructuring Program	'	'	$202		$81		$0
Business realignment and other cost-saving initiatives	'	'	'		21		190
Venezuela devaluation charge	172	'	172		0		0
Charge for French Competition Law Matter related to the Home Care and Personal Care sectors	'	'	23		0		'
Charge for French Competition Law Matter Related to a Divested Detergent Business	'	'	'		'		21
Pretax costs related to sale of land	'	'	3		0		13
Gain on sales of non-core product lines	'	207	0		0		207
Total Net sales	'	'	17,420		17,085		16,734
Total Operating profit	'	'	3,556		3,889		3,841
Total Capital expenditures	'	'	670		565		537
Total Depreciation and amortization	'	'	439		425		421
Total Identifiable assets	'	'	13,876	[1]	13,394	[1]	12,724	[1]
Percentage Of Corporate Identifiable Assets Consisting Of Derivative Instruments	'	'	32.00%		67.00%		73.00%
Percentage Of Corporate Identifiable Assets Consisting Of Investments In Equity Securities	'	'	41.00%		28.00%		22.00%
Total Long Lived Assets	'	'	8,248		8,066		7,926
MEXICO	'	'	'		'		'
Segment Reporting Information [Line Items]	'	'	'		'		'
Pretax costs related to sale of land	'	'	18		24		13
UNITED STATES | Oral, Personal and Home Care [Member]	'	'	'		'		'
Segment Reporting Information [Line Items]	'	'	'		'		'
Total Net sales	'	'	2,771		2,669		2,567
UNITED STATES | Pet Nutrition [Member]	'	'	'		'		'
Segment Reporting Information [Line Items]	'	'	'		'		'
Total Net sales	'	'	1,116		1,052		1,032
Two Thousand Twelve Restructuring Program [Member]	'	'	'		'		'
Segment Reporting Information [Line Items]	'	'	'		'		'
2012 Restructuring Program	'	'	371		89		'
Operating Segments [Member] | Oral, Personal and Home Care [Member]	'	'	'		'		'
Segment Reporting Information [Line Items]	'	'	'		'		'
Total Net sales	'	'	15,209		14,925		14,562
Total Operating profit	'	'	4,083		3,897		3,727
Total Capital expenditures	'	'	497		455		431
Total Depreciation and amortization	'	'	312		307		309
Total Identifiable assets	'	'	12,723		12,263		11,548
Operating Segments [Member] | Pet Nutrition [Member]	'	'	'		'		'
Segment Reporting Information [Line Items]	'	'	'		'		'
Total Net sales	'	'	2,211	[2]	2,160	[2]	2,172	[2]
Total Operating profit	'	'	563		589		560
Total Capital expenditures	'	'	45		37		32
Total Depreciation and amortization	'	'	51		50		51
Total Identifiable assets	'	'	1,087		1,045		1,078
Operating Segments [Member] | North America [Member] | Oral, Personal and Home Care [Member]	'	'	'		'		'
Segment Reporting Information [Line Items]	'	'	'		'		'
Total Net sales	'	'	3,072	[3]	2,971	[3]	2,878	[3]
Total Operating profit	'	'	927		810		768
Total Capital expenditures	'	'	54		43		53
Total Depreciation and amortization	'	'	51		50		56
Total Identifiable assets	'	'	2,301		2,157		2,247
Operating Segments [Member] | Latin America [Member] | Oral, Personal and Home Care [Member]	'	'	'		'		'
Segment Reporting Information [Line Items]	'	'	'		'		'
Total Net sales	'	'	5,012		5,032		4,895
Total Operating profit	'	'	1,385		1,454		1,437
Total Capital expenditures	'	'	235		237		195
Total Depreciation and amortization	'	'	93		91		92
Total Identifiable assets	'	'	4,122		4,288		3,677
Operating Segments [Member] | Europe/South Pacific [Member] | Oral, Personal and Home Care [Member]	'	'	'		'		'
Segment Reporting Information [Line Items]	'	'	'		'		'
Total Net sales	'	'	3,396		3,417		3,508
Total Operating profit	'	'	805		747		715
Total Capital expenditures	'	'	74		71		64
Total Depreciation and amortization	'	'	85		85		82
Total Identifiable assets	'	'	3,949		3,649		3,555
Operating Segments [Member] | Asia [Member] | Oral, Personal and Home Care [Member]	'	'	'		'		'
Segment Reporting Information [Line Items]	'	'	'		'		'
Total Net sales	'	'	2,472		2,264		2,074
Total Operating profit	'	'	698		619		565
Total Capital expenditures	'	'	123		88		103
Total Depreciation and amortization	'	'	72		70		67
Total Identifiable assets	'	'	1,794		1,608		1,548
Operating Segments [Member] | Africa/Eurasia [Member] | Oral, Personal and Home Care [Member]	'	'	'		'		'
Segment Reporting Information [Line Items]	'	'	'		'		'
Total Net sales	'	'	1,257		1,241		1,207
Total Operating profit	'	'	268		267		242
Total Capital expenditures	'	'	11		16		16
Total Depreciation and amortization	'	'	11		11		12
Total Identifiable assets	'	'	557		561		521
Corporate, Non-Segment [Member]	'	'	'		'		'
Segment Reporting Information [Line Items]	'	'	'		'		'
Total Operating profit	'	'	-1,090		-597		-446
Total Capital expenditures	'	'	128		73		74
Total Depreciation and amortization	'	'	76		68		61
Total Identifiable assets	'	'	$66	[4]	$86	[4]	$98	[4]
[1]	Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $8,248, $8,066 and $7,926 in 2013, 2012 and 2011, respectively.
[2]	Net sales in the U.S. for Pet Nutrition were $1,116, $1,052 and $1,032 in 2013, 2012 and 2011, respectively.
[3]	Net sales in the U.S. for Oral, Personal and Home Care were $2,771, $2,669 and $2,567 in 2013, 2012 and 2011, respectively.
[4]	In 2013, Corporate identifiable assets primarily consist of derivative instruments (32%) and investments in equity securities (41%). In 2012, Corporate identifiable assets primarily consist of derivative instruments (67%) and investments in equity securities (28%). In 2011, Corporate identifiable assets primarily consist of derivative instruments (73%) and investments in equity securities (22%).

Supplemental_Income_Statement_2

Supplemental Income Statement Information (Details) (USD $)	3 Months Ended		12 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2013	Sep. 30, 2011	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Other (income) expense, net	'	'	'	'	'
Amortization of intangible assets	'	'	$32	$31	$28
2012 Restructuring Program	'	'	202	81	0
Venezuela devaluation charge	172	'	172	0	0
Charge for French Competition Law Matter related to the Home Care and Personal Care sectors	'	'	23	0	'
Charge for French Competition Law Matter Related to a Divested Detergent Business	'	'	'	'	21
Costs related to the sale of land in Mexico	'	'	3	0	13
Business realignment and other cost-saving initiatives	'	'	0	2	136
Gain on sales of non-core product lines	'	-207	0	0	-207
Sanex acquisition transaction costs	'	'	0	0	12
Equity (income)	'	'	-5	-7	-6
Other, net	'	'	-5	6	-6
Total Other (income) expense, net	'	'	422	113	-9
Interest (income) expense, net	'	'	'	'	'
Interest incurred	'	'	119	81	59
Interest Costs Capitalized Adjustment	'	'	-3	-1	-1
Interest income	'	'	-125	-65	-6
Total Interest (income) expense, net	'	'	-9	15	52
Research and development	'	'	267	259	262
Advertising	'	'	1,891	1,792	1,734
Two Thousand Twelve Restructuring Program [Member]	'	'	'	'	'
Other (income) expense, net	'	'	'	'	'
2012 Restructuring Program	'	'	$371	$89	'

Supplemental_Balance_Sheet_Inf2

Supplemental Balance Sheet Information (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Inventory, Net [Abstract]	'	'
Raw materials and supplies	$340	$362
Work-in-process	60	81
Finished goods	1,025	922
Total Inventories	1,425	1,365
LIFO Inventory Amount	289	268
Excess of Replacement or Current Costs over Stated LIFO Value	37	37
Property, Plant and Equipment [Abstract]	'	'
Land	254	251
Buildings	1,625	1,439
Manufacturing machinery and equipment	5,220	4,987
Other equipment	1,231	1,144
Property, plant and equipment, gross	8,330	7,821
Accumulated depreciation	-4,247	-3,979
Total Property, plant and equipment, net	4,083	3,842
Other liabilities	'	'
Pension and other retiree benefits	1,387	1,786
Restructuring Reserve, Noncurrent	16	0
Other	274	263
Total Other liabilities	$1,677	$2,049

Supplemental_Balance_Sheet_Inf3

Supplemental Balance Sheet Information Supplemental Other Accruals (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Other Accrued Liabilities [Abstract]	'	'
Accrued advertising and coupon redemption	$676	$646
Accrued payroll and employee benefits	361	345
Accrued taxes other than income taxes	22	48
Restructuring Reserve, Current	142	89
Pension and other retiree benefits	94	86
Accrued interest	27	26
Derivative Liability, Current	11	10
Other	647	638
Total Other accruals	$1,980	$1,888

Supplemental_Comprehensive_Inc2

Supplemental Comprehensive Income Information (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Other Comprehensive Income (Loss), Net of Tax [Abstract]	'		'		'
Cumulative translation adjustments, before-tax	($188)		$18		($291)
Cumulative translation adjustment, net-of-tax	-163		-20		-298
Pension and other benefits:	'		'		'
Net actuarial loss & prior service costs arising during the period, before-tax	295		-317		-249
Net actuarial loss & prior service costs arising during the period, net-of-tax	189		-207		-163
Amortization of net actuarial loss, transition & prior service costs, before-tax	111	[1]	101	[1]	85	[1]
Amortization of net actuarial loss, transition & prior service costs, net-of-tax	70	[1]	62	[1]	55	[1]
Curtailment Loss Unamortized Prior Service Costs, before tax	91		0		0
Curtailment Loss Unamortized Prior Service Costs, net-of-tax	59		0		0
Retirement Plan and other retiree benefit adjustments, before-tax	497		-216		-164
Retirement Plan and other retiree benefit adjustments, net-of-tax	318		-145		-108
Available-for-sale securities:	'		'		'
Unrealized gains (losses) on available-for-sale securities, before-tax	-113		28		60
Unrealized gains (losses) on available-for-sale securities, net-of-tax	-73		18		46
Reclassification of (gains) losses into net earnings on available-for-sale securities, before-tax	133	[2]	0	[2]	0	[2]
Reclassification of (gains) losses into net earnings on available-for-sale securities, net-of-tax	86	[2]	0	[2]	0	[2]
Gains (losses) on available-for-sale securities, before-tax	20		28		60
Gains (losses) on available-for-sale securities, net-of-tax	13		18		46
Cash flow hedges:	'		'		'
Unrealized gains (losses) on cash flow hedges, before-tax	20		13		-10
Unrealized gains (losses) on cash flow hedges, net-of-tax	13		8		-7
Reclassification of (gains) losses into net earnings on cash flow hedges, before-tax	-17	[3]	-11	[3]	9	[3]
Reclassification of (gains) losses into net earnings on cash flow hedges, net of tax	-11	[3]	-7	[3]	7	[3]
Gains (losses) on cash flow hedges, before-tax	3		2		-1
Gains (losses) on cash flow hedges, net-of-tax	2		1		0
Total Other comprehensive income, before-tax	332		-168		-396
Total Other comprehensive income, net-of-tax	$170		($146)		($360)
[1]	These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.
[2]	Represents the one-time loss related to the remeasurement of the fixed interest rate bonds in Venezuela, which was recorded in Other (income) expense, net. See Note 7, Fair Value Measurements and Financial Instruments for additional details.
[3]	These (gains) losses are reclassified into Cost of sales. See Note 7, Fair Value Measurements and Financial Instruments for additional details.

Supplemental_Comprehensive_Inc3

Supplemental Comprehensive Income Information (Details 1) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Other Comprehensive Income (Loss), Net of Tax [Abstract]	'	'
Unrecognized pension and other retiree benefit costs, aftertax	$735	$1,053
Foreign currency translation adjustments	$1,772	$1,609

Quarterly_Financial_Data_Unaud2

Quarterly Financial Data (Unaudited) (Details) (USD $)

3 Months Ended

12 Months Ended

In Millions, except Per Share data, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Quarterly financial data (Unaudited) [Abstract]

'

'

'

'

'

'

'

'

'

'

'

Pretax charges related to the 2012 Restructuring Program

'

'

'

'

'

'

'

'

$202

$81

$0

Pretax costs related to sale of land

'

'

'

'

'

'

'

'

3

0

13

Aftertax Venezuela Devaluation Charge

'

'

'

111

'

'

'

'

111

'

'

Charge for French Competition Law Matter Related to the Home Care and Personal Care Sectors

5

'

18

'

'

'

'

'

23

'

'

Costs after tax associated with various Business Realignment and other cost-saving initiatives

'

'

'

'

'

2

9

3

'

14

'

Net sales

4,361

4,398

4,346

4,315

4,286

4,332

4,267

4,200

17,420

17,085

16,734

Gross profit

2,567

[1]

2,585

[2]

2,534

[3]

2,515

[4]

2,505

[5]

2,529

[6]

2,461

[7]

2,437

[8]

10,201

[9]

9,932

[10]

9,590

Net income including noncontrolling interests

601

[11]

699

[12]

604

[13]

506

[14]

636

[15]

697

[16]

665

[17]

633

[18]

2,410

[19]

2,631

[20]

2,554

Net income attributable to Colgate-Palmolive Company

564

[11]

656

[12]

561

[13]

460

[14]

598

[15]

654

[16]

627

[17]

593

[18]

2,241

[19]

2,472

[20]

2,431

Earnings per common share:

'

'

'

'

'

'

'

'

'

'

'

Basic EPS (in dollars per share)

$0.61

[11]

$0.71

[12]

$0.60

[13]

$0.49

[14]

$0.63

[15]

$0.69

[16]

$0.66

[17]

$0.62

[18]

$2.41

[19]

$2.60

[20]

$2.49

Diluted EPS (in dollars per share)

$0.60

[11]

$0.70

[12]

$0.60

[13]

$0.48

[14]

$0.63

[15]

$0.68

[16]

$0.65

[17]

$0.61

[18]

$2.38

[19]

$2.57

[20]

$2.47

MEXICO

'

'

'

'

'

'

'

'

'

'

'

Quarterly financial data (Unaudited) [Abstract]

'

'

'

'

'

'

'

'

'

'

'

Pretax costs related to sale of land

'

'

'

'

'

'

'

'

18

24

13

Aftertax costs related to sale of land

3

2

4

3

3

5

5

5

12

18

9

Two Thousand Twelve Restructuring Program [Member]

'

'

'

'

'

'

'

'

'

'

'

Quarterly financial data (Unaudited) [Abstract]

'

'

'

'

'

'

'

'

'

'

'

Pretax charges related to the 2012 Restructuring Program

'

'

'

'

'

'

'

'

371

89

'

Aftertax charges related to the 2012 Restructuring Program

125

22

79

52

70

'

'

'

278

70

'

Gross Profit [Member] | Two Thousand Twelve Restructuring Program [Member]

'

'

'

'

'

'

'

'

'

'

'

Quarterly financial data (Unaudited) [Abstract]

'

'

'

'

'

'

'

'

'

'

'

Pretax charges related to the 2012 Restructuring Program

6

8

10

8

2

'

'

'

32

2

'

Cost of Sales [Member]

'

'

'

'

'

'

'

'

'

'

'

Quarterly financial data (Unaudited) [Abstract]

'

'

'

'

'

'

'

'

'

'

'

Costs before tax associated with various Business Realignment and other cost-saving initiatives

'

'

'

'

'

1

2

2

'

5

'

Cost of Sales [Member] | MEXICO

'

'

'

'

'

'

'

'

'

'

'

Quarterly financial data (Unaudited) [Abstract]

'

'

'

'

'

'

'

'

'

'

'

Pretax costs related to sale of land

$4

$3

$4

$4

$4

$7

$6

$7

$15

$24

'

[1]

Gross profit for the fourth quarter of 2013 includes $6 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.

[2]

Gross profit for the third quarter of 2013 includes $8 of charges related to the 2012 Restructuring Program and $3 of costs related to the sale of land in Mexico.

[3]

Gross profit for the second quarter of 2013 includes $10 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.

[4]

Gross profit for the first quarter of 2013 includes $8 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.

[5]

Gross profit for the fourth quarter of 2012 includes $2 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.

[6]

Gross profit for the third quarter of 2012 includes $7 of costs related to the sale of land in Mexico and $1 of costs associated with various business realignment and other cost-saving initiatives.

[7]

Gross profit for the second quarter of 2012 includes $6 of costs related to the sale of land in Mexico and $2 of costs associated with various business realignment and other cost-saving initiatives.

[8]

Gross profit for the first quarter of 2012 includes $7 of costs related to the sale of land in Mexico and $2 of costs associated with various business realignment and other cost-saving initiatives.

[9]

Gross profit for the full year of 2013 includes $32 of charges related to the 2012 Restructuring Program and $15 of costs related to the sale of land in Mexico.

[10]

Gross profit for the full year of 2012 includes $2 of charges related to the 2012 Restructuring Program, $24 of costs related to the sale of land in Mexico and $5 of costs associated with various business realignment and other cost-saving initiatives.

[11]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the fourth quarter of 2013 include $125 of aftertax charges related to the 2012 Restructuring Program, a $5 charge for a competition law matter in France related to the home care and personal care sectors and $3 of aftertax costs related to the sale of land in Mexico.

[12]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the third quarter of 2013 include $22 of aftertax charges related to the 2012 Restructuring Program and $2 of aftertax costs related to the sale of land in Mexico.

[13]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the second quarter of 2013 include $79 of aftertax charges related to the 2012 Restructuring Program, an $18 charge for a competition law matter in France related to the home care and personal care sectors and $4 of aftertax costs related to the sale of land in Mexico.

[14]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the first quarter of 2013 include $52 of aftertax charges related to the 2012 Restructuring Program, a $111 one-time aftertax charge for the impact of the devaluation in Venezuela and $3 of aftertax costs related to the sale of land in Mexico.

[15]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the fourth quarter of 2012 include $70 of aftertax charges related to the 2012 Restructuring Program and $3 of aftertax costs related to the sale of land in Mexico.

[16]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the third quarter of 2012 include $5 of aftertax costs related to the sale of land in Mexico and $2 of aftertax costs associated with various business realignment and other cost-saving initiatives.

[17]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the second quarter of 2012 include $5 of aftertax costs related to the sale of land in Mexico and $9 of aftertax costs associated with various business realignment and other cost-saving initiatives.

[18]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the first quarter of 2012 include $5 of aftertax costs related to the sale of land in Mexico and $3 of aftertax costs associated with various business realignment and other cost-saving initiatives.

[19]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2013 include $278 of aftertax charges related to the 2012 Restructuring Program, a $111 one-time aftertax charge for the impact of the devaluation in Venezuela, a $23 charge for a competition law matter in France related to the home care and personal care sectors and $12 of aftertax costs related to the sale of land in Mexico.

[20]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2012 include $70 of aftertax charges related to the 2012 Restructuring Program, $18 of aftertax costs related to the sale of land in Mexico and $14 of aftertax costs associated with various business realignment and other cost-saving initiatives.

Schedule_II_Valuation_and_Qual1

Schedule II - Valuation and Qualifying Accounts (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Allowance for doubtful accounts and estimated returns	'	'	'
Movement in Valuation Allowances and Reserves [Roll Forward]	'	'	'
Valuation Allowances and Reserves, Beginning Balance	$61	$49	$53
Valuation Allowances and Reserves, Charged to Cost and Expense	15	18	6
Valuation Allowances and Reserves, Charged to Other Accounts	0	0	0
Valuation Allowances and Reserves, Deductions	9	6	10
Valuation Allowances and Reserves, Ending Balance	67	61	49
Valuation allowance for deferred tax assets	'	'	'
Movement in Valuation Allowances and Reserves [Roll Forward]	'	'	'
Valuation Allowances and Reserves, Beginning Balance	1	1	1
Valuation Allowances and Reserves, Charged to Cost and Expense	6	0	0
Valuation Allowances and Reserves, Charged to Other Accounts	0	0	0
Valuation Allowances and Reserves, Deductions	-1	0	0
Valuation Allowances and Reserves, Ending Balance	$6	$1	$1